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M2Objectives: To look at the processes and outcomes of
identification and prioritisation in both national and
regional R&D programmes in health and elsewhere,
drawing on experiences of success and failure. Also to
identify the barriers to, and facilitators of, meaningful
participation by consumers in research identification
and prioritisation.
Data sources: Electronic databases and interviews
with UK consumers and research programme
managers. 
Review methods: A framework was devised for
examining the diverse ways of involving consumers in
research. It identified key distinguishing features as: the
types of consumers involved; whether consumers or
researchers initiated the involvement; the degree of
consumer involvement (consultation, collaboration or
consumer control); forums for communication (e.g.
committees, surveys, focus groups); methods for
decision-making; and the practicalities for
implementation. Context (institutional, geographical
and historical setting) and underpinning theories were
considered as important variables for analysing
examples of consumer involvement. This innovative
framework was then applied to the review data from
reports selected for inclusion and interviews.
Results: The study found 286 documents explicitly
mentioning consumer involvement in identifying or
prioritising research topics. Of these, 91 were general
discussions, some of which included a theoretical
analysis or a critique of research agendas from a
consumer perspective, 160 reported specific efforts to
include consumers in identifying or prioritising research
topics and a further 51 reported consumers identifying
or prioritising research topics in the course of other
work. Detailed reports of 87 specific examples were
identified. Most of this literature was descriptive
reports by researchers who were key actors in
involving consumers. A few reports were written by
consumer participants. Fewer still were by independent
researchers. Our conclusions are therefore not based
on rigorous research, but implications for policy are
drawn from individual reports and comparative
analyses. 
Conclusions: Productive methods for involving
consumers require appropriate skills, resources and
time to develop and follow appropriate working
practices. The more that consumers are involved in
determining how this is to be done, the more research
programmes will learn from consumers and about 
how to work with them. Further success might be
expected if research programmes embarking on
collaborations approach well-networked consumers
and provide them with information, resources and
support to empower them in key roles for consulting
their peers and prioritising topics. To be worthwhile,
consultations should engage consumer groups directly
and repeatedly in facilitated debate; when discussing
health services research, more resources and time are
required if consumers are drawn from groups 
whose main focus of interest is not health. These
barriers can largely be overcome with good leadership,
purposeful outreach to consumers, investing time and
effort in good communication, training and support and
thereby building good working relationships and
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Abstract
Involving consumers in research and development agenda
setting for the NHS: developing an evidence-based approach
S Oliver,1* L Clarke-Jones,1 R Rees,1 R Milne,2 P Buchanan,3 J Gabbay,2 G Gyte,4
A Oakley1 and K Stein5
1 Social Science Research Unit, Institute of Education, London, UK
2 Wessex Institute for Health Research and Development, University of Southampton, UK
3 The Breastfeeding Network, Paisley, UK
4 The National Childbirth Trust, London, UK
5 Peninsula Technology Assessment Group, Peninsula Medical School, Universities of Exeter and Plymouth, Exeter, UK
* Corresponding authorbuilding on experience. Organised consumer groups
capable of identifying research priorities also need to
find ways of introducing their ideas into research
programmes. Further research is suggested to develop
and evaluate different training methods, information
and education and other support for consumers and
those wishing to involve them; to address the barriers
to consumers’ ideas influencing research agendas; 
and to carry out prospective comparative studies of
different methods for involving consumers. Research
about collective decision-making would also be 
further advanced by addressing the processes and
outcomes of consensus development that involves
consumers.
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ContentsGlossary
Bioethics The study of ethical, social, legal,
philosophical and other related issues arising
in healthcare and in the biological sciences.
Collaboration Active, on-going partnership.
For example, partnership with consumers has
included committee membership or less formal
collaboration to complete a task, as in
teamworking.
Community development The process of
involving a community in the identification
and reinforcement of the aspects of everyday
life, culture and political activity that are
conducive to health. This might include
support for political action to modify the total
environment and strengthen resources for
healthy living, and also reinforcing social
networks and social support within a
community and developing the material
resources available to the community.
Consultation As a method of involving
consumers, asking consumers for their views
and using these views to inform decision-
making.
Consumers Users and potential users of
services, products and resources (including
natural resources). In health this includes
patients and potential patients; long-term users
of services; carers and parents; organisations
that represent consumers’ interests; members
of the public who are the targets of health
promotion programmes; and groups asking for
research because they believe they have been
exposed to potentially harmful circumstances,
products or services. Depending on the
context, consumers may also be described with
any of the following terms: ‘lay’, ‘non-expert’, 
‘service user’, ‘survivor’ or ‘member of the
general public’.
Descriptive reports (or descriptions) Formal
descriptions or reflections of, in this case,
consumer involvement or of research
management (including agenda setting).
Empowerment in research Changes
conventional research relations from inequality
between active, dominant researchers and
passive, subordinate research subjects to more
equal relations between the two, and increased
inclusion and involvement; the degree to which
consumers are empowered to influence
research may be evident in the source of the
original research topics, the potential benefits
and subsequent spread and use of research
findings, the background and accountability of
the researcher and the control of the research
design, conduct and funding.
Evaluations More than descriptions and
reflections, in that they present clearly and
systematically their methods of investigation
and the results of the evaluation.
Involvement Any form of participation in the
making of decisions, at whatever stage or level,
from consultation at the end of the decision-
making process to joint working throughout
the entire decision-making process.
Learning organisation One in which people
continually expand their capacity to achieve their
objectives, where new and expansive patterns
of thinking are nurtured and where people are
continually learning how to learn together.
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Glossary, list of abbreviations, and key
Technical terms and abbreviations are used throughout this report. The meaning is usually clear
from the context, but a glossary is provided for the non-specialist reader. In some cases, usage
differs in the literature, but the term has a constant meaning throughout this review.
continuedGlossary, list of abbreviations, and key
viii
Glossary continued
Organisational change Purposeful and
reflective management of change within an
organisation.
Participative research, participatory research,
action research and participatory action
research Include collaboration, education and
action. Such research stresses the relationship
between researcher and community, with the
direct benefit to the community as an outcome
of the research and the community’s
involvement as itself beneficial.
Research and development agenda setting
Identifying and prioritising topics suitable for
research and development.
Research management All stages from
identification and prioritisation of research
topics to conducting research and reporting
and implementing the findings (e.g. evidence-
based guideline development and evidence-
based audit).
Consumer-controlled research Consumers
designing, undertaking and disseminating the
results of a research project.
List of abbreviations
HEA Health Education Authority (now
Health Development Agency)
IDDT Insulin Dependent Diabetes Trust
NBCC  National Breast Cancer Coalition
(USA)
NCCHTA National Coordinating Centre for
Health Technology Assessment
NCT National Childbirth Trust
NEAT New and Emerging Applications
for Technology
NIH National Institutes of Health (USA)
NIOSH National Institute for Occupational
Safety and Health (USA)
NPEU National Perinatal Epidemiology
Unit
PCD physical and complex disabilities
PORT Patient Outcomes Research Team
(USA)
R&D research and development
RADAR Society for Research in
Rehabilitation
RAGE Radiotherapy Action Group
Exposure
SDO service, delivery and organisation
All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or 
it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices in which case 
the abbreviation is defined in the figure legend or at the end of the table.
Key
Report written by non-participant
observer
Report written by consumers
Report written by researchers
UK Episode of involvement based in
the UK
Episode of involvement based
elsewhereHealth Technology Assessment 2004; Vol. 8: No. 15
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Background
This is the first systematic study of consumer
involvement in identifying and prioritising
possible topics for research and development.
Objectives
The objectives of the study were to:
1. look at the processes and outcomes of
identification and prioritisation in both
national and regional R&D programmes in
health and elsewhere, drawing on experiences
of success and failure
2. identify the barriers to, and facilitators of,
meaningful participation by consumers in the
research identification and prioritisation.
Framework for examining
consumer involvement
We devised a framework for examining the diverse
ways of involving consumers in research. It
identified key distinguishing features as: the types
of consumers involved; whether consumers or
researchers initiated the involvement; the degree
of consumer involvement (consultation,
collaboration or consumer control); forums for
communication (e.g. committees, surveys, focus
groups); methods for decision-making; and the
practicalities for implementation. We considered
context (institutional, geographical and historical
setting) and underpinning theories as important
variables for analysing examples of consumer
involvement.
We translated the principles for minimising bias
and maximising transparency to reviewing a body
of literature that is largely descriptive or reflective
rather than based on systematic research methods.
We assumed, conventionally, that well-conducted
research studies would be less biased and more
reliable. In order to draw on other reports where
necessary, we assumed that reports where
consumers shared authorship with researchers
would be less biased, that reports originating in
the UK would be more relevant and that findings
supported by more reports or by reports
originating from both the UK and elsewhere
would be more generalisable.
Methods
We systematically sought literature through
databases, handsearching and citation tracking,
and also through people in the UK who were 
(a) known to have worked to identify or prioritise
health research topics or (b) recognised consumer
specialists or advocates.
We included reports if they explicitly mentioned
consumer involvement in identifying or
prioritising research topics. We also interviewed
consumers and research programme managers
from some UK examples. We applied the
innovative framework to review data from
interviews and reports.
Results
We found 286 documents explicitly mentioning
consumer involvement in identifying or
prioritising research topics. Of these, 91 were
general discussions, some of which included a
theoretical analysis or a critique of research
agendas from a consumer perspective,
160 reported specific efforts to include consumers
in identifying or prioritising research topics and a
further 51 reported consumers identifying or
prioritising research topics in the course of other
work. We found detailed reports of 87 specific
examples. These included:
  inviting consumer groups to collaborate in
setting research agendas (13)
  consulting consumer groups (12)
  inviting individual consumers to collaborate in
identifying and/or prioritising research topics
(17)
  consulting individual consumers (13)
  responding to consumer action with a
collaboration (13)
  responding to consumer action by consulting
with consumers (3)
Executive summaryx
  responding to consumer action by conducting
research without consumer input (6)
  consumers independently identifying or
prioritising research topics (10).
Most of this literature was descriptive reports by
researchers who were key actors in involving
consumers. A few reports were written by
consumer participants. Fewer still were by
independent researchers. Our conclusions are
therefore not based on rigorous research, but
implications for policy are drawn from individual
reports and comparative analyses. 
Conclusions
Research programmes have sufficient collective
experience of involving consumers to plan their
agendas working directly or indirectly with
consumers. Appropriate methods depend upon
the tasks to be undertaken, the consumers to be
involved and the support required. Productive
methods for involving consumers require
appropriate skills, resources and time to develop
and follow appropriate working practices. The
more that consumers are involved in determining
how this is to be done, the more research
programmes will learn from consumers and about
how to work with them.
More success might be expected if research
programmes embarking on collaborations
approach well-networked consumers and provide
them with information, resources and support to
empower them in key roles for consulting their
peers and prioritising topics. To be worthwhile,
consultations should engage consumer groups
directly and repeatedly in facilitated debate; when
discussing health services research, more resources
and time are required if consumers are drawn
from groups whose main focus of interest is not
health.
Barriers to consumer involvement include: poor
representation of consumers; consumers’
unfamiliarity with research and research
programmes’ unfamiliarity with consumers;
negative attitudes and poor working relationships;
difficulties in communication; and time
constraints. These barriers can largely be
overcome with good leadership, purposeful
outreach to consumers, investing time and effort
in good communication, training and support and
thereby building good working relationships and
building on experience.
Organised consumer groups capable of identifying
research priorities need to find ways of
introducing their ideas into research programmes.
They should be aware that consumers making
efforts to (re)design structures and procedures
have had greater influence over research 
agendas. Consumers are particularly well 
placed to reflect on their experience of research
agenda setting in order to build the evidence
about their priorities and methods for involving
them.
Recommendations for research
The following areas are recommended for further
research.
  Research to develop and evaluate different
training methods, information and education
and other support for consumers and those
wishing to involve them.
  Research to address the barriers to consumers’
ideas influencing research agendas. 
  It is suggested that research programmes
embarking on working with consumers do so
with a view to learning more about these
processes using an ethos of reflexive research.
At a minimum they should involve consumers
in reflecting on and reporting the process and
outcome. Whenever possible, they should
involve consumers in considering the methods
and implications of working together both in
advance and with hindsight. There is also a
place for independent researchers to work with
research programmes and consumers to
investigate and record working practices.
Consumers should be involved in conducting
and reporting this work.
  We suggest carrying out prospective
comparative studies of different methods for
involving consumers. 
  It is suggested that research about collective
decision-making be further advanced by
addressing the processes and outcomes of
consensus development that involves
consumers.
Executive summaryBackground
Setting research agendas is a specific aspect of
priority setting. Hence, this study focuses on the
intersection of priority setting and consumer
involvement in research and development. Since
1990, priority setting for services in the NHS has
generally become more explicit and has more
commonly involved consumers. Since 1991 this
has also involved the newly established NHS
research and development (R&D) strategy.
Priority setting in NHS research
Traditionally, setting priorities for healthcare has
been implicit in the decisions made by clinicians
for their patients. In the UK, more formal and
explicit methods were called for with the
introduction of the internal market in 1991. This
required purchasers of healthcare to act on behalf
of the populations they served: taxpayers and
patients. Justifying their decisions required
developing explicit methods for priority setting.
Similarly, priorities for research were set in an
uncoordinated fashion by academics and industry.
The launch of the NHS R&D programme, also in
1991, provided a needs-led programme of
commissioned research that counterbalanced the
responsive programmes which relied primarily on
researchers suggesting potential research projects
to funders.1 This was the beginning of a
“systematic approach to identifying and setting
R&D priorities in which NHS staff and the users of
the Service are being asked to identify important
issues which confront them and, in partnership
with the research community, to characterise and
prioritise these problems as the basis for seeking
solutions”2 [emphasis added]. This approach has
evolved through a series of agenda-setting
exercises by multidisciplinary advisory groups,
some of which have involved consumers.
Consumer involvement in health
services research
The NHS R&D strategy is committed to involving
consumers in the work it undertakes – not as
‘subjects’ of research, but as active participants.
The Central Research and Development
Committee (which advises the Director of R&D)
set up a unique group to advise them on how best
to involve consumers in the R&D process. This
group, which met for the first time in 1996, at the
time of the study was called Consumers in NHS
Research (it is now known as INVOLVE). It aims to
ensure that consumer involvement in R&D in the
NHS, public health and social care improves the
way in which research is prioritised,
commissioned, undertaken and disseminated.
Consumers may be involved in research because
the NHS is politically mandated to involve those
most intimately affected (the users of health
services) and those who provide the funds, either
directly or through taxes or insurance. They may
also be involved because their experience and
insights can complement those of health
professionals and researchers, so that collectively
these people can produce ‘better’ research. ‘Better’
research may be research that: has a higher
methodological or ethical quality; produces
findings which are more relevant to practical
decisions made by consumers and those caring for
them; is presented in more accessible and widely
disseminated reports; or more appropriately
influences policy and practice.
Consumer involvement in identifying and
prioritising research topics should be considered in
the context of the increasing involvement of
consumers in making decisions about their own
personal healthcare and about the development
and delivery of services. Pressure for this increasing
involvement comes from individual patients and
service users, their families and carers, and from
organised groups of such people.3 Between them,
these individuals and groups challenge the
professionally dominated social structure of
healthcare. They challenge indirectly, by using and
developing alternative services within the voluntary
or commercial sectors, and directly, by calling for
change in established/statutory services, during
clinical encounters, through complaints procedures
and by campaigning.
With policy support for consumer involvement in
research, and guidelines prepared on the basis of
the pooled experience of consumers, academics
and NHS staff by the Consumers in NHS Research
group,4 there is increasing interest and activity in
this area. This was reflected in a special issue of
Health Technology Assessment 2004; Vol. 8: No. 15
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Chapter 1
Introductionthe BMJ in September 1999. The articles in this
issue illustrated the extent of consumer
involvement in health. They included opinion
articles about consumer involvement in health
services, research articles about patient
involvement in shared decision-making in clinical
settings and an interpretative review about
participative research. However, there were no
details about methods for involving consumers in
identifying or prioritising research topics.
Research questions
This study aimed to review such literature as there
is on consumer involvement in setting research
agendas, to cover the health research field but also
going beyond it. The review was required to
record what methods have been attempted, for
what purpose, how they have been evaluated and
what can be learnt from their documentation
and/or their evaluation.
Options for drawing on related literature beyond
the immediate focus of the review included
literature about: consumer involvement in
evidence-based health decisions generally;
consumer involvement in research apart from
agenda setting; priority setting in health services;
and research agenda setting in other sectors. The
relevance and usefulness of each of these
literatures was considered before defining the
scope of the review, as described below.
The literature is most advanced for consumer
involvement in evidence-based decision-making
for personal healthcare, where there are well-
established methods for consumer involvement
and its evaluation5 and a growing collection of
systematic reviews of impact.6 Other appraised
and synthesised literature addresses eliciting
public preferences, but not involvement in service
decisions;7 consensus development for clinical
guidelines, but not involvement of consumers;8
and priority setting for health services.9 Despite
their convenience, these publications were
dismissed for being insufficiently relevant to
consumer involvement in agenda setting which
requires engagement with:
  organisational decision-making
  research methods
  gaps in knowledge, which is conceptually more
challenging than engaging with gaps in services.
The literature about consumer involvement in
research more broadly (i.e. not restricted to
research agenda setting) is extensive. It includes
numerous reports of individual initiatives and
traditional reviews, but no conveniently appraised
and systematically synthesised summary or a
widely agreed characterisation of the diverse
methods for consumer involvement or their
evaluation. This literature was therefore dismissed
for being potentially overwhelming and in need of
a systematic review independent of this project.
Ultimately, it was decided that the nature of
research agenda setting set it apart from these
other activities and their literature, that the act of
prioritising gaps in knowledge, along with the
technical nature of that knowledge, distinguished
it from involvement in service provision decision-
making and in other aspects of research.
There were therefore no restrictions applied in
terms of the health sector, or other sectors, and
the review’s scope was therefore broadened to
encompass research agenda setting in other
sectors in order to answer the research 
question:
  What are the advantages and disadvantages of
different methods of involving consumers in
identifying and prioritising possible topics for
R&D?
The objectives of the study were to:
1. look at the processes and outcomes of
research identification and prioritisation in
both national and regional R&D
programmes in health and elsewhere,
drawing on experiences of success and
failure
2. identify the barriers to, and facilitators of,
meaningful participation by consumers in
research identification and prioritisation.
In order to address these research questions, we
brought together a research team of nine people
including two consumers. In addition to formal
roles in consumer organisations, academia and
public health, as authors of this report we 
brought direct experience as consumers and
researchers involved in research agenda setting.
We subscribe to the belief that research agendas
should reflect the needs and values of the 
people who use and pay for health services, and
that this is unlikely to be achieved without 
directly involving some of these people. Our
experience of consumer involvement in research
has introduced us to many challenges and a few
successes, but it has not led us to conclude that
particular methods are reliably beneficial whatever
the context. 
Introduction
2T
his chapter proposes a framework for
examining consumer involvement in research.
It provides definitions for key concepts to help
further define the scope of this review. It identifies
key distinguishing features of different methods of
consumer involvement and structures these into a
framework for describing and analysing reports of
specific episodes of consumer involvement. It
finishes by discussing the applicability of
principles for minimising bias and maximising
transparency to reviewing a body of literature that
is largely descriptive or reflective rather than
based on systematic research methods.
Definitions
Consumers
The Consumers in NHS Research group
recommended the following definition of
consumers of healthcare. Consumers include
patients and potential patients; long-term users of
services; carers and parents; organisations that
represent consumers’ interests; members of the
public who are the targets of health promotion
programmes; and groups asking for research
because they believe they have been exposed to
potentially harmful circumstances, products or
services.4 In order to draw on other sectors 
(e.g. commercial and agricultural), we have
extended this definition to include users and
potential users of resources, including natural
resources.
Research agenda setting
Research agenda setting includes both identifying
and prioritising research topics. Although there
are formal methods for both activities, reports of
other activities such as collaborative service
planning or environmental campaigning reveal
examples of consumers identifying research topics
in the course of those debates. For instance, gaps
in evidence may be identified opportunistically
when planning services, although they may not
necessarily be captured in a useful way to inform a
research agenda. We labelled this as opportunistic
agenda setting, as opposed to purposeful agenda
setting.
There is a similar distinction in prioritising
research topics. Prioritising research topics may be
purposeful in a formal agenda setting exercise,
particularly for commissioned research
programmes. Alternatively, prioritisation may be
an amalgamation of researchers’ priorities and the
responses of peer referees and funding panels, as
is more common where funders respond to
unsolicited proposals from researchers (responsive
programmes). Lastly, consumers may identify
principles for prioritising topics, without
necessarily being involved directly in
prioritisation. We have included all these activities
in the scope of our review as they are all aspects of
research agenda setting.
Consumer involvement
Consumers involved in research have traditionally
been given the role of research ‘subject’. An
alternative role requires more active involvement
in guiding the research rather than merely
providing data. In this review, our interest is in
consumers providing their views in order to
influence research. We have included reports of
purposeful agenda setting where consumers have
been actively involved, where they have consulted
or where they have been involved indirectly
through other activities (such as asking questions
in Parliament or to helplines). We have also
included reports of consumers being involved
opportunistically in identifying research topics,
such as women raising research issues in the
course of campaigning for better maternity
services.10 We have not included most of the
research literature where consumers are subjects
and researchers conclude their analyses with
recommendations for further work.
Characteristics of consumer
involvement in research agenda
setting
Describing reports of consumer involvement in
research agenda setting coherently and
consistently was a challenge that we struggled to
overcome throughout the duration of the study.
Consumers have been involved in many types of
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involvement in researchresearch through a diversity of methods. The
names of particular activities appear to label them
without providing a consistent system for
distinguishing them. For instance, the Cochrane
Consumer Network emphasises (with the name of
Cochrane) its central importance of contributing
to systematic reviews, whereas the National Breast
Cancer Coalition of member organisations is
named according to the health condition in which
they share an interest. In contrast, participative
research initiatives11 and community participation
and development often employed in health
promotion12,13 are identified by their underlying
philosophy rather than their specific interests. In
seeking to identify the advantages and
disadvantages of different methods, we needed to
set aside labels of specific examples commonly
and conveniently used in discussions, and describe
methods in terms that would distinguish examples
in meaningful ways.
We sought distinguishing characteristics of
different methods for involving consumers in
research agenda setting from our own experience,
current policy documents, abstracts of relevant
literature, key methodological literature and
related systematic reviews.
We chose as key features for our framework those
characteristics which we assumed would influence
the process and outcome of consumer
involvement: the consumers involved, who
initiated the involvement, the degree of
involvement, the forum for exchanging ideas and
the methods for decision-making. Each of these is
considered below.
Consumers involved
The definition of consumers provided above is
broad. Although there are clearly important
differences between patients, carers and the
broader public, for the purpose of reviewing
methods for involving consumers, we recognise
the most pertinent distinction being between
people involved as individuals and people
involved as members of organised consumer
groups. Members of organised groups are not
typical of the general public. In being a member
of a group they have expressed an active interest
and, potentially, they have access to a broader
range of views than those formed by their own
experience alone. Another overlapping distinction
is between consumers who have volunteered their
involvement (for instance, through their
membership of a group or by responding to an
advertisement) and consumers who have been
targeted for involvement (for instance, through
representative opinion polls). These distinctions
are analogous to distinctions between health
professionals who volunteer to represent their
peers in consultations or formal reviews about
professional practice and experience and those
who have been targeted for their involvement.
Similarly, there is a distinction between health
professionals who express an active interest in
research and those who do not despite current
policy supporting research-based practice. 
Proactive and reactive involvement
Consumer involvement can be an expression of
consumer empowerment. This empowerment can
be initiated in specific encounters between
consumers and professional services by either
party and this affects not only how involvement
has developed, but also how this involvement is
viewed by health professionals and by different
sectors of society.14
Where researchers or research programmes have
taken the initiative, they may be embarking on an
exercise in organisational change where theories
about learning organisations highlight the
importance of inclusion, reflection and managing
diversity.15,16 An alternative theoretical approach is
participatory research, which probably requires the
greatest changes in organisational structures and
procedures and is claimed to maximise community
and lay involvement.17 The three primary features
of participatory research include collaboration,
mutual education and acting on the results
developed from research questions that are
relevant to the community. It therefore embraces
more of the research to service pathway than
merely research agenda setting.
Consumers taking the initiative was part of a
broader collective social action, where campaigns
and self-help groups emerged in response to
health problems to engage in research under their
own initiative. In these circumstances, self-help
groups or other social service or political advocacy
groups act as social movement organisations.3
Degree of involvement
The extent to which consumers can influence
decisions rather than just be aware of them
depends on their degree of involvement. Arnstein
proposed a ‘ladder of participation’ with rungs on
the ladder representing increasing degrees of
participation, from non-participation or
manipulation and therapy, through the tokenism
of informing, consulting and placating to citizen
power through partnership, delegated power and
citizen control.18 She described contrasting
A framework for examining consumer involvement in research
4examples in America of frequent ‘attitude surveys’
in ghetto neighbourhoods where residents see
their time being taken up for no benefit, and
residents elsewhere being delegated and funded
the power to prepare an entire ‘model cities’ plan.
This ladder of participation has been contracted
to three steps by Consumer in NHS Research:
consultation, collaboration and consumer control.4
We anticipated finding examples of consultation,
collaboration and consumer control in research
agenda setting and adopted this terminology for
our framework. 
  Consultation was defined as asking consumers
for their views and using these views to inform
decision-making. For example, funders of
research have held one-off meetings with
consumers to ask them about their priorities for
research, or write to consumers in accessible
terms to invite their views. Consumers’ views
were not necessarily adopted, although they
may inform decisions.
  Collaboration was described as active, on-going
partnership with consumers. For example,
consumers have been committee members or
collaborated less formally to complete a task. 
  Consumer-controlled research was described as
consumers designing, undertaking and
disseminating the results of a research project.
‘Professionals’ were only involved at the
invitation of the consumers.
Consultation, collaboration or consumer control,
defined as above throughout this report, have
been used at different stages of the same projects.
Forum for exchanging ideas
However a working relationship has been
initiated, and whatever the degree of involvement,
there are also many options for the type of forum
for exchanging ideas. The choice of forum will be
determined by the type and range of tasks on
which consumers and others are embarked. A
recent review of public involvement in healthcare
priority setting described how methods for
engaging consumers in collaborations or
consultations have been chosen for different
purposes.9 The authors distinguished qualitative
methods such as one-to-one interviews, focus
groups, Delphi technique and citizens’ juries,
which elicit ideas, from quantitative methods such
as ranking or rating, which set priorities.19
Methods for decision-making
These methods for engaging in a working
relationship can vary further in the way in which
decisions are made. Methods that support
collective decision-making include those for
eliciting values (such as voting, ranking, scoring,
visual scales and Delphi surveys) and those for
aggregating values. A systematic review of
consensus development for clinical guidelines
drew a number of conclusions which might be
applicable to research agenda setting.8 These
conclusions related to selecting the participants,
choosing and preparing background information,
structuring the interaction and synthesising
individual judgements. However, few of the studies
specifically related to consumers.
Implementation
The final details of any methods are the
practicalities of implementation. These can
include planning, resources, coordination and
training. We anticipated, for example, that
dedicated resources or training materials would
lead to greater consumer influence. How methods
are implemented may facilitate or hinder
consumer involvement. For instance, attention to
the facilitation of multidisciplinary groups, as
advised by Consumers in NHS Research, is likely
to affect the extent to which consumers are able to
express their views and be heard.4
Context of consumer involvement in
research
As we became more familiar with the range of
examples of consumer involvement in setting
research agendas, we encountered more contextual
issues, which we considered were likely influences
of how methods developed and how appropriate
or successful they appeared to be. We recognised
contextual issues that were associated with the
consumers and the researchers involved,
particularly the organisational setting of the
players (see Box 1). These included institutional
settings (e.g. academic or commercial research or
self-help or charitable voluntary sector
organisations), geographical settings (e.g. regional,
national, international), and historical settings in
relation to rights movements (e.g. with or without
a legacy of consumer activism).
Theories underpinning consumer
involvement
Similarly, our understanding of the role of theory
in investigating consumer involvement advanced
as we became more familiar with the diversity of
methods and circumstances of consumer
involvement. We recognised (see above) that
different initiators of consumer involvement are
likely to have different motivations and different
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research programmes have employed an
organisational change approach to management
whereas forward-looking consumers have
employed collective social action. A diversity of
theories relate to how consumers are involved (see
Box 2). For instance, a framework of evidence-
informed patient choice invokes attention to
patients’ questions in order to identify research
questions.5 Alternatively, community development
invokes recognising research topics in the course
of working with communities in order to identify
their own health needs and support them in
taking action to address them.12,13 On a broader
scale still, bioethics brings ethical, social, legal and
philosophical perspectives to public debates about
health services and related research.20
Evaluating consumer involvement
Advantages and disadvantages
The main reasons for involving consumers are
pragmatism, in the face of consumer demand or
non-cooperation, political principle and the
pursuit of ‘better’ research. The principles and
practicalities of consumer involvement may be
satisfied by the presence of consumers during the
planning process, and the quality of their
involvement in those processes may be a measure
of success. These can be considered as
intermediate benefits or, when success is not
assured, intermediate harms and costs. The
objective of better research has a range of more
ambitious interpretations. ‘Better’ research could
mean methodologically or ethically superior
research, or research that is more likely to
influence practice and improve health. Some of
A framework for examining consumer involvement in research
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The research programme: 
  the research focus (e.g. topic focus and type of
research)
  organisational setting of the research programme (e.g.
geographical scope and nature of funding body)
  experience and resources for consumer involvement.
The consumers:
  focus of interest (e.g. services, population, patients or
carers)
  function of group (e.g. campaigning, mutual support)
  organisational setting of the consumers 
(e.g. geographical scope of group)
  experience and resources for involvement in research.
The interaction
  initiated by research programme or by consumers
  methods employed to involve consumers in identifying
or prioritising research topics
  tasks undertaken by consumers
  relationship between consumers involved and wider
consumer population.
BOX 1 Characteristics of players and methods for interaction –
framework for selecting UK cases
  Bioethics (the study of the ethical, social, legal, philosophical and other related issues arising in healthcare and in the
biological sciences.20
  Collective social action (where people join forces with the aim of improving lives through campaigning and peer support).3
  Community development is the process of involving a community in the identification and reinforcement of the aspects of
everyday life, culture and political activity that are conducive to health. This might include support for political action to
modify the total environment and strengthen resources for healthy living, as well as reinforcing social networks and social
support within a community and developing the material resources available to the community.12
  Consumerism (where the motivation for involving consumers is financial and consumers are seen as direct users of a
commercial product).75
  Empowerment in research changes conventional research relations from inequality between active, dominant researchers
and passive, subordinate research subjects to more equal relations between the two, and increased inclusion and
involvement; where service users play a greater part in identifying the topic for research and the benefits of research,
designing and conducting the research, disseminating and acting on the research findings, and having more control over the
funding and the research process.21
  Evidence-informed patient choice (where the interests of patients are framed in terms of evidence required to support
personal health decisions).5
  A learning organisation is one where people continually expand their capacity to achieve their objectives, where new and
expansive patterns of thinking are nurtured, and where people are continually learning how to learn together.16
  Managing diversity (where methods were adapted specifically to encourage input from populations who might otherwise
find existing structures and procedures too great a barrier).15,16
  Organisational change (where there was an intention within an organisation to develop new formal methods through
piloting and reflection).15,16
  Participatory research (where collaboration, education and action combined to enhance the relationship between
researcher and community, with direct benefit to the community as an outcome of the research and the community’s
involvement being itself beneficial).17
BOX 2 Theories of consumer involvement in research or service planningthis better research may be better because it better
fits the needs of an important and arguably under-
represented stakeholder group. These objectives
can be considered as final benefits or, if not met,
final harms and costs (such as lack of research,
poorer research, opportunity costs and bad
publicity).
The degree to which consumers influence research
may be evident in the source of the original
research topics, the potential benefits and
subsequent spread and use of research findings,
the background and accountability of the
researcher and the control of the research design,
conduct and funding.21 For instance, plans for a
conventional survey by a researcher of disabled
people using cash payments provided by the
Independent Living Support Service was
challenged by the service users obtaining funding
and directing a piece of research themselves, with
the help of a professional researcher as a
consultant, thereby controlling the presentation of
the findings and their use in future decisions
about funding.22
Based on their collective experience of consumers,
practitioners and researchers, Consumers in NHS
Research attributed advantages and disadvantages
to different degrees of involvement.4 The
advantages of consultation were seen as obtaining
consumer views quickly without being committed
to act on them and being a ‘safe’ way to start
working with consumers. Disadvantages were also
recognised. Some consumers have found it
frustrating to be asked their views without any
commitment to act on them. Some consumer
organisations have declined to become involved,
arguing that it is a waste of their time if they are
not seen as partners in the research process,
particularly if their views had been ignored in the
past. The advantages of collaboration were seen as
increasing the likelihood that the outcome
measures, assessment criteria and evaluation
would be relevant to consumer participants in
research, access to consumers as research
participants would be improved and consumers
could help with recruitment and informed
consent, and with interpreting and understanding
data. Following collaboration, consumers were
likely to feel more ownership of research results
and be more likely to actively disseminate them.
The perceived disadvantages included the
additional time, costs and possible alienation. This
approach involved an active commitment to
collaborate, which meant that some control over
the research was lost by the researchers. The
perceived advantages of consumer-controlled
research included increased involvement of
consumers who have often been marginalised,
research likely to address questions that may not
have been considered important to researchers
and the development of research skills among
consumers and the professionals with whom they
worked. Commitment from consumer
organisations to disseminate the results of research
and to influence change in practice was
considered more likely. This type of involvement
requires researchers to hand over the ownership of
a project to consumers. Some researchers have
found this difficult or unacceptable.
Box 3 lists outcomes and processes that may be
assessed in attempts to evaluate consumer
involvement in setting research agendas. These
include recording participants’ views on the
process, demonstrating changes in the process and
consumers’ consequent influence on the research,
and subsequently on healthcare and health. The
remit of this study is limited to investigating the
processes of research agenda setting and consumer
influence on the research agenda. The importance
of a benefit or harm may be perceived differently
by researchers and by consumers. For instance,
greater uptake of research findings may be
welcomed by a profession embracing evidence-
informed practice, but not by consumers who are
critical of the original research.
Advantages and disadvantages of methods may
also be conceived not as measures of achievement,
but as features that facilitate or hinder consumer
involvement. For instance, good communication
or skilled facilitators may benefit consumer
involvement, whereas short timetables or technical
language may hinder it.
Hence an advantage or disadvantage may be
perceived as a facilitator of, or a barrier to,
agenda setting or consumer involvement, a
benefit, or cost resulting from agenda setting or
consumer involvement, at an intermediate stage
or as a final outcome, as seen by consumers or
researchers.
A framework for analysis
Facing such a diversity of methods for consumer
involvement, we needed an analytical framework
for grouping similar episodes of consumer
involvement, comparing similarities and
differences between them and identifying common
conclusions. From the concepts described above,
we conceived a framework based on:
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or as members of organised groups
  whether the involvement was at the invitation of
the research programme or in response to
consumer action (approach to engagement)
  the degree to which consumers were involved
(consultation, collaboration and user control). 
This combined a simplified version of Arnstein’s
ladder of involvement18 as operationalised by
Consumers in NHS Research4 and Mullen and
colleagues’ distinction between reactive and
proactive consumer involvement14 (see Figure 1).
The columns represent decreasing consumer
involvement and the rows represent decreasing
researcher commitment to consumer involvement.
Examining the different possible combinations
would allow us to describe the methods that were
employed to support such an engagement in
terms of who was involved, how and with what
consequences (as discussed above). When this
A framework for examining consumer involvement in research
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Benefits Harms and costs
More informed discussion between consumers  Increased work load. 
and professionals. Diverting consumers’ efforts from services and 
Greater understanding by consumers of technical  campaigning.
issues. Decreased enthusiasm amongst consumers and 
Improved sensitivity to consumer concerns in  professionals for working together.
planning research. Greater confusion about the purpose of research.
Reduced barriers to broad participation. Damaged public profile of research.
Improved public profile of research. Reduced credibility of consumers.
Increased credibility of consumers. Lack of reporting of consumer involvement.
Increased enthusiasm amongst consumers and 
professionals for working together.
Consumer and manager descriptions of success 
in involving consumers in R&D.
Research incorporating consumers’ ideas and  Delayed research.
addressing consumers’ concerns and needs. More expensive research.
Greater uptake of research findings. Disappointment in limitations of research.
Improved care. Reduced uptake of research findings.
Improved health.
BOX 3 Evaluating consumer involvement
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FIGURE 1 Framework for describing consumer involvement in research agenda settingframework is illustrated as a table, some cells
remain empty because they represent scenarios
that are illogical or imply minimal engagement
between the two groups. For instance, consumer-
controlled action was unlikely to be initiated by
research programmes (column 1, row 1), and
research programmes cannot consult or
collaborate with consumers if they are minor
partners or absent (row 4, columns 2 and 3).
The details of methods applied within each type
of approach to engagement were conceptualised
as the operational methods of an episode of
consumer involvement. Thus each type of
engagement might have embraced one or more
forums for discussion (e.g. committee
membership, written consultation, focus groups or
public meetings) that may have employed formal
or informal methods for building consensus or
other decision-making. We therefore needed to
consider included specific interactions between
consumers and research programmes in terms of
both the approach to engagement and the
operational methods of involvement.
In addition to the above five dimensions
describing each model of interaction:
  consumers involved
  direction of approach
  degree of consumer involvement
  forum for exchange
  methods for decision-making
we hypothesised that the context (in terms of the
research focus and the historical, geographical or
institutional setting) would also be significant, as
would the selection or self-selection of participant
consumers. Together these provide a set of key
variables for describing the diverse episodes of
consumer involvement in research agenda setting.
Methodology
Typical of a newly developing area, research about
consumer involvement is scant. Enthusiasts
initially report their reflective descriptions, and
research programmes report consumer
involvement with little or no detail. Formal
research, exploring or evaluating consumer
involvement, is rare. In order to identify those
methods that appear most advantageous, we
applied the principles from systematic review
methodology of maximising relevance, reliability
and generalisability and minimising bias. We
assumed, conventionally, that well-conducted
research studies would be less biased and more
reliable. In order to draw on other reports where
necessary, we assumed that reports where
consumers shared authorship with researchers
would be less biased, that reports originating in
the UK would be more relevant and that findings
supported by more reports or by reports
originating from both the UK and elsewhere
would be more generalisable.
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his study had two main parts:
1. a systematic review of the empirical research
literature about methods for consumer
involvement in research agenda setting
2. a description of cases illustrating the range of
methods used for consumer involvement in
research agenda setting in the UK.
Part 1: systematic review of the
literature
Searching
The full searching strategy is reported in
Appendix 1. A brief description follows here. We
interrogated commercially available and
specialised bibliographic databases for references
to literature at the intersections of ‘consumer’
involvement in decision-making, research and
development and agenda setting. Database search
strategies were developed by (i) using controlled
and free-text terms and (ii) combining terms for
consumer involvement with those describing
research and development and agenda setting.
Searches were made of commercially available
bibliographic databases (MEDLINE, EMBASE,
CINAHL, Social Science Citation Index and
Applied Social Sciences Index and Abstracts) and
specialised databases and registers [ERA, the EPPI
Centre’s in-house database of consumer
involvement in research (http://eppi.ioe.ac.uk),
and CAREDATA, from the National Institute of
Social Work].
We handsearched conference reports and scanned
web pages of R&D programmes. References of
several reviews of consumer involvement were also
searched for studies of possible relevance. Because
details of consumer involvement in research
agenda setting are often not reported, either in
research papers or programme reports, we wrote
to over 250 researchers and consumers. We
identified them from NHS R&D programme
reports and web pages, presentations about
consumer involvement at conferences, records
held by consumers and researchers working with
them and references in reports and papers. We
asked for information about potentially relevant
episodes of consumer involvement and for other
contacts and related documents. Of these 250, 15
consumers and 57 researchers replied. All but one
of these was from the UK.
Selecting reports for inclusion in the
review
A set of inclusion criteria (Box 4) was used to
identify studies to review in depth. A team of three
researchers screened potentially relevant reports.
In order to facilitate discussion of the inclusion
criteria and their application, two researchers
independently screened abstracts and titles found
by searching bibliographic databases. Full copies
of all relevant reports were retrieved. Where there
was any doubt, researchers were over-inclusive and
retrieved full reports. Once obtained, the full
reports were screened by two researchers
independently. Any discrepancies were resolved by
discussion.
Reports meeting the inclusion criteria for the
review could be original descriptions or formal
studies of episodes of consumer involvement.
Literature reviews of consumer involvement were
not selected for in-depth review. Instead, they were
used to identify primary reports, and the findings
of reviews were included in the discussion of the
current review.
Review of reports’ content and quality
assessment
Each report was then examined to identify and
describe specific episodes of consumer involvement
in research agenda setting. Where episodes were
described in more than one report, information
on each episode was pooled from all the relevant
reports. Each episode was then described using
the following structured summary format:
  A description of the episode in terms of each of
the aspects required for inclusion criterion
number 4 listed in Box 4; characteristics of the
research programme concerned; the sort of
consumers involved; the methods employed to
involve consumers; the tasks consumers
undertook; the roles consumers undertook; and
an indication of the time frame for involving
consumers.
  The theories underpinning this interaction
where the characteristics of the aims, methods
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11
© Queen’s Printer and Controller of HMSO 2004. All rights reserved.
Chapter 3
Methodsor context clearly indicated particular theories
of involvement (as judged by the reviewers or,
when included in reports, as described by the
reports’ authors) (see Box 4).
  The output (in terms of research topics
identified or prioritised with or by consumers).
  Factors that advantaged (facilitators) or
disadvantaged (barriers) consumer involvement
and the advantages and disadvantages which
ensued (outcomes and outputs).
  When facilitators or barriers, or outcomes and
outputs were described, to what the reports’
authors attributed them.
  The nature of the evidence, in terms of 
(a) whether the episode was examined with a
formal study or was presented in a descriptive
report, (b) whether those reporting it were
independent of the episode or had been
participants in the episode and (c) whether
those reporting it did so from a consumer or
research programme perspective.
These data were collated in tables to facilitate a
qualitative analysis within each type of
engagement.
Synthesis of findings
The findings were synthesised within the
framework described in Chapter 2. This
framework allowed us to describe and synthesise
the findings from a large and disparate literature.
It helped us to navigate the various approaches
and operational methods of involvement and we
have adopted this framework as a structure for the
findings of this report.
The reports were synthesised in successive steps of
summary and analysis. Reports were initially
sorted into the types of approaches to engagement
(A–H) depending on whether they were 
researcher or consumer initiated, and whether
consumers were consulted, collaborators or in
control. Within each type of approach, forums
identified for exchanging ideas were listed (e.g.
committee membership, teamworking, written
consultations, face-to-face consultations, single or
repeated consultations). The descriptions for 
these forums were not mutually exclusive, but were
chosen within each type of approach in order 
to group similar episodes of consumer
involvement.
Within each of these forums, individual episodes
of involvement were briefly outlined in terms of
the methods employed for identifying and
prioritising research topics and the methods for
involving consumers. These descriptions are also
summarised in Tables 1–8.
Methods
12
To be included in the reviewa, a report needed to meet all four of the following criteria. The report needed to:
1. be about the involvement of consumers, or an attempt to involve consumers
2. be about research agenda setting (or the identification or prioritisation of research topics)
3. describe one or more specific episodes of consumer involvement in agenda setting (as opposed to being, for example,
solely a discussion of theory or methods for consumer involvement in research agendas or a description of a research
agenda written from a consumer perspective)
4. report, in some way, about each of the following aspects of an episode
(a) characteristics of the research programme concerned (reports needed to describe one or more characteristics of the
programme defining its scope, such as its geographical boundary, research methods, or health topic focus)
(b) the sort of consumers involved (reports needed to describe one or more defining characteristics of the consumers
involved, such as their group identity, their primary function, or their geographical scope)
(c) the methods employed to involve consumers (reports needed to describe how consumers were involved, e.g.
through written consultations, committee membership, focus groups)
(d) the tasks that consumers undertook (reports needed to describe whether consumers were involved in identifying
and/or prioritising research)
(e) the roles that consumers undertook (reports needed to describe how consumers related to their peers, e.g. whether
they acted independently, or represented or consulted other consumers)
(f) the time frame for involving consumers (reports needed to include when and for how long consumers were
involved).
a Reports found to meet the first two, but not all four, of these criteria (i.e. discussions of consumer involvement in agenda
setting not allied to a specific episode, or insufficiently detailed reports of specific episodes) have been coded so that they
are available for further research.
BOX 4 Inclusion criteria for literature reviewAfter each forum, or forums combined in single
episodes of consumer involvement, had been
described and illustrated with specific examples,
we highlighted what we considered could be learnt
from this collective experience of each forum in a
reviewer’s commentary. Specifically, we noted
those circumstances and attributes of the
interaction (processes) that appeared to advantage
or disadvantage consumer involvement
(facilitators and barriers), and the advantages and
disadvantages which ensued (outcomes and
outputs). In an overview of each type of
involvement, we listed our interpretation of what
could be learnt from these data (our conclusions)
as key messages relevant to each type of approach
to engagement. These key messages were
prioritised if they were drawn from reports written
by consumers and researchers, or from more than
one report, and considered widely applicable if
they were drawn from reports prepared both in
the UK and elsewhere. Following this analysis of
each type of engagement, we conducted a
qualitative synthesis of the findings based on a
detailed comparison of the findings as they related
to the different approaches to engagement, forum
for exchange, methods for decision-making,
context and underpinning theories (see Chapter 4).
Part 2: illustrating methods used
in the UK
The authors’ collective experience of consumer
involvement in research includes working as
consumers and as researchers and research
commissioners on individual projects and
programmes in the UK and internationally that
actively involved consumers. From this experience
of consumer involvement in research, we
hypothesised about the variety of circumstances,
researcher and consumer participants and
methods of working that might be employed
within the UK. We developed a classification to
describe methods for consumers and research
programmes to interact in setting research
agendas (see Box 1).
The classification incorporated characteristics of
both research programmes and consumers in
terms of their research focus, their organisational
setting and their ethos towards participative
working and/or research. It incorporated
characteristics of interactions between the two
groups in terms of the relationship of consumers
with their peers during the interaction, the tasks
they undertook, the methods for interaction and
the timescale. For instance, the NHS R&D
programme could be characterised as national or
regional programmes with a central focus on a
specific condition (e.g. asthma or cancer) or
broader tasks (e.g. health technology or
primary/secondary care interface); with different
funding mechanisms (e.g. commissioned or
responsive programmes) and attitudes towards
working with consumers (e.g. with or without
experience and resources for supporting consumer
participation in research). The consumers they
interacted with might be identified by their roles
(e.g. patients or carers), health or social conditions
(e.g. Alzheimer’s disease or homelessness), or
populations (e.g. mothers and children or older
people) and the primary function of the group
(e.g. self-help, campaigning or charitable
funding). The interactions between the research
programmes and the consumers may have varied
in how consumers are represented (e.g. individual
patients, expert advocates or group consultation),
the tasks they were involved in (e.g. identifying or
prioritising topics, or offering general advice) and
the routes for inputting their ideas (e.g. committee
membership, written consultations, structured
surveys, workshops/focus groups, drawing on
literature/secondary data or unsolicited consumer
suggestions).
This predetermined classification had two
purposes. First, it was available for purposive
sampling of episodes of consumer involvement to
ensure that the illustrative cases addressed a
diversity of experiences. Second, it was available to
guide a narrative synthesis that could address the
influence of diverse circumstances for consumer
involvement (see Chapter 6).
We sought examples of consumer involvement in
the UK in order to maximise the relevance of
findings to research in the NHS. We sought
examples of consumer involvement in R&D
programmes which, between them, presented a
wide variation in terms of the characteristics of the
research programme, the consumers and the
interaction (see Box 1).
We found 38 episodes of consumer involvement in
research agenda setting in the UK that were
reported in sufficient detail to include in the
systematic review of the literature. Of these, we
chose 11 to investigate in more detail, purposively
selected to cover the range of characteristics which
were thought likely to influence the aims,
processes and outcomes of interactions between
consumers and research programmes (as described
in Box 1). To capture both consumer and
programme perspectives, we selected some
Health Technology Assessment 2004; Vol. 8: No. 15
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involved more generally in research, and others
from research programmes involving consumers.
For 10 of these episodes, a semi-structured
telephone interview was held with at least one
participant, usually more, including both
consumer and programme representatives. (We
were unable to interview researchers for one case
or consumers for another and, for another case,
data were taken from internal consumer group
papers.) Interviewees were encouraged to describe,
in their own words, methods used to involve
consumers as part of the episode, the roles taken
on by consumers, the kind of consumers involved
and the length of time taken to develop consumer
involvement. Interviewees were encouraged to
discuss both positive and disappointing aspects of
consumer involvement. We did this specifically to
counterbalance the bias imposed by the greater
attention we expected to find in the published
literature to those examples perceived as positive.
The interviews were taped, with the consent of
each interviewee, and then detailed notes were
made of each interview. Each interview was
listened to by at least three of the authors, at least
one consumer and at least one involved in a
research programme, in order to gain a broader
range of views on themes arising. Themes
identified from the interviews are presented 
in this report without reference to the individuals
or organisations in order to maintain
confidentiality.
Documents relating to each episode were
requested from interviewees and others were
identified by broader literature searches. These
were added to the literature review and analysed
as described in part 1, above.
For a more in-depth analysis, each episode was
described in terms of the methods for identifying
or prioritising research topics, the approach for
engaging consumers in the task, the detailed
methods of the interaction with consumers and
the output of the programme. This was followed
by consumer and research programme staff
descriptions of their experiences and perceptions.
We then analysed these data in terms of barriers
and facilitators to consumer involvement, and
advantages and disadvantages of methods for
consumer involvement.
Methods
14Consumer involvement in
research agenda setting
Some of the 286 documents that explicitly
mentioned consumer involvement in identifying
or prioritising research topics (see Figure 2) were
general discussions. These included theoretical
discussions of differing priorities, conceptual
frameworks, community equipoise, power,
democratic practice and advocacy and a manual
for involving consumers, across a range 
of research topics including animal
experimentation, organ transplants, human
cloning and autism.
Of these 286:
  23 were discussions of theory (e.g.
empowerment) and/or process (i.e. methods for
involving consumers in research agenda
setting). 
  28 were records or analyses of research
programmes or topics from a consumer
perspective. 
The majority of the 286 reports identified
reported specific episodes: 
  160 related to specific episodes of efforts to
include consumers in identifying and/or
prioritising research topics – ‘purposeful agenda
setting’; 103 of these included sufficient detail
for in-depth review.
  51 reported consumers identifying and/or
prioritising research topics while undertaking
related work (e.g. health service development,
voluntary sector development, campaigning) –
‘opportunistic agenda setting’; 32 of these
opportunistic episodes included sufficient detail
for in-depth review.
Examples of purposeful and opportunistic agenda
setting were found for specific:
  health conditions (asthma, breastfeeding,
cancer, cystic fibrosis, dental health, diabetes,
disfigurement, HIV, hyperactivity, learning
difficulties, mental health, physical and
complex disabilities)
  populations (older people, young people)
  interventions (physiotherapy, organ transplants,
wheelchairs and other assistive devices)
  settings (homelessness, occupational health,
school health, urban health)
  research methodologies (systematic reviews,
technology assessment)
  disciplines (agriculture, genetics, environmental
studies).
‘Methods of involvement’ described how either
individuals or groups engaged with research
programmes. Individuals were engaged as part of
their clinical encounters where the questions they
ask or the decisions they make about their own
health problems and care inform research,
through their use of complaints procedures or by
invitation. They were also involved indirectly when
their activities (e.g. choice of services or
treatments) were analysed in order to inform
research. Similarly, groups of consumers were
engaged directly by responses to their campaigns
or by invitation, or indirectly through analysis of
their activities (e.g. their literature or alternative
services). Specific interactions were initiated either
by consumers or by research programmes and are
described (as types A–H) below (see Figure 1).
All these documents varied in the strength of
evidence they used for drawing conclusions. They
either:
  described methods of involvement, with or
without reflection, or
  reported formal studies of consumer
involvement, where the research methods used
to analyse the interaction were clearly reported.
Of these reports, all were descriptions of episodes
except four that were reviews and six that were
formal studies of specific episodes of consumer
involvement that reported their methods of
investigation. These methods varied from
monitoring and requesting feedback on
involvement to ethnographic study, and were
reported with more or less detail. There are no
agreed quality criteria for appraising the
observational and qualitative study designs
employed,23 nor could we be confident that the
formal studies, varying as they did in their
methods and detail, were necessarily more reliable
Health Technology Assessment 2004; Vol. 8: No. 15
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Approximately 3800
citations found
About consumer
involvement in agenda
setting (n = 286):
Purposeful (n = 160)*
Opportunistic (n = 51)
Not about consumer involvement (n = 3149)
About consumer involvement in areas other
than agenda setting (n = 367)
e.g. in research outside agenda setting
e.g. in developing priorities for services
About one or more specific
episodes of consumer
involvement in research
agenda setting (n = 199)
Not a report of a specific episode (n =91)
e.g. analyses of research agendas (n =28)
e.g. theoretical discussions (n = 23)
Detailed report of specific episode(s) of consumer involvement in research agenda
setting (n = 135)
13 Type A: Research programmes inviting the collaboration of consumer groups†
14 Type B: Research programmes consulting consumer groups
  5 Type C: Research programmes inviting the collaboration of individual consumers
13 Type D: Research programmes consulting individual consumers
12 Type E: Research programmes responding to consumer action with collaboration
  2 Type F: Research programmes responding to consumer action with consultation
  7 Type G: Research programmes tapping consumer perspectives indirectly
  7 Type H: Consumer-led research programmes
Insufficient detail of agenda-setting episode
(n = 76)
*12 of these reports contained accounts of both purposeful and opportunistic
involvement of consumers.
† Numbers in this box relate to the number of episodes; elsewhere, numbers relate to
the number of reports.
FIGURE 2 Identifying reports of consumer involvement in setting research agendasthan detailed descriptive reports drawing on
reflective discussion of participants. For this
reason, we have not distinguished reports
according to their strength of evidence, and the
findings of this review must depend upon pooled
opinions.
Type A: inviting consumer group
involvement through
collaboration
Where research programmes invited consumer
groups to collaborate, we designated it as 
Type A engagement (Figure 3). Collaboration
involved ongoing, developing working
relationships.
We found that the typical forum for Type A
approaches was the research committee.
Consumer groups have been invited to participate
in setting research agendas through various forms
of committee membership. Our definition of
committee membership incorporates consumer
membership on advisory groups, panels and
committees of research programmes. One
example was consumer committee membership of
NHS research programmes such as prioritising
panels for the NHS HTA programme.
An alternative forum was the research team, which
covered interactions where consumers worked as
equal partners with researchers. Teamworking was
a less formal process than research committee
membership and sometimes included researchers
working with members of communities.
Collaborations with consumers within the
Cochrane Collaboration were international and
appeared to be less formal or more flexible than
committee membership. An independent review of
consumer agendas combined recommendations
for consumer involvement with both committee
membership and more flexible team working.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type A approaches to consumer involvement.
A.1 Committee membership
Committee membership has been a common
method for seeking consumer perspectives for the
priority setting exercises during the first decade of
the NHS R&D programme. Most examples that
we found combined collaboration with a few
consumers with a broader consultation, and these
are described in Section A.4. We found two other
examples of committee membership. One of these
was too new for details to be available and the
other was a series of ‘working groups’ about the
research needs of vulnerable people.
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer
groups
Type B
Inviting
individual
consumers
Type C Type D
Responding to
consumer
action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner
or absent
Type H
Type A: Committee
membership, teamworking,
international collaboration,
FIGURE 3 Framework for describing Type A consumer involvement in research agenda setting: inviting consumer group involvement
through collaboration  The Health Education Authority (HEA)
convened a series of agenda setting working
groups in 1996 which addressed the research
needs of vulnerable groups: older people, low-
income groups, people who are homeless,
refugees, people with mental health problems,
lone parents and children and young people.
The HEA published the findings in a series of
monographs. We considered in detail the group
addressing the needs of homeless people. The
group of 11 included clinicians, sociologists,
public health consultants, specialists in housing,
health promotion, mental health and sexually
transmitted diseases and two members from
organisations representing homeless people.
The group pooled their expertise and 
prepared a report that was based on a 2-day
workshop.24 They recommended a research
agenda of mapping exercises, process
evaluations and action research. How and what
the consumer members of the group
contributed are unclear. Further details are
reported in Chapter 5.
  The recently convened UK National
Programme on New and Emerging Applications
for Technology (NEAT) is managed through an
Advisory Group composed of ‘representatives
from a range of stakeholders’ including one
member from a national patient interest
group.25 Further information was not available
at the time of writing.
Reviewers’ commentary
Neither of these programmes offered any reflection
on the methods they employed for agenda setting
or for consumer involvement, although the NEAT
programme is ongoing and may do so in future.
Little could be learnt about consumer involvement
in the absence of detailed reporting or critical
reflection. The NEAT programme had only one
consumer member. This may be considered
insufficient for effective participation and may
attract concerns about ‘tokenism’.
A.2 Team working
More flexible team working was a feature of some
collaborations that had been convened to conduct
research or review services.
  The Center for Health Policy and Programme
Evaluation at the University of Wisconsin’s
Medical School led a collaborative research
project between 1994 and 1996 and published
their work in 1997.26 The Center actively
engaged grass-roots organisations, service users
and volunteers from five diverse groups in a
two-stage evaluation strategy of a community
partnership programme funded by the
American Federal Center for Substance Abuse
Prevention. In stage 1 they involved community
groups in the design of instruments for
evaluating grass roots organisations. In stage 2
the grass-roots organisation members selected
topics they wanted to explore in detail. These
ranged from evaluation of single events to
researching the long-term effects of collective
social activism. The groups were then trained in
research methods and given ongoing support to
conduct their chosen projects.
Reviewers’ commentary
In this episode, the broad topic of evaluating
grass-roots organisations was set by the research
programme. Subsequently the academics claimed
to have elicited a consumer agenda by investing in
training, resourcing and developing a working
relationship with community groups. The
opportunity for consumers to conduct the research
they called for may have been a factor in their
choice of topics.
A.3 International collaborations
The Cochrane Collaboration is an international
organisation with the mission of preparing,
maintaining and promoting the accessibility of
systematic reviews of the effects of healthcare
policy and practice.27 Its principles include
“minimising bias through … ensuring broad
participation; striving for relevance by promoting
the assessment of interventions using outcomes
that matter to people; [and] enabling wide
participation … by reducing barriers to
contributing and by encouraging diversity”. These
principles encapsulate consumer involvement and
we found several reports of consumer involvement
in the Cochrane Collaboration. Cochrane Review
Groups are collaborations between consumers and
professionals which are often less formal than
committee membership,28–31 perhaps necessarily
in view of their international nature. Teamworking
may be a more appropriate descriptor.
  The College of Health, a national charity set up
to represent the interests of patients and
promote greater user involvement in health and
social care, surveyed Cochrane Review Groups
in 1998 to find out the extent to which the
Cochrane Collaboration involved consumers as
members of Cochrane Review Groups, and to
explore the emphasis that Review Groups
placed on identifying and collecting
information on outcomes identified by patients
as being important indicators of quality and
Results of systematic review
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defined outcomes).31 The emphasis on ‘patient-
defined’ outcomes rather than ‘patient-centred’
outcomes invoked consumer involvement in
setting research agendas. The survey found 
that four Review Groups had made some
headway involving consumers through a variety
of mechanisms. Of these, the Consumer and
Communication Group had a consumer as their
coordinating editor in a team of four editors
and a list of consumer-defined outcomes
incorporated into the formal description of its
scope of work. It also required reviewers to
identify how they were going to assess 
patient defined outcomes as part of their
methodology.
  The Cochrane Musculoskeletal Review Group
reported their working methods at the
Cochrane Colloquium in 1999.29 They found
consumers by following the advice of contacts
including the Canadian Cochrane Centre, the
Cochrane Consumer Network and the Arthritis
Society and by hearing consumers speak at
meetings. The roles for these consumers were
defined through a process of consultation and
consensus development. These roles included
working “in the community to seek consultation
on various topics in the area of musculoskeletal
disorders which members of [the Arthritis
Society] feel are important topics to have
systematically reviewed”. The group had
identified different ways for making consumer
involvement successful. These were related to
communication, support, facilitated discussions,
formal terms of reference, feedback and
recognition of achievements. With such a
supportive framework, consumers have
contributed in various ways. These included
giving advice on consumer needs (for instance,
evidence comparing different drugs, rather
than evidence comparing drugs with placebos
alone), and assistance in developing
partnerships with other like-minded
organisations. The Review Group concluded
that “the enthusiasm and involvement of the
consumer groups has led to new consumer-
driven initiatives and having consumers as
partners in the review group process results in
more research truly relevant to consumer and
health workers’ concerns”.
  Four Cochrane Review Groups (for breast
cancer, HIV/AIDS, Consumers and
Communication and Musculoskeletal problems)
collaborated to review their efforts for involving
consumers in setting priorities and presented
their findings at the Cochrane Colloquium in
1999.28 They concluded that “consumer
involvement in priority setting within review
groups is achievable and has numerous benefits
including the production of systematic reviews
addressing questions (and using outcomes) of
relevance and meaning to consumers”. All four
groups had at least one consumer editor. In the
breast cancer group two consumer editors
represented and reported to their relevant
constituencies. In the HIV/AIDS group, the
consumer editor participated in priority setting,
liaised with consumer groups, offered a
perspective from the developing world and was
responsible for consumer synopses of systematic
reviews. Consumers also provided a wide 
range of perspectives as members of advisory
boards. In addition, the Breast Cancer Group
convened a working party to determine
priorities within specific areas. For instance, the
consumer member of the Advanced Breast
Cancer Working Party brought a unique
perspective, held the same responsibilities as
other members and was a named co-
investigator on a grant application. In addition,
some consumers were themselves undertaking
reviews addressing questions generated by
consumers.
  The Diabetes Review Group also included
members of a consumer organisation.30 The
Insulin Dependent Diabetes Trust (IDDT)
proposed some topics for review that were not
taken forward. We were unable to find any
record of terms of reference or methods for
involvement. Further details are reported in
Chapter 5.
Reviewers’ commentary
Broad representation and ongoing involvement
were outlined as advantages for consumer
involvement in Cochrane Review Groups, with
consumers representing multiple constituencies
and nationalities.28 Outcomes of such ongoing
relationships were highlighted by a review of ways
in which consumers were involved in Cochrane
Review Groups, with consumers consulting their
constituencies and developing their own roles and
responsibilities.29 The underpinning philosophy of
collaboration did not always translate in practice
into partnerships of equals. Lack of a consistent
strategy for involving consumers in review
groups28,31 could be seen as a disadvantage. This
may explain why some groups lagged behind in
identifying patient-defined outcomes31 and why
some faced difficulties involving consumers 
at all.30,31
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consultation
Some agenda-setting exercises combined
collaboration and consultation with consumer
groups.32–37
  The NHS embarked on a period of
reorganisation with the establishment of its
research and development strategy in 1991.
The Advisory Panel on Methods to Promote the
Implementation of Research Findings in the
NHS, established in 1994, was the eighth panel
to set priorities for the NHS R&D programme33
and completed its review in 6 months. The group
was multidisciplinary and included purchasers,
providers, researchers, policy makers and a
consumer. The group was informed by wide
consultation within the NHS and a
supplementary consultation of targeted key
individuals in other sectors, and by expert papers.
Four workshops were convened to focus on the
role of consumers, the media, changing clinical
practice and policy and financial levers. The
consumer member of the panel was resourced
to convene the consumer workshop. The
workshop “engaged a wide range of consumers
to discuss consumers as levers for change in
others (for instance, as a lobbying force) and as
users of research findings themselves. …
Examples of issues raised at this workshop
included how to involve users in developing
practice guidelines, the use of patient care 
plans for users to monitor treatment and
evaluating the effects of different formats of
information for patient use”. The workshop was
reported in full by the consumer panel
member37 and a summary appeared in the
published report by the research managers.33
The consumer report37 described how the
participating consumers were new to
researching the implementation of findings but
were ready to build on their experience of
working in partnership with researchers and
health professionals in clinical trials. Stumbling
blocks included the need to explain to
consumers the exact questions they were being
asked to address and the technical and
organisational background of the exercise. This
was partly overcome with the use of visual aids
and practical examples.
  A parallel NHS R&D programme was
established in 1994 for Mother and Child
Health.38–40 The group approached national
organisations and individuals, representing
consumer interests in a written consultation and
through regional workshops. A series of small
focus groups and surveys were also carried out
to engage ordinary users of the service in
informal discussion on problems and
opportunities for research in child health. The
aim of this work was to provide a ‘dipstick’ of
consumer views in settings such as general
practice, health centres, residential children’s
home, playgroups and nursery schools,
secondary school and child development
centres. The report of this work was made
available to three panels on child and
adolescent health convened to prioritise
research. One of these panels included one
member from a consumer group. Other sources
of consumer views made available to the panel
on mother and infant health included a
National Childbirth Trust survey of its local
branches on problems and opportunities for
research41 and a national Delphi study
conducted by the National Perinatal
Epidemiology Unit.42,43 The NHS report did
not include a record of the research topics
identified or prioritised by consumers. The
formal reflections on the process did not
address consumer involvement. However, in
considering research in the area of mother and
child health, the group recognised the
importance of patient-centred services and
recommended that “those taking forward
research in the priority areas seek actively the
views of consumers”. Further details are
reported in Chapter 5.
  The Department of Health ‘Health in
Partnership’ initiative lived up to its name by
involving consumers through a variety of
methods throughout the process, from
identifying topics to commissioning the
research. In 1999, the Department of Health
took into account the experience of Consumers
in NHS Research Standing Group, and involved
lay representatives in all stages of
commissioning the programme. Decisions about
research topics were informed by a literature
review and made in consultation with
researchers, practitioners and patient and carer
organisations via individual discussions and a
large consultation meeting. A commissioning
group was established with representatives from
each of these constituencies. This group
decided to focus on lay involvement in shared
decision-making in relation to three areas:
individual treatment and carers, service
development and the implications for staff
training and development. This agenda setting
process was reported in no further detail at the
‘Research: who’s learning?’ conference in
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commissioning research that actively involved
consumers in each project.
  The NHS HTA programme aimed “to ensure
that high quality research information on the
costs, effectiveness and broader impact of
health technologies was produced in the most
efficient way for those who use, manage and
provide care in the NHS”. People from all these
groups were involved in determining priorities
for the programme. Widespread consultation
identified up to 1500 suggestions each year.
These were prioritised by expert panels, aided
by short scientific summaries of possible
research areas (vignettes) written by in-house
National Coordinating Centre for Health
Technology Assessment (NCCHTA) staff with
the help of experts in the field. Researchers
were then commissioned, following peer review,
to produce health technology assessments,
which are published – again after full peer
review – in the HTA monograph series.
Consumers were formally introduced in 1997
and have since been engaged throughout the
process.32 A feasibility study piloted consumer
membership of prioritisation panels and
consultation of consumers for identifying and
refining research topics.
Some consumers have taken questions about
their care to telephone helplines. The NHS
HTA programme explored the feasibility of
translating records of consumers’ questions into
research questions. Unfortunately, records for
service monitoring were not sufficiently detailed
for the task, and lack of direct communication
precluded discussion to elucidate the relevant
research issues.32
When seeking research topics, face-to-face
discussion with a consumer group was more
productive than scanning consumer research
reports or contacting consumer health
information services. Consumers were willing
and able to play active roles as panel members
in refining and prioritising topics and in
commenting on research plans and reports.
When refining research topics, a representative
of a condition-specific consumer group was
consulted for the preparation of each of three
vignettes. Consumers tended to highlight issues
about patients’ views, social contexts,
information and support needs and long-term
outcomes. These issues were usually not
addressed by professionals, who tended to focus
more on technical and economic aspects of the
work. Thus consumers provided important
background information for panel discussions
about priorities for research.
The feasibility report identified ongoing
relationships as an advantage for effective
consumer participation. Support such as
induction, training and mentoring was also
considered essential, as was avoiding ‘tokenism’
by having two consumer members of each
panel. Disadvantages in terms of ‘process’
barriers to consumer involvement on
committees were outlined in the HTA pilot
study in terms of attitudes of professionals, time
pressures and language barriers.32 The authors
recognised within the HTA programme
elements of a learning organisation: learning
from each other, from experience and from
outsiders and willing to accept and adapt to
new ideas and changes through a shared
vision44 (see also Section B.2; further details are
reported in Chapter 5.)
  The priority-setting phase of the national NHS
programme of commissioned research for
primary dental care spread over a period of
11 months from 1993 to 1994.45 Like the other
time-limited NHS R&D programmes, the
programme was directed by an advisory group.
The 260 areas identified were first condensed
into 26 broad topic areas and justification
papers were prepared for each topic area by
independent reviewers, who had been identified
by the advisory group. These broad areas were
then prioritised by the advisory group, with a
final 20 priorities being identified, of which the
top 10 were noted as the highest priority. This
programme differed from other national
programmes in that it was required to pay
particular attention to methods of incorporating
a consumer viewpoint at the development and
evaluation stages of their work.
In addition to taking their concerns to consumer
health information lines, consumers may
approach their MPs. The NHS R&D programme
for primary dental care turned to both of these
sources for records of consumers’ queries. From
these they found that consumers were concerned
about access and availability of services, school
dental services, water fluoridation and cross-
infection control in general practice.
Other input included a consumer member of
the panel, a written consultation of consumer
groups and charities, a review of evidence
submitted by the Association of Community
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review of questions raised in Parliament. The
report also differed from reports of other
advisory groups in that it was required to reflect
on the process of consumer involvement and
recorded consumer concerns. The general
broad themes of concern were consistently
identified through different routes: written
consultations to consumer groups, reviewing
parliamentary questions and questions to
telephone helplines, and consumer membership
of the prioritising panel. These could be
matched against the research areas subsequently
prioritised, but no information about research
commissioned was available from the website in
June 2001. (Further details are reported in
Chapter 5.)
  Over a 12-month period from 1999, the
Northern and Yorkshire NHS Regional R&D
Directorate used a combination of methods to
determine priorities for research. They started
with questionnaires and focus groups that
identified older people as a priority area. This
was followed by two workshops to identify and
prioritise research questions within this area.36
A range of consumers was involved in each of
these stages. The programme worked with local
individual consumers and representatives of
consumer groups with little previous experience
of research. Five research topics were identified.
These were subsumed into three broader
research areas in the commissioning brief. The
commissioning brief also asked researchers for
“recognition of the user perspective within
applications”. (Further details are reported in
Chapter 5.)
Reviewers’ commentary
All these programmes were able to draw on direct
prior experience of involving consumers in
research. Combining collaboration and
consultation seemed to be an effective way of
involving consumers. More was learnt from the
reports that both distinguished clearly the
contributions of the consumers from the overall
output of the programme agenda; and reflected
on the methods of involvement. 
Key messages
When research programmes invited consumer
groups to collaborate:
Details of Type A approaches are given in Table 1.
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  Committee membership and
international teamworking provided a
structure for consumers to consult their
peers and input a broader range of
consumer views into the process and for
responding to criticism from advocacy
groups. Indeed, topics for research were
identified and recorded by consumers
when they were empowered to lead
wider consultations.29,33,37
  Consumers needed to be informed
about the technical and organisational
background of the work in which they
are involved. This has been helped
with the use of visual aids and
discussion of practical examples.32,37
  Consumer involvement methods were
developed further when consumers
were involved as partners in reflecting
on working practices.28,29,32
  More was learnt about consumer
priorities and methods for identifying
them when programmes were
required to reflect on the methods for
incorporating consumer perspectives.45
  Consumer perspectives were reported
with greater confidence when a range
of methods had given consistent
views.45
  Consumer membership of committees
needed facilitated democratic
processes, openness, appropriate
recruitment, support and training.32
  Collaborations needed to confront
tensions and benefit from careful
management to avoid divisions or
breakdowns in communication
between consumer members and
professionals.32
  Collaborations convened to set
research agendas may continue by
conducting collaborative research.34
  Collaboration was similarly successful
when consumers were empowered as
partners, and reflection on working
practices led to further
developments.28,29
  Broader consumer representation was
possible through advocates as
members of teams.28
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TABLE 1 Type A Inviting consumer group involvement through collaborations
Author(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
A.1 Committee membership
Power et al.,
199924
Case
investigated in
more depth for
UK episodes (see
Chapter 5)
Health Action for
Homeless People
Two working group
meetings
HEA Experience of
collaboration led
to research project
Only one consumer on advisory group. No
reflection on consumer involvement and no
lessons learned
Description by
participant
researcher/
manager, interviews
with researcher/
manager and
consumer
NHS Executive,
200025
Committee
membership
New and
Emerging
Technologies
Only one consumer on advisory group. No
reflection on consumer involvement and no
lessons learned
Description by
participant
researchers/
managers
A.2 Teamworking
Empowerment Lackey et al.,
199726
Activists from
grassroots
organisations,
service users,
volunteers
Teamworking:
training and
support for
conducting
research
Centre for Health
Policy and
Programme
Evaluation,
University of
Wisconsin
Medical School
Consumer and
academic criteria
for evaluating
empowerment
Broad involvement from diverse community
groups
Description by
participant
researchers/
managers
A.3 International collaboration
Partnership Kelson, 199931 Consumer groups International
collaboration
Cochrane Review
Groups
Consumers
identifying
patient-defined
outcomes for
some groups
Lack of consistency. 
Lack of overall strategy
Independent
survey by
consumer
researcher
Partnership Kelly, 199829 National
consumer groups
International
collaboration
Cochrane
Musculoskeletal
Review Group
Consumer
suggestions for
research and
ways of
collaborating
Consumers defining own roles/responsibilities
within collaboration and taking consultation
to own constituencies
Description by
participant
researchers/
managers
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TABLE 1 Type A Inviting consumer group involvement through collaborations (cont’d)
Author(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Partnership Ghersi et al.,
199928
National review
groups
International
collaboration
Four Cochrane
Review Groups:
Musculoskeletal;
Breast Cancer;
HIV/AIDS;
Consumers and
Communication
Broad representation. Lack of coordination of
methods for involvement. Range of consumer
groups developing methods in relative
isolation
Description by
participant
researchers/
managers
Partnership Hirst, 199730
Case
investigated in
more depth for
UK episodes (see
Chapter 5)
National review
group: IDDT
International
collaboration
Cochrane
Diabetes Review
Group
Researchers did not address consumers’
priorities
Description by
participant
consumer
A.4 Combining collaboration and consultation
Organisational
change
Oliver, 1995;32
NHS
Management
Executive
199529
Individual
consumers and
representatives of
consumer and
community
groups
Committee
membership +
consumer-led
workshop
NHS R&D
implementation
of research
findings
Consumers
identified:
promising
methods for
involvement;
topics for
research;
reflections on
agenda-setting
process
Consumer committee member led wider
consumer consultation with programme
resources
Description by
participant
researchers/
managers.
Description by
participant
consumer
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TABLE 1 Type A Inviting consumer group involvement through collaborations (cont’d)
Author(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
CRDC Advisory
Group on
Mother and
Child Health
1994;38
Trent Regional
Health
Authority
1994;40 NHS
R&D
Directorate
199439
Consumer groups
and individual
service users
Committee
membership,
focus group,
surveys
NHS R&D
Mother and Child
Health
Research agenda
without specifying
consumer
contributions
Broad involvement with multiple methods Description by
participant
researchers/
managers
Partnership Hills and Farrell,
200034
Patient and carer
groups
Individual
discussions, large
consultation
meeting
Department of
Health
Health in
Partnership
Research agenda
focus on lay
involvement in 3
areas: individual
treatment and
carers, service
development, lay
involvement in
staff training
Description by
participant
researchers/
managers
Organisational
change; learning
organisation
Oliver, 199832
Case
investigated in
more depth for
UK episodes (see
Chapter 5)
National consumer
groups; journalist
Committee
membership
NHS HTA Three consumer
topics identified;
research priorities
published without
detailing consumer
contributions
Continued collaboration in light of perceived
success. Recognition of barriers to consumer
involvement. Training and mentoring schemes in
place. Attitudes of professionals, time pressures
and language presented barriers
Description by
participant
researchers/
managers
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TABLE 1 Type A Inviting consumer group involvement through collaborations (cont’d)
Author(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Breckenridge,
199445
Case
investigated in
more depth for
UK episodes (see
Chapter 5)
Members of public,
consumer groups
Trawling helpline
records, and
questions asked in
Parliament;
committee
membership;
written
consultation
NHS R&D Primary
Dental Care
Identified areas of
concern to
consumers
Indirect methods applicable where consumer
population hard to define
Description by
researcher/
manager and
interviews with
researcher/
manager
Doble, 199936
Northern and
Yorkshire
Regional
Research And
Development
Programme
1999118–121
Case
investigated in
more depth for
UK episodes (see
Chapter 5)
Older people’s
groups
Written
consultation, focus
group
Northern and
Yorkshire Older
People 
Five topics
prioritised, without
specifying
contributions of
consumers. Grant
applications asked
for ‘recognition of
the user
perspective’
Drew on personal experience of voluntary sector Description by
participant
researchers/
managersType B: inviting involvement of
consumer groups through
consultation
Where research programmes consulted consumer
groups, we designated it as Type B engagement
(Figure 4). We found that consumer groups have
been invited by a variety of research programmes
to participate in setting research agendas 
through written consultations and through 
face-to-face discussions or a combination of 
the two.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, 
key messages that we have deduced from
reviewing Type B approaches to consumer
involvement.
B.1 Written consultations
In the UK, consumers have been involved in
broad written consultations conducted by research
programmes,46,47 a research unit48 and a
professional body.49
  An NHS Advisory Group was established in
1993 to set R&D priorities for cancer.47 The
Group had 15 members with expertise in
organisation, management and delivery of
cancer services and research. Research topics
were identified from a widespread 
consultation, NHS reports and five workshops.
The consultation included 16 patient 
interest groups. Seven of these responded.
Included in the terms of reference of this 
group was the responsibility “to evaluate the
approach taken by the group to setting
priorities, and to provide a paper on this
approach to the Central R&D Committee”.
There was no mention of consumer involvement
in the reflection on the methods for agenda
setting, nor were consumers’ priorities
recorded.
  A similar exercise by a parallel Advisory 
Group for cardiovascular disease and stroke
research,46 with similar terms of reference,
received responses from 12 of 31 consumer
groups. Again, this group did not record
consumers’ priorities or lessons learnt from 
the experience of involving them in agenda
setting.
  The Chartered Society for Physiotherapy
consulted its members and external audiences
to establish its 1997 priorities for physiotherapy
research.49 A Delphi study attracted a broad
cross-section of respondents including
physiotherapists, consumers and medical
research charities, Directors of Public Health,
other professional bodies, general practitioners,
Health Technology Assessment 2004; Vol. 8: No. 15
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer groups
Type A
Inviting
individual
consumers
Type C Type D
Responding to
consumer action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner or
absent
Type H
Type B: Written, face-to-face,
multiple face-to-face, written + 
face-to-face consultations
FIGURE 4 Framework for describing Type B consumer involvement in research agenda setting: inviting consumer group involvement
through consultationDirectors of R&D programmes and the
Department of Health. Too few people were
interested in a subsequent consensus conference
to continue with this plan. The responses of
consumer groups and medical research charities
were combined in the report of this exercise.
Twelve of 91 consumer groups and medical
research charities responded, suggesting 20
(10%) of the topics. Nine of these 20 topics
appeared in the Delphi study’s final list of 24.
All nine were also suggested by other groups.
The results were used to submit priorities to the
NHS R&D HTA programme’s call for
suggestions in 1997. This exercise was reviewed
later by independent researchers, who
concluded that the advantages of involving
consumers in a Delphi survey were that 
(a) consumers may well identify priorities that
professionals at first neglect and (b) the
exchange of views may lead to increased
consensus, but not necessarily.35
  In 1993, the Department of Health funded the
National Perinatal Epidemiology Unit to
conduct a three-round Delphi survey to identify
priorities for research as perceived by a random,
stratified sample of midwives.48 The first
questionnaire aimed to elicit important practice-
relevant topics for research. The second
questionnaire listed these topics after they had
been sorted and categorised and respondents
were asked to rank the topics in order of their
perceived importance. The third round enabled
respondents to refine their priorities further.
The result of this study43 informed the NHS
R&D Mother and Child Health agenda-setting
exercise. A second complementary survey
explored the views of representatives of the
major UK maternity organisations,48 but the
findings were not published.
Reviewers’ commentary
These written consultations were all reported from
the perspective of professional research. They
targeted a broad range of people but low response
rates and self-selection may have influenced the
priorities. These low response rates could be
attributed to the short timetable, lack of guidance
or support for (or dialogue with) the consumers
and consultation overload or failure to engage
consumers who are faced with competing 
interests, such as campaigning or peer support. 
An independent review of written consultations35
confirmed the lack of dialogue in this method 
and concluded that this led to mismatches
between priorities of consumers and 
professionals.
When research programmes have taken the lead in
setting the research agenda, even when reflecting
on their methods, some have overlooked the
efforts and consequences of trying to involve
consumers.46,47 In this way, opportunities to learn
about consumer involvement have been lost.
The output of an agenda-setting exercise can be
assessed in terms of the agenda or the
subsequently commissioned research. The
Chartered Society of Physiotherapy listed its
20 top priorities for 1997 and submitted them to
the NHS HTA programme. The HTA programme
prioritised five of these and commissioned three
research projects. However, all five of these topics
had previously been identified by the programme,
between 1993 and 1996. This highlights the need
for good information systems to support agenda-
setting exercises across organisations.
B.2 Single face-to-face consultations
We found face-to-face interactions between
consumers and research programmes that have
included focus groups,32 interviews,50 and
seminars.51 For each episode, either single face-to-
face events were supplemented by other information
or communication before or afterwards32,37,51 or
more than one face-to-face consultation was
involved.52–55 All of these were reported from the
perspective of the research programme.
  The NHS HTA programme was introduced in
Section Type A and further details are reported
in Chapter 5. Here we report the consultation
aspect of this work. In 1997, the NHS HTA
programme piloted new methods for involving
consumers in identifying research topics. Efforts
to elicit consumer suggestions for health
technology assessment included a meeting
between staff of the NHS HTA programme and
a consumer group.32 The consumer group had
experience of conducting its own research and
its staff all had personal experience of mental ill
health. The consumers hosted the meeting and
were sent background information and a
request to think about possible research topics
in advance. Discussion focused on research that
is relevant to health service users and
developing skills for framing research questions
in order to evaluate the effects of care. The
research programme reported that the
consumers found framing their concerns to fit
the scope of the HTA to be an easy exercise but
other commitments prevented them from
finding the time to submit their ideas via the
HTA website. The research questions identified
were:
Results of systematic review
281. How effective are primary care interventions
for parents of children with mental health
problems?
2. Can acupuncture relieve symptoms of
schizophrenia, manic depression or acute
severe depression?
3. What impact does addressing religious and
spiritual needs have on mental health?
This was more productive than indirect methods
of scanning consumer literature or questions
posed to consumer helplines.
  In 1994, the Royal College of Nursing’s
research unit invited user groups with
experience of the research process (MIND,
Cruse Bereavement Care, The Spastics Society,
the National Consumer Council, the National
Childbirth Trust and The Patients’ Association)
to a seminar with the aim of discussing how
users might become more involved in the
research for health and in the Royal College of
Nursing’s own research.51 The seminar
participants identified key issues and methods
for user involvement in research for health and
agreed that consumers wish to be involved in
“setting research agendas in partnership with
professionals and sponsoring bodies with equal
weight given to all views”.
  One of the UK national programmes for
commissioning research addressed the challenge
of getting research findings into practice. This
work was introduced in Section Type A,
combining collaboration with consultation.
Here we focus on the consultation. The
Advisory Group for Methods to Promote the
Implementation of Research Findings in the
NHS was convened in 1994 and had 6 months
to report its work.33 It included two consumer
organisations and an umbrella group in the
written consultation for research topics, and
received only one response from a consumer
perspective. More fruitful was convening a
working group on the involvement of consumers
in the implementation process.37 “The working
group … engaged a wide range of users to
discuss consumers as a lever for change in
others (for instance, as a lobbying force) and as
users of research findings themselves.
Consumers included members of the public,
individual patients or carers, organised user
groups and statutory bodies such as Community
Health Councils. Examples of issues raised at
this workshop included how to involve users in
developing practice guidelines, the use of patient
care plans for users to monitor treatment and
evaluating the effect of different formats of
information for patient use.”33 The subsequent
agenda included “exploring and evaluating
roles for health service users in research
implementation”.33 The Advisory Group
reflected on their task of delivering a research
agenda within 6 months while balancing the
need for scientific rigour and a pragmatic
acceptance of working within a tight timescale.
“Given these constraints the Advisory Group
found the four working groups particularly
helpful. These enabled informal discussion in
some depth in particular areas, including the
involvement of consumers … .” In less formal
correspondence, a consumer participant
reflecting on this process saw particular value in
the style of the consumer-led workshop where
“the level of debate was significantly more
passionate (for want of a better description) than is
the case in most meetings of this kind … I think
this is a tribute to the freedom allowed by the
[consumer] Chair and the level of psychological
‘safety’ that participants felt within the workshop.
This freed people to speak their mind (both a risk
and a benefit in some instances) and to participate
more fully in discussions.
“I personally feel that this sort of subjective
element will be crucial if consumers are to be full
participants in any aspect of R&D programmes.
People must be able to feel free to express their
feelings about the issues under consideration, and
not simply give a dispassionate reasoned response
– that is more often the job of professionals such as
clinicians and academics! Consumer representation
often fulfils the function of a sort of unknown ‘X-
factor’ … a catalyst for new ideas, new ways of
looking at something that those of us who are
more formally involved in research and
implementation often forget.”56
  The number of Americans over 65 years of age
with psychiatric disorders was predicted to
increase from 4 million in 1970 to 15 million in
2030. Current services for geriatric mental
disorders were considered poor. Against this
backdrop, a workshop was convened to develop a
consensus statement to influence the national
research agenda for mental disorders.57 It
involved professionals from different disciplines
and institutions and members of advocacy
groups. The resulting research agenda 
addressed “prevention, translation of findings
from bench to bedside, large-scale intervention
trials with meaningful outcome measures, 
and health services research”. However, there was
no record of consumers’ contributions nor
reflection on the process of consumer
involvement.
Health Technology Assessment 2004; Vol. 8: No. 15
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Face-to-face events supplemented by other
information or communication had the
advantages of informed debate. This was
recognised as such both in reports written from
the research programme perspective32 and in
reports written from the consumer perspective,37
and can be attributed in each case to the
circulation of background information in advance.
Consumers reported the debate as fully involving
participants and attributed this to the choice of
facilitator, a fellow consumer.37 The informality
and ‘psychological safety’ within a workshop were
held to be important in defining its success.56
On all these occasions, consumers identified 
topics for research.32,37,58 The advantages of
partnerships and building alliances between
consumers and professionals were emphasised in
two of these reports.56,58 These advantages were
attributed to enabling effective participation by
developing relationships and understanding 
over time.
Identification of research topics by consumers did
not necessarily lead to prioritisation and
commissioned research. Ultimately, no research
was commissioned by the HTA for any of the three
questions identified by consumers.32 A search of
the UK National Research Register 2001 issue 2
revealed both completed and ongoing
observational studies addressing topics 1 and 3,
but no studies addressing impact of intervention
and no studies addressing topic 2.
Consumers’ ideas presented to the Advisory Group
on the Implementation of Research Findings37
encompassed the involvement of consumers in
their individual care and in the development and
evaluation of services. These were incorporated
into a broad topic of “Exploring and evaluating
roles for health service users in research
implementation”.33 Of the 35 research projects
subsequently commissioned, eight were explicitly
about consumer involvement, but all of these
considered consumers in their role of individual
patients rather than active participants in
planning and evaluating services. See
http://www.doh.gov.ntrd/rd/implem/commiss/
complist.htm, searched 6 June 2001.
B.3 Multiple face-to-face consultations
Two or more face-to-face consultations were
convened to address a workplace safety research
programme in the USA,54 and an inner city health
research programme in the UK,52,53 a UK national
disability research programme55 and, in Australia,
gene therapy for cystic fibrosis.50
  In the USA, the National Institute for
Occupational Safety and Health (NIOSH)
published its research agenda in 1996. This had
been prepared by NIOSH and its public and
private partners using a consensus building
process in response to a broadly perceived need
to address systematically those topics most
pressing and most likely to yield gains to
workers and to the nation.54 Because of the
research agenda’s national scope, the process
focused on achieving openness and
inclusiveness via the broadest possible public
participation. Final research priorities were
based on input from working groups (including
one of stakeholders), written comments, oral
comments made at public and town meetings
and other comments made during the
deliberations. Three liaison committees
(corporate, worker and broader-based
stakeholder outreach) increased the range of
input into the agenda by securing the
involvement of employers, employees, health
officials, health professionals, scientists and
public health, advocacy, scientific, industry and
labour organisations. Town meetings in Boston,
Chicago and Seattle captured input directly
from health professionals, researchers,
organised labour, workers, consumers,
businesses, state and local health officials,
elected officials and the public at large. 
A draft agenda was widely distributed for
comment before the final all-partners 
meeting of liaison and advisory group
members, agency representatives, working
group members and interested individuals. The
top priorities of the five working groups and
the final agenda were published in the American
Journal of Public Health, but without any
reflection specifically about consumer
involvement.
  The NHS Physical and Complex Disability
programme was a national commissioned
programme that set research priorities over a
period of 7 months from November 1992.55
Like all the other ‘time-limited’ NHS
programmes, it was directed by an advisory
group. To identify topic areas for the
programme, consumer groups, along with other
organisations nation-wide, were targeted by a
written consultation. Regional workshops were
held to gauge the regional concerns and needs
of users and carers. The programme’s advisory
group had a consumer member. In addition to
helping direct the programme, the advisory
group members identified and prioritised the
research areas identified through the written
Results of systematic review
30consultation and workshops. The 11 broad
research priorities included ‘consumer views’
and ‘using carers’ views to develop and evaluate
new forms of support’, and these were well
represented in the subsequently commissioned
research. Three commissioned projects gave
consumers a role in service planning and
evaluation: practice guidelines for primary
health care teams to meet the needs of Asian
carers’ needs, evaluating service support to
families with a child with sickle cell disorders or
thalassaemia and carers’ perspectives on
discharge procedures for young adults with
physical and complex disabilities. (See
http://www.doh.gov.uk/research/swro/rd/national/
pcd/funded/fulllist.htm. Further details are
reported in Chapter 5.)
  In 1996, a UK consultation exercise aimed to
gather consumer views on priorities for research
and development within the NHS urban areas
of North Thames.52,53 The College of Health, a
national charity set up to represent the interests
of patients and promote greater user
involvement in health and social care, was
commissioned to undertake a study involving
focus group interviews with 10 established inner
London groups, chosen to give insight into a
range of experience and views. Ten groups were
formed with lay participants and two groups
were formed with workers from London-wide
voluntary organisations with an interest in
health issues. The focus groups with lay
participants were convened by working through
existing social and community groups. This
approach was chosen to achieve the
consultation within the project’s timetable. It
meant that focus group participants knew one
another before the meeting, which may have
made it easier for them to engage in discussion
freely. Organisations were selected from lists of
voluntary agencies to represent broad sections
of the community (Indian people, young
people, older Caribbean people, Bangladeshi
women, older white women, tenants’
associations, Chinese people, employees,
unemployed young people and Somali people).
Groups with a particular interest in specific
health services or conditions were excluded.
Organisations that agreed were given
responsibility for convening and hosting a
group of up to 12 people. Various difficulties
were encountered in setting up the groups.
These included:
1. People who had promised to attend the
group not turning up – perhaps because they
had received no incentive themselves.
2. People not having a clear understanding of
the subject area and its importance, although
a project information sheet was sent to all
organisations in advance and further
explanation was given at the start of each
focus group meeting.
3. People not committing themselves for the
complete time period of the group.
4. People finding the concepts of research and
development difficult to grasp, especially
those for whom English was a second
language.
5. Problems in translating the concepts into
other languages as diverse as Somali and
Gujerati, Cantonese and Bengali.
6. Ascertaining in advance the groups’ need for
interpreting, and ensuring that the
interpreter had appropriate skills to assist in
facilitating the group.
7. Finding translators competent to translate
and transcribe the tape recorded group
discussions.
8. Convening meetings within a short time
frame.
Both the community groups and the voluntary
organisations suggested specific R&D projects.
A broad spectrum of priorities emerged:
housing, drug misuse, mental health, transport,
and the needs of carers. Wider messages from
these groups were:
1. Where appropriate, the voluntary sector and
the communities themselves would like to be
involved in their local R&D programme.
2. No one population group has a bigger
priority than others and opinion was divided
on priority given to specific issues.
3. Priority should be given to projects likely to
make a difference.
4. Improving access to health care for the most
disadvantaged groups was a consistent
theme.
The consumers’ broad priorities and key
messages for an inner city health research
programme and their concerns were taken
forward in the commissioning document but it
is unclear what impact they had on the
subsequent research. Part of the problem may
be that consumers’ ideas were broader than the
remit of the NHS itself, presenting an
organisational challenge to taking their ideas
forward.
  A 3-year project on Public Perceptions of
Biotechnology at Murdoch University, Western
Australia, held a series of communication events
with consumer groups, culminating with a
workshop in 1997.50 Although not convened
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were discussed. The development of gene
therapies for cystic fibrosis was discussed in
qualitative one-to-one interviews and focus
groups facilitated by research staff with 16
consumer groups and voluntary organisations
such as the Cystic Fibrosis Association of
Western Australia, the Birth Issues Group,
Tourette Syndrome Association and Buddhists.
The aim of the earlier focus group interviews
was to explore conversationally the views of a
range of ‘interested publics’ on developments in
genetic medicine. The aim of a subsequent
gene-technology communication workshop was
to continue these conversations by enabling
representatives of each focus group to pose
some of the questions raised in their group for
discussion to a panel of experts in medical
genetics, public health and medical ethics.
Consumers’ questions about setting research
priorities included: ‘Who will benefit from gene
technology, given financial limitations?’, ‘What
does it replace?’, and ‘Is gene technology
motivated by private ownership and profit
rather than the betterment of mankind?’
Consumers wanted to know whether too much
money was spent on gene technology and not
enough on possible causes of health problems,
such as environmental or nutritional causes.
The authors drew conclusions from the 
workshop about the nature of consumers’
questions and the workshop as a tool for public
debate and public policy development. They
considered that consumers’ questions arose
from a comparatively extended process of
reflection and emphasised the broader, more
contextual, social and ethical ramifications of
the new genetics that should be central to
continuing debates. They considered that their
invitations to ‘interested publics’ brought to 
the discussion groups valuable knowledge and
experience that helped to contextualise the
more technical discussions of medical experts.
These groups were seen as potential allies to
scientists and educators to the wider public. The
authors also valued the process for allowing
consumers to raise issues for discussion rather
than only responding to a pre-set agenda.
Reviewers’ commentary
Multiple face-to-face consultations on a national
or regional scale enabled a variety of consumer
groups to be involved in research programmes. As
with the single face-to-face events, this method was
considered successful in gauging the views of local
people about research.52,53
The NHS Physical and Complex Disabilities 
(PCD) programme appeared to be unusually
strongly influenced by consumer perspectives.55
This may reflect the long history of disability
campaigning.57 In contrast, the impact of
involving consumers in the inner city programme
was disappointing. It is worth noting that these
consumers came in the main from community
groups that had not come together in order to
campaign on health issues, but were largely
passive participants in a consultation 
exercise.
The workshop convened as a two-way
communication event differed in its output from
the other consultations.50 Rather than recording
consumer views or priorities, the authors recorded
consumers’ questions that they needed answers to
in order to formulate their views or priorities. This
emphasised the value of deliberative consumer
involvement.
B.4 Combinations of face-to-face and
written consultations
We found two programmes that used a combination
of face-to-face and written consultations59,60 to
engage a range of consumers. 
  An NHS Advisory Group was convened in
March 1993 to identify priorities for research
relating to the interface of primary and
secondary care.59 A wide-ranging consultation
exercise was undertaken including informal
evidence from workshops and a consumer focus
group, written evidence from within the NHS
and other interested bodies and submissions
from the Advisory Group themselves. The
consultation included 27 patient interest 
groups or charities in its written consultation
and received 14 responses. The Carers’
National Association devoted one of its 
monthly meetings to discussing issues relating
to the interface between primary and secondary
care from the perspective of those looking after
sick or dependent individuals. They did not
identify specific research topics but discussed
issues that they perceived as problematic:
availability of facilities, discharge arrangements,
professional boundaries and communication.
Programme staff hoped that the “anecdotal
information generated by this group [would]
give a flavour of some of the concerns and
needs of the individual user (carer and
dependent) of the services”. Subsequently the
agenda included “systematic evaluation of
patients’ and carers’ needs and views of
services”.
Results of systematic review
32  NHS research priorities for asthma
management were set by an advisory group
working over 9 months and reporting in April
1995. A doctor represented patients’ interests
during group discussions. The group drew
evidence from a written consultation with the
NHS and other interests, an informal 
workshop, expert papers and members’ views
and interests. They combined written
consultation with consumer groups with face-to-
face consultation with patients.60 The
programme report stated a commitment to
dialogue with a variety of stakeholders
including consumer groups and patients.
Consumer groups consulted by post included
the National Asthma Campaign and the British
Thoracic Society. Patients in Trent were
consulted at a 1-day workshop, which was also
attended by clinicians, managers and
researchers, but it is unclear whether consumer
concerns were taken on board in the
prioritisation process. The Advisory Group’s
reflections on the agenda setting process did
not address the methods for consumer
involvement.
Reviewers’ commentary
A combination of face-to-face and written
consultations recorded positive outcomes:
capturing consumers’ ideas for research topics33,37
and identifying priorities which placed consumers
at the focus of the research topic.33,59
The commitment to consumer involvement of 
the Advisory Group for R&D priorities in relation
to the interface between primary and secondary
care was evident from their investment of effort,
their reflections on the process and the priority
they gave to “systematic evaluation of patients’ 
and carers’ needs and views of services”. The
report from Asthma Group’s management
programme was less forthcoming about consumer
involvement, even though it used similar 
methods and was set in the same organisational
context.60
We found several exercises, including these two
episodes, within the NHS R&D programme where
consultation exercises, and reflection on their
methods, were integral to the organisational
change programme for setting research
agendas.32,37,46,47,55,59,60 Of these, only those that
also adapted their methods for involving
consumers, thereby managing a diversity of input,
also recorded consumer priorities or lessons
specifically about methods for consumer
involvement.32,37,59
Key messages
When research programmes consulted consumer
groups:
Details of Type B approaches are given in 
Table 2.
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  More was learnt from interactions
where consumers were more directly
involved in debate, for instance,
through the iteration of a Delphi
study,49 or face-to-face
meetings32,33,36,37,53,55,58,59 or even
leading the debate.37
  Reflections on the methods for agenda
setting sometimes neglected to
consider the methods for consumer
involvement, and opportunities for
learning and sharing were lost.54,60 In
particular, organisational change
approaches captured consumers’ ideas
and priorities32,33,36,37,49,59 or lessons
about consumer involvement32,33,37,55
only when reflection on the agenda-
setting exercise specifically addressed
consumer involvement.47,48 More was
learnt from an organisational change
framework when the need to reflect
on consumer involvement was an
advance requirement.45
  Working with established community
groups was feasible, although it could
be time consuming. It provided a route
for gauging local opinion from broad
sections of the community, including
people who were not activists and
people who may be unfamiliar with the
English language.36,52,53,59
  Working with consumers whose
shared interests were not health
focused faced difficulties with lack of
attendance, lack of understanding and
lack of commitment.52,53
  Least was learnt from simple, written
consultations either in terms of
consumers’ ideas and priorities for
research or about the methods used to
involve them possibly owing to the low
response rates, short timetables and
lack of guidance or support for
consumers.47,48
  The application of community
development and health promotion
theory54 attracted broad consumer
involvement although did not specify
consumers’ ideas and priorities.
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TABLE 2 Type B Inviting consumer group involvement through consultation 
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
B.1 Written consultations
NHS Management
Executive, 199447
NHS R&D Cancer 16 patient interest
groups
Written
consultation
Organisational
change
Research agenda
published without
detailing consumer
contributions
No lessons learned from CI.
No reflection on CI
Description by
participant
researchers/
managers
Advisory Group on
Setting Priorities in
Cardiovascular
Disease and Stroke
R&D, undated46
NHS
Cardiovascular
Disease and Stroke
Wide range of
consumer
organisations
Written
consultation
Organisational
change
Research agenda
published without
detailing consumer
contributions
No lessons learned from CI.
No reflection on CI
Description by
participant
researchers/
managers
Chartered Society
of Physiotherapy,
199849
Chartered Society
of Physiotherapy
Recorded on ASLIB Delphi survey Organisational
change
Consumer-
identified research
topics (not unique
to consumers)
Substantial consumer response.
General lack of interest in
consensus conference
Description by
participant
researchers/
managers
Sleep and Clark
1993;48
Sleep et al., 199543
NPEU: midwifery
research
Maternity
consumer groups
Written
consultation
Reflective
professional
practice
Research agenda
published without
detailing consumer
contributions
Only reported the Delphi
survey of midwives, not the
parallel consultation of
consumer groups
Description by
participant
researchers/
managers
B.2 Single face-to-face consultations
Oliver, 199832
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D HTA National consumer
group
Focused discussion
at meeting
Organisational
change; managing
diversity
3 research topics
from consumer
group submitted to
the programme –
not prioritised
Background information sent in
advance. Informed discussion
with a consumer group.
Consumer view – more time
would have been useful
Description by
participant
researchers/
managers; interview
with consumer
Poulton, 199451 Royal College of
Nursing
National consumer
groups
One-day seminar Organisational
change
Consumer-
suggested research
topics and views on
methods of
involvement
Targeted invitations. Built on
experience of consumer
groups’ experience of research
Description by
participant
researchers/
managers
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TABLE 2 Type B Inviting consumer group involvement through consultation (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
NHS Management
Executive; 1995;33
Oliver, 199537
NHS R&D
implementation of
research findings
Individual
consumers and
representatives of
consumer and
community groups
Prior consultation
of participants to
inform their
workshop
discussion
Organisational
change
Consumer-
identified research
topics, promising
methods for
consumer
involvement
Background information in
advance. Time for thought and
discussion. Consumer-led
event. Informed and animated
debate
Description by
participant
researchers/
managers.
Description by
participant
consumer
Jeste et al., 199957 Geriatric mental
health
Advocacy groups Consensus
conference
Organisational
change
Research agenda
published without
detailing
consumers’
contributions
Description by
participant
researchers/
managers
B.3 Multiple face-to-face consultations
Rosenstock et al.,
199854
NIOSH ‘Stakeholders’, e.g.
employees
Town meetings Health promotion,
community
development
Research agenda
published without
detailing consumer
contributions
Broad participation/
inclusiveness. Variety of
meetings involved different
publics. Consumers not
involved in all stages of process
Description by
participant
researchers/
managers
NHS R&D
undated55
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D Physical
and Complex
Disabilities
Members of
consumer network
Regional meetings Organisational
change
Research agenda
published without
detailing consumer
contributions.
Lessons for
consumer
involvement
Reflection on working methods.
Recommend more balanced
involvement of purchasers,
providers, users and researchers
in future exercises
Description by
participant
researchers/
managers
Wiles and
Brownfoot, 1997;52
NHS Executive
North Thames,
199649
North Thames
Inner City Health
Established
community groups
and voluntary
sector groups
Focus groups Consumers set
criteria for
prioritising; 3 broad
priorities outlined
and key messages
for research
Open discussion with
community groups. Gauged a
‘regional’ view. There were
unresolved conflicting views.
Full reporting of consumer
involvement. Consumer
concerns were taken forward
in commissioning document
Description by
consumer
involvement
facilitators
continued
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TABLE 2 Type B Inviting consumer group involvement through consultation (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
CI, consumer involvement. 
Schibeci et al.,
199950
Public Perceptions
of Biotechnology,
Perth, Australia
Consumer groups
and voluntary
organisations
Interviews, focus
group discussion
and workshop
Partnership Consumer
concerns about
broader contextual,
social and ethical
issues
Description by
participant
researchers/
managers
B.4 Combining face-to-face and written consultations
NHS Management
Executive, 199459
NHS R&D
interface of
primary and
secondary care
National carers’
group
Written
consultation, focus
group hosted by
carer’s group
Organisational
change
Agenda item:
“systematic
evaluation of
patients’ and
carers’ needs and
views of services”
Aimed for ‘flavour of
[consumers’] concerns and
needs’ to be reflected in
agenda
Description by
participant
researchers/
managers
Department of
Health, 199560
NHS R&D Asthma Consumer groups
for asthma
Written
consultation
Organisational
change
Research agenda
published without
detailing consumer
contributions
No lessons about consumer
involvement
Description by
participant
researchers/
managersType C: inviting involvement of
individual consumers through
collaboration
Where research programmes invited individual
consumers (not consumer groups or
representatives of consumer groups) to
collaborate, we designated it as Type C
engagement (Figure 5). We found that individual
consumers have been invited to participate 
in setting research agendas through 
teamworking.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, 
key messages that we have deduced from
reviewing Type C approaches to consumer
involvement.
C.1 Teamworking
Our definition of teamworking covers interactions
where consumers work in partnership with
researchers. Teamworking is a less formal process
than committee membership and may include
researchers working with members of
communities.
  For instance, a research team in California set
out to make children not the object of their
research, but equal co-investigators.61 The
young people came from different backgrounds,
but most were from families with a low income.
Funding was allocated for four pilot projects in
which teenagers from poor urban
neighbourhoods were brought together daily for
6–8 weeks during the 1995 summer vacation.
Each project undertook some form of
participatory action research. The young people
selected an issue or problem in their
environment that was important to them,
researched it and presented their findings to
the community. A small number of adults took
part, assisting and guiding as needed, and
documenting the process, but not directing. All
participants, adults and young people, were
paid for their work. One adult at each site acted
as monitor, maintaining an ethnographic
narrative account of events as they occurred,
largely through participant observation. The
overarching question of the researchers was,
‘how can adults engage young people in
community-based public health research and
action to improve their environments?’ Specific
questions included: What is the appropriate role
of adults? What help (if any) do adults or
children need in this kind of work? What kind
Health Technology Assessment 2004; Vol. 8: No. 15
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer groups
Type A Type B
Inviting
individual
consumers
Type D
Responding to
consumer action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner or
absent
Type H
Type C: 
teamworking
FIGURE 5 Framework for describing Type C consumer involvement in research agenda setting: inviting individual consumer
involvement through collaborationof problems do young people select to work on?
What kinds of solutions do they propose? What
benefits might be expected from this kind of
work?
The authors concluded that teenagers,
including those living in very difficult
circumstances, can make a strong contribution
to research and action on their own behalf, if
given the opportunity, respect and support they
need. Allowing them to select and frame their
own issues seemed to be a crucial element. In
this study they chose pollution of a bay where
their families fished, a lack of youth recreation
places, library closures, alcoholism in the home
and local environmental politics. All of these
pointed to children’s increasing lack of ‘safe
spaces’. Adults doing this work must be
prepared to share decision-making (and funds)
with boys and girls [authors’ emphasis]. In this
case success was marked not only in identifying
research problems and solutions, but also in the
young people’s increased self-esteem, social
awareness and social responsibility, revealed by
their discussion at a 3-month follow-up
workshop.
The authors described their initiative as
“multicultural, transdisciplinary research …
[that] drew on four principle sources, all of
which require an ecological and participatory
approach: participatory action research, self-
directed problem-based learning,
environmental education, and community
learning”. They drew on other literature to
define these four theoretical bases.
“Participatory action research is an empowering
form of communal inquiry … led by a
community ‘promoter’; it validates local
knowledge and is consciously directed towards
community action to improve local conditions.
It involves elements of research, community
organising, planning and advocacy.
Practitioners claim that it can, under certain
circumstances, help make individuals more
aware and equip them to cope with change in
their world and that it produces serious and
trustworthy knowledge that can open the way
for new forms of creative collaboration and
alternatives to authoritarian structures and
traditional patterns of exploitation.”
  Another example of teamworking was an Israeli
training programme for older people. In 1990,
the Bar-Elan University began to engage older
people in social gerontological research.62 The
older people were active participants in a
process of their own design and under their
own control, offering a new social role for
retired people and empowering older people as
creators of new knowledge about ageing.
Rigorous efforts were made to clarify with the
participants that they were not being trained as
research technicians, interviewers, statisticians
or experts in research methodology. The
emphasis was on: (1) what is important to study
and why; (2) the importance of the research
question and the relationship between the
definition of the research questions and the
meaning of the results; and (3) the nature of the
interaction effect between researcher and the
subjects of the research process. Graduates of
the programme were given the opportunity to
continue research in a supportive environment.
Research projects have been completed,
sometimes on difficult and sensitive topics.
Some have been published in academic journals
or presented at national conferences. This
model of educational training programme was
relatively cheap to develop and maintain and
did not require special facilities or equipment.
Such programmes do not require mass
participation of large numbers of older people,
but the impact of the research generated by
such small group efforts can be very significant
by legitimising new forms of knowledge 
about ageing via its dissemination in the news
media and through the national ‘ageing
network’. Specific research topics identified by
older people, and researched by them,
included: abuse of older people; life contexts of
80-year-olds who are learners in this
programme or are learners in non-university
settings such as old-age clubs; the effect of pre-
retirement training and adjustment to
retirement; evaluation of a home-bound
learning project; and the impact of knowledge
about old age on worry about ageing. In
addition to equipping students with new skills,
the programme worked to empower third-agers
to assume an active role in developing the
knowledge base of social gerontology and social
policy on ageing.
The programme was also valued for its 
effect on the participants themselves and 
their teachers and mentors. “We [the teachers]
have undergone a liberating experience in 
the classroom as the boundaries between older
adult students and teacher have broken d
own. A moment exists when a person can 
teach as an expert and simultaneously be a
student to his students … The raising of
questions is a value-based process where
Results of systematic review
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sensitivity”.
  A two-way transfer of knowledge between
consumers, rehabilitation engineering centres
and Federal research and development
laboratories has been established in the USA:
the Consumer Assistive Technology Transfer
Network.63 People with disabilities and those
caring for them have collaborated with assistive
technology programmes, engineers and
researchers to solve practical problems with
assistive technology devices. Assistive
technology devices were defined as any item,
piece of equipment or product system, whether
acquired off-the-shelf, modified or customised,
that is used to increase, maintain or improve
the functional capacities of an individual with a
disability. The Network included 56 assistive
technology centres (one in each State), 16
rehabilitation engineering centres and over 600
Federal research and development laboratories.
Collaboration was through end users being
members of the advisory board, and through
ongoing mechanisms for addressing consumer
requests and researcher responses to assistive
technology problems. The Internet provided
vitally important communications for the
Network. Its multimedia capabilities were
especially valuable for people who had
difficulties with vision, hearing, speech and/or
mobility. 
Some practical problems were solved by
identifying suitable devices, some by amending
or combining devices and some by research 
and development. Solutions have helped a 
man with cerebral palsy wishing to officiate
baseball games, improved communication
devices and improved light weight and durable
mobility devices (wheelchairs, canes, crutches
and walkers). Each of these scenarios was
described from both the developers’ and
consumers’ perspectives. Developers and
researchers have gained from having consumers
define problems and test prototype solutions.
Consumers have benefited by acquiring
solutions to their practical problems. Additional
benefits have come in the shape of development
funding, which has sometimes been secured
through disability-related laws enshrining
independence and equal participation in
society. This investment was supported by the
technological advances of the Internet and laws
which could secure funding and protect
research and development in the commercial
sector. The report presented a vision (and
routes for achieving this vision) of independent
lifestyles in terms of family, homes, telephones,
jobs, school and leisure pursuits and this
brought a humanity to the report.
  The Alzheimer’s Society, although established
by a consumer in 1979, 20 years later was
funding research largely on the basis of
professionals’ decisions. Broader involvement of
carers and people with dementia began with an
invitation circulated by newsletters and the
Internet.64,65 Respondents have been
coordinated through the Quality Research in
Dementia Advisory Network. Support and
training were available to carers before they
were involved in prioritising research topics and
commenting on research proposals. Ideas for
research from 150 carers and people with
dementia were posted on the Internet and
researchers applying for funding were asked to
consult this list before submitting their
proposals. Further details are reported in
Chapter 5.
  CABI-Bioscience, an international organisation,
originated in London. Their Integrated Pest
Management programme employed an action
research model in developing countries. Local
farmers were trained through discovery-based
learning, to choose topics for research, and then
carry out their own research projects.66 In
Kenya they have experimentally evaluated
different methods for controlling pests. This
was a fundamental change to traditional
education and support methods. Some staff felt
the pressure to supply ready-made advice and
complete answers. They found it difficult to
admit to farmers that they did not know the
answers. Further details are reported in 
Chapter 5.
Reviewers’ commentary
Advantages of collaborations for individual
consumers were broadly similar to those identified
for the collaborations with consumer groups.
Ongoing relationships between consumers and
researchers63,67 and empowerment and
partnership benefited consumer involvement.62,63
Far fewer examples were found of individual
consumers/users or members of the general public
being involved in collaborations, than of consumer
groups.
Two exceptional examples involved considerable
investment in establishing an infrastructure. One
was an Internet network that facilitated
communication between consumers, service
Health Technology Assessment 2004; Vol. 8: No. 15
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In all of these examples consumers are involved
not just in identifying topics for research, but also
in conducting research and evaluation themselves.
Rather than merely identifying the questions, they
could look forward to finding some answers.
Another was a charity that invested in training and
communication to involve carers in setting
priorities and peer reviewing research.65
Success in identifying consumers’ priorities
through participative training and research
requires particular skills for providing support and
letting consumers take the lead rather than
employing didactic methods to educate
consumers.
Key messages
When research programmes invited individual
consumers to collaborate: Details of Type C approaches are given in Table 3.
Results of systematic review
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  Training, education or ‘knowledge
transfer’ was an integral part of all
examples.61–64,66
  The exercise required investment of
time, resources and personal
relationships.61–63,66
  There was the motivation of finding
research-based answers, not just
identifying the questions.61–63,66
  Topics for research were identified by
consumers who were empowered to
learn from the collaboration.61,62,66
  Participative training methods provided
a learning experience for trainers too,
and sometimes changed their
attitudes.62,66
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TABLE 3 Type C Inviting individual consumer involvement through collaboration
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
C.1 Teamworking
Schwab, 199761 Young people from
low-income
families
Teamworking –
participatory action
research
Empowerment/
partnership/power
sharing
Young people
selecting and
framing own issues
for research
Increased self-esteem, social
awareness and social
responsibility
Description by
participant
researchers/
managers
Glanz and Neikrug,
199562
Gerontological
research
Older people Training
programme
Empowerment Older people doing
own research;
articles published in
journals
Mutual learning Description by
participant
researchers/
managers
Newroe and
Oskarsdottir,
199763
Consumer Assistive
Technology
Transfer Network
Disabled people Committee
membership
Consumerism,
partnership
Consumers defined
problems and
tested prototype
solutions
Independence and equal
participation values; end users
involved in advisory board
Description by
participant
researchers/
managers
Alzheimer’s
Society, undated;64
Harvey, 200061
Alzheimer’s Society Alzheimer’s
patients and carers
Written
consultations,
workshops
Empowerment Consumer
priorities posted on
Internet to inform
research grant
applicants
Integral training programme Description by
participant
researchers/
managers
Kimani et al.,
undated66
Case investigated in
more depth for UK
episodes (see
Chapter 5)
CABI Bioscience –
Integrative Pest
Management
Farmers Farmer participatory
training and
research
Participatory
research
Farmer identified
research topics.
Farmers become
‘active learners’
Farmers become ‘active learners’;
time-consuming
Description by
participant
researchers/
managers.
Interviews with
participant
researcher/managerType D: inviting involvement of
individual consumers through
consultation
Where research programmes consulted individual
consumers, we designated it as Type D
engagement (Figure 6). We found that consumers
have been invited to participate in setting research
agendas through written consultations, face-to-face
discussions or a combination of the two.
We defined individual consumers as individuals who
were not representing consumer groups. They were
service users, patients or carers – people whose lives
are directly affected by a particular condition – or
they were members of the general public.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type D approaches to consumer involvement.
D.1 Opinion surveys
Opinion surveys sought opinions on pre-set
statements or questions about priorities for research.
  Surveys have been conducted simultaneously in
the 12 countries of the European Community in
1991, 1993 and 1996.68 They aimed at a better
understanding of European opinion on
biotechnology. The 1993 survey focused on
seven different themes:
1. expectations regarding biotechnology and
other new technologies such as computer
science and space exploration
2. knowledge (both ‘objective’ and ‘subjective’)
of biotechnology
3. attitudes and opinions on diverse
applications of biotechnology
4. information sources that people use to draw
their knowledge on ‘the new developments
which affect our way of life’
5. information sources on biotechnology that
people trust
6. biotechnology and questions of ethics
7. influence that persons or groups concerned
about the potential risks associated with
Results of systematic review
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer
groups
Type A Type B
Inviting
individual
consumers
Type C
Responding to
consumer
action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner
or absent
Type H
Type D: opinion surveys,
small and large face-to-
face encounters
FIGURE 6 Framework for describing Type D consumer involvement in research agenda setting: inviting individual consumer
involvement through consultationadvances in biotechnology and its diverse
applications can actually have on this
development. 
In each country, these questions were asked of a
representative sample of the national
population aged at least 15 years old. In total,
12,800 people were interviewed. Together these
surveys provided standardised information
about attitudes towards particular applications
of biotechnology (food, plants, medicines, basic
research, transplants and genetic testing) and
priorities for research and development.
This approach did not reveal suggestions for
research topics. It did indicate an order of
preference for encouraging R&D. In 
decreasing order of priority, this was testing for
genetic diseases; genetically engineering
medicines; developing pest-resistant crops;
developing genetically modified animals for
laboratory research; developing genetically
modified foods; and genetically engineering
organs in animals for transplant into 
humans.
  Much smaller surveys conducted in Japan69
between 1991 and 1993 sought the opinions of
members of the public, high-school biology
teachers, scientists and nurses about in vitro
fertilisation, genetic engineering and
biotechnology. Questionnaires to the public
were distributed by hand into letter boxes
chosen at random in different areas of Japan,
and mail response was requested with an
enclosed stamped, addressed envelope. The
potential respondents’ names and addresses
were not written or recorded so no reminders
could be sent. This method was chosen to
ensure that there were no fears about privacy,
and for its low cost, but the authors considered
this to be the cause of the low response rate of
26%. This method captured quantitative data
about public perceptions. For instance, among
the public respondents who had heard of in
vitro fertilisation, 58% saw it as a worthwhile
area of research, less than all other
developments. 
The authors concluded that:
“The emotions concerning these technologies are
complex, and we should avoid using simplistic
public opinion data as measures of public
perceptions. The level of concern expressed by
scientists and teachers in Japan suggests that
public education ‘technology promotion
campaigns’ will not reduce concern about science
and technology. Such concern should be valued 
as discretion that is basic to increasing the
bioethical maturity of society, rather than being
feared.”
Reviewers’ commentary
Opinion surveys68,69 have the advantage of
targeting a broad range of people who can be
randomly selected in order to represent whole
populations. Both of these documents described
international opinion surveys aimed at the general
public. Advantages of this method may be the
scale, the numbers of individuals consulted and
the comparability of the attitudinal data from nine
EU countries.68 Disadvantages may be the 
limited nature and understanding of that data,
with no communication, feedback or ongoing
involvement for the respondents. This method
does not identify research topics but may 
identify broad attitudes (in this case perceived
favourable and unfavourable areas for
biotechnology and genetic engineering research
evidence) that can be applied in priority-setting
exercises.
D.2 Face-to-face encounters on a small
scale
We found interactions where individual
consumers, rather than members of consumer
groups or consumer representatives, were
consulted face-to-face to set research agendas for
specific issues: school health,70 environmental
conservation,71 prostate disease,72 arthritis,73
service delivery and organisation74 and devices to
help people with disabilities.75–78
  A literature review and face-to-face consultation
exercise were conducted in 1997 to develop an
evaluation plan for school health programmes
in Nebraska, Canada. This priority-setting
exercise was set against a background of
increasing financial constraints.70 “At the same
time that public funds to support programs
[had] continued to shrink, new legislation and
policies [had] been enacted requiring public
sector agencies such as schools to plan and
report outcomes associated with program
implementation.” The literature review revealed
little information about what most legislators,
school boards and parents wanted to know
about the impact of a health programme and
little evidence of the community having been
included previously in the evaluative process. To
design the plan for school health programme
evaluation, a group of stakeholders was
assembled to obtain community input.
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community members who had a vested interest
in the outcome of the school’s health activities.
The group was limited to 10 to facilitate
discussion and consisted of two teachers, a
principal, a school nurse, a custodian, a
dietician, a student, a counsellor, a parent 
and a state legislator. Focus group discussion
and a prior questionnaire considered 
(a) what key questions needed answering to
judge the value of their school’s health
programme, (b) what questions other tax 
payers in their district would want answered
regarding the effectiveness of school health
activities, (c) which individuals should be
responsible for conducting an evaluation of the
school’s health programme and (d) specific
indicators for subjective or objective
measurement. The final evaluation plan was
developed and implemented as a State-wide
evaluation of comprehensive school health
services.
  Madagascar’s biodiversity is of extremely high
international significance, yet comprehensive
efforts to assess current knowledge and set
priorities have been absent until recently. A
major participatory effort to assess the country’s
scientific and conservation priorities began in
1995.71 A scientific workshop with over 100
experts set biodiversity priorities for the island.
A principal finding of the workshop was that
many areas of outstanding biodiversity and
research importance are located outside
protected areas. Workshop participants also
agreed that corridors needed to be created
between the high-priority protected areas in
order to maintain gene flow and exchange of
species. The second stage of the process was a
stakeholder consultation that integrated
scientific findings, national priorities, local
stakeholder views and donor input. “Local
resource users” included farmers, ecotourism
operators and forest-product gatherers. They
identified “environmental problems and
possible solutions” through interviews.
Stakeholders at regional level further prioritised
problems and possible solutions. The net result
of the process was the adoption of a landscape
approach to conservation that integrated
regional planning, biodiversity monitoring and
institutional strengthening.
  The US Patient Outcomes Research Team
(PORT) strategy led to programmes designed to
provide a mechanism to ensure systematic
evaluation of all relevant treatment theories, not
just those that are for regulation purposes or
those of particular interest to investigators. In
the 1980s the Prostate Disease PORT saw its
first task as “learning what mattered to patients
and to develop an instrument that captured the
events”.72 They undertook “unstructured
interviews with patients (using a focus group
format) … [and] amassed a list of outcomes that
mattered to patients and then set out to build
and validate a questionnaire to quantify
symptoms, complications and quality of life
states and to measure the subjective impact that
the … condition had on the individual patient –
how much he was bothered by his symptoms
and what his expectations were from
treatment.” Subsequently, 400 patients were
interviewed. The research team learnt that
“most patients, including those with less than
high school education, want considerable
information and feel this experience is valuable
in making a treatment choice”. On the basis of
this work, they planned a technology
assessment network to gather evidence for all
the treatments available for prostate disease in
terms of outcomes that matter to patients, and
to facilitate informed patient choice. This plan
foundered after its pilot work through lack of
funds.
  Face-to-face consultation with patients was also
employed by the NHS Advisory Group for
Asthma (described in Section B.4). No details of
the process or outcome were reported.
  A study of arthritis of the knee compared the
current evidence base for treatment with the
views of arthritis patients. Focus groups and a
questionnaire for arthritis patients were
conducted to establish what treatments they had
tried to alleviate their suffering and which
treatments should be prioritised for research.73
A comparison with the evidence base for the
effects of these treatments concluded that the
current research agenda did not match current
treatment patterns and consumer needs.
Current evidence focuses on drugs and surgery.
Patients would like all treatments to be
evaluated, including education and advice,
physical therapy and complimentary therapy.
Although the findings have been disseminated
by publication in The Lancet, this exercise was
not directly linked to the commissioning of
research.
Reviewers’ commentary
Consulting individuals made it possible to draw
opinions from a broad range of people who were
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groups. This was applied to gauge views 
within a nation,71 views of people using 
particular services70 and products72,73,75–79 and the
views of patients recruited from clinical
settings.72,73
Recruiting patients from clinical settings for 
focus groups and questionnaires had the
advantage of including a broad range of people,
specifically not excluding those who were less
educated.72
For organisational research, purposeful sampling
of individuals with service provider and client
roles was more appropriate. This has provided a
team for designing a service evaluation
programme that could be widely implemented.70
However, there was no record distinguishing the
views and contributions of providers and clients.
Similarly with environmental research,
conservationists and resource users collaboratively
set a research agenda, but we have no indication
of how views varied or how consensus was
achieved.71
Unless setting the agenda was part of a larger
commitment to conduct research,70,71 practical
difficulties such as lack of funding or links with a
research programme could reduce setting the
research agenda to a largely theoretical 
exercise.72
D.2b Face-to-face encounters on 
a small scale in commercial 
settings
A variety of small face-to-face encounters have
been reported in the literature about setting
research agendas for assistive technology
devices.75–78 These involve consumers in
innovative development and evaluation. The
methods they used included focus groups for
‘brainstorming and prioritising’,75 combining
focus groups and surveys,76 a focus group 
process based on a modified version of the 
Delphi method,78 and the Kano focus group
model.77
These enterprises rested on theories of
consumerism76 and “the expanding variety of
assistive technology devices from medical
instruments to consumer product”. Their
changing image coincides with consumer-directed
efforts to shift the orientation of service
programmes from a medical model to a 
consumer model. Under a consumer model,
manufacturers and suppliers in the marketplace
compete to deliver the most useful product 
in the most efficient manner possible.
Understanding consumer behaviour is critical to
providing competitive products in the
marketplace. Examples of innovative approaches
to involving consumers are described 
below.
  The Rehabilitation Engineering Research
Center on Technology Evaluation and Transfer
in New York employed the Kano focus group
model where consumer perspectives were first
introduced at the stage of designing ‘probing
questions’ for a focus group.76,77 Typically teams
designing these questions included an engineer,
a marketer, a knowledgeable end user, the focus
group moderator and an expert in qualitative
data analysis. The team would draw upon
personal experience, standards, consumer
reports, academic research, market research,
industry and consumer interviews to write the
questions. The aim of the focus group
discussion was to identify three types of product
requirements: expected, revealed and exciting.
The most basic were unspoken requirements of
products that were ‘too obvious’ to mention:
‘expected requirements’. Requirements that
were normally spoken of and referred to as day-
to-day concerns that seemed important were
‘revealed’ requirements. Previously unknown
concepts or those that might appear ‘too far
fetched’ were the ‘exciting’ requirements.
Generally, a product design that does not satisfy
expected requirements fails in the marketplace.
A product redesigned to incorporate revealed
requirements is evolutionary and should retain
or increase its market share. A product design
incorporating exciting requirements is
revolutionary, with potential to become a
market leader. Probing questions were
considered especially useful for introducing
focus group participants to exciting product
requirements represented by new technologies
and technological concepts. Systematic
preparation of probing questions also lessened
the likelihood that critical expected
requirements would be overlooked. 
Following an analysis of the focus group
statements, surveys were then developed to
establish the importance and priorities of the
product requirements derived from the focus
groups. In this instance, consumers placed the
highest importance on the three evaluation
criteria of physical security and safety, product
reliability and effectiveness, and the
implications of these were made clear for
product designers. The authors reported the
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downs77 and battery chargers.76 In each case
100 experienced users rated over 150
statements pertinent to the ideal product and
rated the 11 evaluation criteria. The authors
expected the findings to guide the development
of better products.
  The panel members for a modified Delphi
method were not statistically representative of
the disabled population. Rather, they were a
hand-picked group of analytical and articulate
long-term users of assistive devices with a
variety of disabilities.78 As such, they could
“provide valuable insight into the evaluation
factors used by one group of disabled persons
whose members have given careful thought to
how assistive devices should be designed,
manufactured and selected”. The basic premises
of this consumer-based evaluation theory were
that (a) the consumer, the disabled person who
has used a device, must be the ultimate
evaluator of whether a device is satisfactory, and
(b) the consumer who has used the device for
an extended period of time is in the best
position to offer factors to be considered in
developing normative evaluation criteria for the
device.
  ‘Quality function deployment’ is the name of a
process in which the voice of the consumer is
deployed throughout the R&D, engineering
and manufacturing stages of product
development.79 Individual and focus group
interviews have been used to guide the
development of consumer products in the USA
and Japan. Their research concluded that (1)
one-to-one interviews may be more cost-
effective than focus groups, (2) interviews with
20–30 customers are necessary to identify
90–95% of the customer needs and (3) multiple
analysts or team members should read and
interpret raw transcripts.
  Involvement of consumers in identifying R&D
priorities for power wheelchair input devices
and controllers has been justified by the notion
of the ‘smarter wheelchair’, which has a 
smarter, more dynamic process between the
user and the technology.75 There was an
assumption that if an awareness of users’
feelings and perceptions was present before and
during the design stage, the resulting
technology should have a better chance of
success because useful features would be
available and the user interface would facilitate
easy setup and operation.
In a ‘consumer-responsive development
process’, brainstorming and five rounds of
voting led to five priorities:
1. durability and reliability
2. user adjustable and programmable
3. standard power take-off port
4. availability of alternative modalities for
feedback and user
5. emergency sensors for tilt, obstacles and
stairways.
Reviewers’ commentary
The aim of these interactions was to achieve new
product success and more profitable products.
They rest on the assumption that a greater
awareness of users’ feelings and perceptions of
technology leads to a greater likelihood of
successful technology with benefits for people with
disabilities and assistive technical device
producers.75
These interactions differed from those which we
found in the public sector. They purposely
recruited atypical consumers who were
knowledgeable, analytical and articulate. They
purposely sought high consumer expectations and
tried to meet them. They invested in an
infrastructure of consumer testing sites and teams
of consumers and analysts to capture consumer
concerns.
Face-to-face interactions with individual consumers
were reported with more emotive language. They
had the potential for a greater immediacy and
potential for fundamental changes in attitudes.
Researchers talked about users’ “voice”79 and
reported how working with consumers “deeply
influenced our thinking”,72 gave them a “greater
awareness of users’ feelings and perceptions”75
and outlined the impact of consumers on
priorities in terms of “breaking institutional
preconceptions of problems and aiding new
solutions”.71
D.3 Face to face encounters on a large
scale
Face-to-face encounters on a large scale included
town meetings and consensus conferences. In
America, NIOSH published its research agenda in
199654 (see Type B.3). Consensus conferences have
a more standardised format and have been
described as:
“a public enquiry at the centre of which is a group of
10–16 citizens who are charged with the assessment 
of a socially controversial topic of science and
technology. These lay people put their questions and
Results of systematic review
46concerns to a panel of experts, assess the experts’
answers, and then negotiate amongst themselves. The
result is a consensus statement which is made public in
the form of a written report at the end of the
conference.”80
• The advantages of broader representation in
terms of face-to-face multiple interactions were
addressed by a review of consensus conferences
on public participation in science.80 Advantages
of involving members of the general public
were expressed in terms of informed debate and
participatory democracy, attributed to the
dialogue encouraged between scientists and the
public and lay perspectives being brought into
decision-making. Similar advantages are
claimed for citizens’ juries (smaller counterparts
of consensus conferences).19 Neither method
has been employed for the purpose of
identifying research topics, but research topics
have emerged where members of the public
have been encouraged to seek research
evidence on which to base their decisions, and
have been unable to find the evidence they
needed.
Reviewers’ commentary
Although consensus conferences or their smaller
counterparts, citizens’ juries, have not been
convened for the purposes of setting research
agendas, debate has revealed topics which needed
more research.19,80 However, these ideas may not
be captured while conferences are convened under
the banner of public understanding of science
where they involve consumers in debate focusing
on the impact of science on decision-making
rather than considering the impact of consumers
on science.
D.4 Combining written consultations
with face-to-face encounters
  The NHS Service Delivery and Organisation
(SDO) research programme combined 
written consultations with face-to-face
encounters. There were no sufficiently 
detailed reports for inclusion in the literature
review, but further details can be found in
Chapter 5.
Key messages
When research programmes consulted individual
consumers:
Details of type D approaches are given in Table 4.
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  Little is known about how consumers 
view consultation of individuals
because all of these documents have
been written from the research
perspective,60,68–79 with the exception
of a report of consensus conferences,80
which was written from both research
and consumer perspectives.
  Even less is known about consultation 
of individual consumers in the UK as all
these reports are from
abroad.68–73,75–80
  Commercial interests which involved 
consumers as partners were
particularly successful in capturing and
making use of consumers’ ideas and
priorities. Their motivation for
investing in consumer involvement was
a greater market share through more
advanced technologies and a greater
profit.75–79
  Least was learnt when research
programmes perceived consumers
primarily as users of research.72,80
  Opinion surveys gave a broad but
shallow picture of attitudes,
perceptions of benefit and harm of
research, and limited data about
research priorities or reflection about
the process of involvement owing to
the ‘closed’ questions.68,69
  Patients recruited in clinical settings
have been interviewed to identify
interventions73 and outcomes72,73 to
frame evaluation agendas.
  Involving individuals with personal
experience of problems has sometimes
added an immediacy to the debate
which is sometimes expressed in
emotive and persuading language, and
could be particularly thought-provoking
for researchers.72,75,79
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TABLE 4 Type D Inviting individual consumer involvement through consultation
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
D.1 Opinion polls
European
Commission,
199368
European
biotechnology
Representative
sample over age
15 years
Opinion poll in
9 EU countries
Bioethics Public’s
preferences for
biotechnology
identified
Random sampling. Closed
questions. Wide
scope/comparability of data.
Limited data in terms of
research priorities
Description by
participant
researchers/
managers
Macer, 199469 Public attitudes
towards IVF,
genetic
engineering,
biotechnology
Representative
sample
Opinion poll Bioethics Public’s
preferences for
biotechnology
identified
Random sampling. Closed
questions. Wide scope of
consultation. Simplistic data
Description by
participant
researchers/
managers
D.2 Face-to-face encounters on a small scale
Cramer and
Iverson, 199970
Nebraska School
Health
‘Stakeholders’
including student,
parent
Prior questionnaire
to participants to
prepare them for
focus group
discussion
Health promotion/
community
development;
public
accountability
Research agenda
published without
detailing consumer
contributions
Community/stakeholder
participation. Gauging views of
those with ‘vested’ interests.
Planned consumer participation
in evaluation
Description by
participant
researchers/
managers
Hannah et al.,
199871
Conservation in
Madagascar
Farmers,
ecotourism
operators, forest
gatherers
Interviews and
stakeholder
workshop
Consensus
development
Identified research
needs without
detailing consumer
contributions
Broad range of participants.
Large-scale participatory effort.
Gauged regional view. Helped
break institutional
preconceptions of problems –
new solutions
Description by
participant
researchers/
managers
Wennberg et al.,
199372
Prostate Disease
PORT
Patients with
experience of the
disease
Focus group Evidence informed
patient choice
Research agenda
published without
detailing consumer
contributions
Involvement of patients in
identifying information needs.
Professionals learning from
patients – “deeply influenced
our thinking”. Gauged regional
view through direct service
users
Description by
participant
researchers/
managers
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TABLE 4 Type D Inviting individual consumer involvement through consultation (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Department of
Health, 199560
NHS R&D Asthma Patients One-day workshop Organisational
change
Suggested
problems needing
R&D
Description by
participant
researchers/
managers
Tallon et al., 200069 Contract
researchers
Patients with
arthritis
Focus groups and
questionnaire
Evidence informed
patient choice
Consumer-
identified priorities
Involved patients with direct
experience. Low consumer
response
Description by
participant
researchers/
managers
Lane et al., 199776
Stone et al., 199877
Rehabilitation
Engineering
Research Center
on Technology
Evaluation and
Transfer
‘Experienced’
technology users
Focus groups,
(Delphi) survey –
“capturing
consumer voice”
through Kano focus
group
Organisational
change
Consumerism,
partnership
Consumer
priorities for
criteria for
evaluation
Gauged regional views through
14 testing sites, focus groups
and survey. Criteria for
development set by consumers,
circulated among experts
Description by
participant
researchers/
managers
Batavia and
Hammer, 199078
Rehabilitation
Engineering
Research
All users of AT
devices on panels
Face-to-face:
modified Delphi
method
Consumerism,
partnership
Evaluation criteria
incorporated by
research
programme
Consumer-driven prioritisation
exercise. Assumed end users
must be ultimate evaluators of
whether a device is satisfactory
Description by
participant
researchers/
managers and
consumers
Griffin and Hauser,
199379
Engineering
product
development
Individual product
users
Various face-to-
face multiple
Consumerism,
partnership 
Evidence about
methods for
involving
consumers
Gaining the customer voice was
part of product design and
evaluation. Model for achieving
new product success and more
profitable products
Independent
review
Brienza et al.,
199574
Power wheelchair
development
3 out of 7 in the
group were
individual
wheelchair users
Face-to-face: result
of brainstorming of
issues, multivote
and ranking of
priorities
Consumerism,
partnership
5 priorities set Equal participation of
consumers and professionals.
Mutual benefits for consumers
and producers. Assumed
greater awareness of users’
feelings leads to greater
likelihood of successful 
(+ profitable) technology
Independent
review
continued
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TABLE 4 Type D Inviting individual consumer involvement through consultation (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
D.3 Face-to-face encounters on a large scale
Joss and Durant,
199580
Various authorities Members of the
public
Consensus
conference
Participatory
democracy
Few research
topics identified
Dialogue between scientists
and the public – clarity of
language and concepts by
panellists. Focus on appropriate
impact of science on society
rather than impact of public on
science
Independent
review
D.4 Combining written consultations with face-to-face encounters
Dalziel and Fulop,
200074
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D 
SDO
Consumer groups,
patients and carers
Focus group ‘Listening’ Research agenda
published without
detailing consumer
contributions
InterviewsType E: responding to consumer
action with collaboration
Where research programmes responded to
consumer action by collaborating with consumers,
we designated it as Type E engagement (Figure 7).
We found research programmes that have
responded to consumer group attempts to
influence research agendas (advocacy and
campaigning) through various forms of
committees involving consumers and through
teamworking. Although the methods employed for
the interactions may be the same as in Types A–D
(e.g. committee membership and teamworking),
when the issues have been raised initially by
consumers, and the consumers and research
programmes have engaged as a result of strong
campaigning, the balance of power between the
two may be different and for this reason we have
reviewed them separately. Research programmes
responding to consumer groups with a
collaboration were generally seen as successes
from the consumer perspective.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type E approaches to consumer involvement.
E.1 Teamwork
The late 1990s in New York saw strong advocacy
for the needs of homeless people and a dramatic
growth of homelessness research. A homelessness
research programme provided the first systematic
assessments of consumer and provider preferences
regarding the content of research about
homelessness.81 In the winter of 1996–97 they
involved clients and staff at a veterans project in
the selection and prioritisation of research topics.
Working methods emphasised collaborative and
non-hierarchical relationships between researchers
and other participants. Research topics were
identified through a 15-item questionnaire to 87
clients and 28 staff, requesting the five most and
five least important research topics. Staff and
clients differed significantly on six items
considered most important and four items
considered least important. Clients wanted more
research that focused on material needs.
Appreciable data already exist for many of the
topics requested, raising concerns about the
accessibility of homelessness research, and the
need to combine consultations with literature
reviews.
E.2 Multi-level participation designed
in partnership with consumers
Some programmes incorporated consumers
throughout their work with multiple advisory
structures.82,83
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer
groups
Type A Type B
Inviting
individual
consumers
Type C Type D
Responding to
consumer
action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner
or absent
Type H
Type E: committee membership,
teamworking, multilevel
participation, community-
based research
FIGURE 7 Framework for describing Type E consumer involvement in research agenda setting: responding to consumer action with
collaboration  The National Breast Cancer Coalition (NBCC)
has described how its campaigns in the USA led
to a National Action Plan.84,85 In 1991, the
NBCC orchestrated the delivery of 600,000
letters to the House of Congress and the
President, convened ‘research hearings’ with 15
prominent scientists in Washington and
coordinated 38 events in 31 states during
Mothers’ Day weekend in 1992. This led to vast
increases in funding for breast cancer research:
US$132 million for breast cancer research to the
National Cancer Institute in 1992 (almost a
50% increase on the previous year’s spending),
$210 million from the Department of Defense
and $200 million to the National Institutes for
Health (NIH). Further media attention, letter-
writing campaigns, a nation-wide petition and
another Washington march preceded a
conference in 1993 convened to design a
national action plan for breast cancer. Breast
cancer advocates, members of Congress and 
of the Administration, the scientific community,
private industry and the media met to share
ideas and reach consensus on the elements of a
strategy to end breast cancer.84 Objectives
addressing research were to “include consumers
at every level of the decision-making 
process”.
  This story is continued from the perspective of
the Department of Defense Breast Cancer
Research Program86 with a description of how
“consumers sit side-by-side with scientists in
setting research priorities”. The programme
acknowledged that this innovation was a direct
result of pervasive, persistent and highly visible
grass-roots lobbying. The programme funded
research responsively through a two-tier
scientific review system. In the first-tier,
discipline-specific peer review panels assess the
scientific and technical merit of proposals. In
the next tier, an independent review group, the
Integration Panel, reviews meritorious proposals
and recommends funding of those submissions
that best meet the programme goals and advises
the Department of Defense in identifying gaps
in research. Consumers were initially only on
the Integration Panel but in 1995 their role was
expanded to include participation as reviewers
on scientific peer review panels. By 1998, 318
consumers had served on over 150 review
panels contributing their expertise and first-
hand experiences, “ensuring that the human
dimensions of breast cancer are fully
incorporated into decisions about research
funding”. Following evaluation of the initiative,
consumer involvement in scientific review was
incorporated into all research programmes
conducted by the Department of Defense
Congressionally Directed Medical Research
Programs.
“Organisation and commitment to the goals of
consumer involvement were critical … the
introduction of change in the traditional scientific
review process by this novel program was met with
scepticism and some resistance. These issues were
addressed throughout the program’s history. Four
major factors were essential in meeting this
challenge: (a) effective program management, (b) a
process of improvement focus, (c) firm leadership,
and (d) the allocation of sufficient resources.”86
A consumer working group played a crucial
management role, establishing clear goals and
core objectives, prioritised programme
functions, developed and organised procedures
and processes, motivated and built consensus
amongst participants and designed systems for
feedback and analysis. Ongoing review and
analysis of the programme by the consumer
working group, and documentation of the
programme modifications, led to a model
programme which has since been adapted to
other settings.
  Women in breast cancer groups in California
campaigned for and helped write the legislation
for the Breast Cancer Act of 1993, which led to
the setting up of the California Breast Cancer
Research Program.83 The Breast Cancer
Research Council was composed of breast
cancer survivors and related advocacy groups
(one-third of the members), clinicians and
scientists (one-third of the members) and
representatives of non-profit health
organisations, private industry and practising
breast cancer clinical specialists; and women
with breast cancer have chaired or vice-chaired
the council. In 1996, the programme held a
Public Advisory Meeting with representatives of
academic research scientists, biotechnology
researchers, clinical scientists and practitioners,
healthcare providers, voluntary health
organisations, community-based agencies 
and breast cancer advocacy organisations who
were invited to develop its funding priorities.
These priorities included an emphasis on
“innovative and creative research, especially on
research that complements, rather than
duplicates, research funded by the Federal
Government or other agencies”. This
involvement was summarised as a “pyramid of
influence” of consumers within the 
programme.
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described by the research programme as a
participatory research approach where the
catalyst for consumer involvement was grass-
roots campaigning. They described their
participatory research as: “(a) extensive
collaboration between traditionally defined
researchers and the community in each stage
from identifying the problem to applying and
disseminating the results; (b) a reciprocal
educational process between community and
researchers; and (c) an emphasis on taking
action on the issue under study.”82 The
National Forum on Breast Cancer, held in
November 1993, was the first major activity of
the initiative. Women affected by breast cancer
were involved on the organising committee and
on various sub-committees and working groups
developing background information and
materials for the Forum. Approximately one-
quarter of the 650 invited participants were
women and their families, the remainder being
clinicians, researchers, representatives of non-
government agencies and policy makers. “The
concerns of women dealing with the day-to-day
reality of breast cancer were articulated clearly
in presentations by breast cancer survivors in
the plenary sessions as well as in the small
group discussions, in which all participants
reviewed and refined the initial sub-committee
recommendations.” Thus the community made
its voice heard. Areas of research that were
strongly identified at the Forum included the
psychosocial support of women with breast
cancer and their families, the study of potential
environmental causes of breast cancer and the
effectiveness of alternative therapies.
Recommendations of survivor participants at
the Forum led to the setting up of the Canadian
Breast Cancer Network. This was a non-profit,
charitable organisation that was a survivor-
driven national network of organisations and
individuals. The Cancer Network sought to
promote education and communication about
breast health, increase awareness of breast
cancer as a major national health issue, increase
openness and accountability in the research
process, sustain a national network of breast
cancer groups and survivors and help survivors
develop support systems that meet their unique
needs. Representation on the Breast Cancer
Initiative committees was drawn from this
network.
Key aspects seen by the Breast Cancer Initiative
as likely contributors to the effectiveness of
consumer participation included: involvement
of all key stakeholders, including consumers, at
a very early stage of the planning process
‘without pressure from above’; being and being
seen to be responsive to the identified needs of
the consumers in a meaningful way; and
including those stakeholders who can assist in
implementing the final products of the
Initiative. Challenges included those
organisational pressures that influence the
political will to involve and respond to
consumers, the sublimation of science to the
pressures of advocacy and the reality that the
health of consumers may deteriorate at critical
points during the process.
Reviewers’ commentary
These breast cancer campaigns were examples of
grass-roots advocacy. They differed from
collaborations instigated proactively by research
programmes (Type A) in that they led to
fundamental changes in research funding
structures. The Department of Defense breast
cancer research programme differs from others we
have reviewed in being a responsive programme.
Rather than setting specific priorities for research,
the funders invited suggestions from researchers.
Prioritisation was through judging individual
proposals.
Breast cancer advocates in all the multilevel
participation examples described above were
instrumental in designing a new programme
rather than being recruited into an existing
programme. The Canadian example was described
by the authors as participative research. This
differs from other examples of participative
research, which more often were local rather than
national in scale, and tended to involve consumers
directly in conducting research rather than
increasing openness and accountability in the
research conducted by professionals. Both national
and local examples of participative research
emphasised a commitment to action.
E.3 Consumer activism leading to
organisational change and multilevel
participation
We found two examples of established research
organisations responding to a culture of consumer
activism by amending their working systems in
order to attract broad consumer input into their
work.58,67
  One such example in Australia entailed
consumers being involved in setting a research
agenda for breast cancer.58 Consumers were
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Breast Cancer Centre and attended a consensus
conference, in which consumer representatives –
women with breast cancer – were equal
participants in the process. The National Breast
Cancer Centre in Australia worked “in
partnership with women, health professionals,
cancer organisations, researchers and
governments to improve breast cancer outcomes
for women”. In 1996, the Centre held a
consensus meeting to establish views about
future research priorities and strategies for
encouraging work in these areas. Care was taken
in the choice of participants and procedures to
reduce the possibility of bias. All groups to be
represented at the meeting were identified at
the outset and individuals selected to provide
this representation. In this case, key groups
included researchers, clinicians, policy makers,
women with breast cancer and well women.
Representatives of each group were required to
have a comprehensive understanding of the
issues, to be seen as peer leaders and capable of
providing a wide view rather than focusing only
on their own clinical or research areas.
Background information was circulated 1 week
in advance of the meeting, and a structured
process involved an independent facilitator
using a modified nominal group technique.
Seven priority areas emerged from the
discussion. Brief definitions for each area were
written by subgroups of participants and were
approved by the whole meeting. Although there
was a high degree of consensus about the
priorities, there was considerable disagreement
about the value of ranking the seven priorities.
The ethos of research programmes with a
commitment to consumer involvement was
recognised as an advantage in the report. It was
felt that the Australian breast cancer
programme “focused on the needs of the 
end user”, because consumers were involved 
in the setting up of the research programme,
and their involvement was incorporated
throughout the advisory processes of the
programme.
  In 1998, the US Institute of Medicine published
an independent review of priority setting and
public input at the NIH.67 Congress requested
this review against a background of NIH
appropriating US$13.6 billion of the total $16
billion of public funds for research from the
Federal Government. The review committee was
to examine the criteria for allocating research
funds, mechanisms for public input and the
impact of congressional directives. The
committee heard from NIH directors and
legislative aides in key Congress offices. It also
held a full-day public meeting at which
members received written and verbal testimony
from patients, advocacy and interest groups,
foundations and professional societies. They
recognised the frustration felt by some groups
at not being listened to and heard by NIH, and
found that some Institutes lacked mechanisms
for orderly, regular public input and outreach.
This frustration may have been compounded by
the lack of transparency needed to satisfy
people that allocation decisions were made on
the basis of equity and justice, as well as
scientific opportunity. A number of
recommendations related specifically to public
input, including:
1. More public members of the Advisory
Committee to the Director, and greater
involvement in the priority-setting process.
2. An Office of Public Liaison in the Office of
the Director and … in each Institute office to
document, in a standard format, their public
outreach, input, and response mechanisms,
with review by the Director’s Office of Public
Liaison to evaluate and identify best
practices.
3. A Director’s Council of Public
Representatives … to facilitate interactions
between NIH and the general public.
4. Public membership of NIH policy and
programme advisory groups selected to
represent a broad range of public
constituencies.
5. Adjusted levels of funding for research
management and support so that NIH can
implement improvements in the priority-
setting process, including stronger analytical,
planning and public interface capacities.
Establishing an Office of Public Liaison was to
facilitate and enhance a two-way communication
with the public. Its key functions were to
include: receiving input from a broader range
of constituencies, disease-specific interest
groups, and others…; organising this input to
inform priority setting; documenting the ways
in which this input is provided to those 
involved with NIH decision-making processes
and NIH’s responses to this input; involving
NIH leadership in receiving and responding 
to input from the public; advising the 
Office of Communications so that NIH
maximises its resources by providing
information and programmes that are most
responsive to the public; and evaluating all
these activities.
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Representatives would meet three or four times
a year to advise the Director on how best to
engage the public in priority setting, achieve
broad representation for all public liaison,
enhance public understanding of NIH, consider
the health concerns of special populations,
improve transparency and identify best practice
for receiving public input and advocating their
replication across the NIH.
Reviewers’ commentary
From a consumer perspective, taking the initiative
with campaigns and grass-roots advocacy has led
to huge advantages of new programmes in which
consumers were instrumental in establishing
structures and procedures for ongoing
involvement.82–85,87 Reports prepared from a
research perspective have also noted such
advantages.10,67,86 Consumer campaigns have also
had some success in provoking changes within
research organisations to increase consumer
input.58,67
Consumers reported the debate as fully involving
participants and attributed this to the choice of
facilitator, a fellow consumer37 on one occasion
and an independent facilitator on another.58
E.4 Community-based research
  An example of community-based research was a
study of child accidents and the maintenance of
safety which ran alongside a parents’ action
group on child safety in Corkerhill,88 Glasgow,
Scotland. The community view was that
“too often we have been subjected to the ‘goldfish
bowl’ approach to research. We have been
researched upon. The researcher selects the topic,
studies his subject and returns to the lofty towers of
academia leaving a bemused community who very
soon realise that they have gained nothing from
the experience … . If community research is to be
meaningful it must be carried out with the full
cooperation of the community in partnership with
the academics. It must also address issues which
are identified as prioritised by local people.”
On this occasion, the community approached
the researchers, who acknowledged that:
“Research agendas do not drop from the sky,
and…at the time the work was set up, child
accident research did not have the priority which
subsequently resulted from the publication of The
Nation’s Health (Department of Health, 1992). The
research derived from anxieties parents felt about
the safety of their children in Corkerhill.”
Hence the topic of research went well beyond
whether they would be run over by a car to
include the lack of safe play areas. Instead,
children played in cold, damp housing,
residential entrance halls littered with needles
and a run-down children’s playground next to a
main road as alternatives. As the community
educated the researchers into the broad scope
of child safety in unsafe environments, the
researchers were able to bring to the community
understandings about the role of social
epidemiology in describing and understanding
patterns of accidents and ways in which these
could be used. The result was a community-led
research programme and consequent health
gains. Three times a week up to 50 children
joined a ‘Dangerwatch’ scheme where, rather
than being ‘talked at’ about safety, children were
given the much more interesting task of
identifying potential dangers in their homes,
backcourts and streets. Also, Glasgow City
Council invested £970,000 in a central heating
system for Corkerhill. This was probably the
result of a number of initiatives: the Corkerhill
Damphouse inquiry; representations made by
Corkerhill Community Council to the Scottish
Office; and evidence from the accident
prevention research on risks people perceived
as being related to their damp housing. “While
in traditional accident prevention terms, the
installation of central heating might seem a
long way from getting children to cross the road
safely, from the tenants’ perspective, a warm
house is more likely to be a safer house for their
children.”
Reviewers’ commentary
Most community-based research, like the example
above, shares elements of participatory action
research.
A very different model sprang from the collective
social action of HIV campaigns. The campaigns of
breast cancer activists described above seem mild
in comparison with those of people with AIDS.
  “Never before have people with a disease
organised so effectively to challenge
government, the pharmaceutical industry, and
researchers to change the way drugs are tested
and approved.”89 AIDS spread rapidly amongst
a population of young people who already had
experience of organising themselves to fight
discrimination based on their sexual
orientation. People with AIDS built on this to
plan traditional lobbying campaigns, made-for-
the-media protests and civil disobedience to
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Federal Funding for AIDS research and
education. They won scientific acceptance of
and funding for a novel type of research,
community-based clinical trials, by the
Community Research Initiative in New York,
where community physicians with AIDS
practices planned clinical trials designed with
patient input. In this way, community physicians
could recruit patients to participate in research
more easily, access to experimental drugs would
be broadened and people with AIDS could
exercise more control over what drugs were
studied and how trials were designed, and thus
would be more likely to follow trial protocols.
The expectation was for quicker, cheaper
research compared with the more usual large
academic centres. Similar organisations
developed in other cities. Federal funds were
secured in 1989: US$9 million to 18 pilot
programmes for community-based research in
14 cities, and a further $1.4 million was
awarded by the American Foundation for AIDS
Research.
One activist group, the AIDS Coalition to
Unleash Power, developed ‘The National
Treatment Research Agenda’ which called for
sweeping changes in AIDS research and drug
regulatory processes, including (a) broadening
trial eligibility criteria so that most people with
AIDS could enrol in trials, (b) permitting
concurrent treatment to prevent opportunistic
infections while enrolled in clinical trials, (c)
involving people with AIDS in designing trials,
(d) avoiding placebos and (e) not using death as
the sole clinical end-point. A constructive
response from scientists was to propose that the
community-based clinical trial programme
provide the infrastructure for conducting ‘low-
technology’ trials which accommodated the first
three demands.
  The story of a small-scale study of the
relationship between HIV and suicide describes
explicitly how the idea developed in London in
the 1990s.90 The UK Coalition of People Living
with HIV and AIDS brought suicide to the
attention of Members of Parliament,
government officials, healthcare professionals
and the HIV voluntary sector, highlighting the
need for action and the urgency they felt. The
increasing number of people attempting or
succeeding in suicide was not anecdotal to
them, but a reality. As front-line supporters they
bore the burden of many people turning to
them for information on effective ways to
commit suicide or for a listening ear. Formal
evidence was needed to justify resources to
address the issue and this was the motivation
for a collaborative study which brought together
the HEA, researchers at the Royal Free
Hospital, London, and people with HIV and
AIDS.91
  The National Childbirth Trust (NCT) was a UK
user group with 40 years’ experience and
approximately 40,000 members. It ran
antenatal classes, breastfeeding counselling and
postnatal support. Some of its members and
staff were concerned about the conflicting
information about breastfeeding given to
women with flat or inverted nipples. They
needed to know what treatment, if any, for flat
or inverted nipples was worth recommending
for women wishing to breastfeed. They
approached the National Perinatal
Epidemiology Unit for help. This research unit
had also been approached by a midwife asking
for help in extending a trial comparing
treatments. As midwives and childbearing
women had the same research agenda, they
worked together to conduct a trial in which
consumers were involved in the design of the
study and the recruitment of participants.92
  A much younger and smaller consumer
organisation has influenced the research agenda
of the Royal College of Radiologists. In 1991, a
legal report in the national press about a
compensation suit for damages following
radiotherapy attracted the attention of other
women with similar injuries. Until then they
had thought they were unique in sustaining
severe and permanent brachial plexus injury
following radiotherapy treatment for breast
cancer. The women met and formed RAGE
(Radiotherapy Action Group Exposure). This
grew into a self-supporting voluntary group
with the additional aim of campaigning for an
investigation into the cause of radiotherapy
injury in order to avoid future incidence and
ensure that patients are warned of any risk.
Public awareness grew and media interest
during 1993 increased the list of RAGE contacts
and members to 1500. RAGE reported how
they advanced their cause through persistent
pro-active campaigning and cooperation with
the Department of Health and Royal College of
Radiotherapists. As a result of a House of Lords
debate, a committee was convened to consider
how women with axial tunnel damage
associated with radiation should be managed.93
Four of the 14 members were consumer
Results of systematic review
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members about their injuries and their attempts
to treat them and relieve pain. The findings of
this consultation were included in the report
published by the Royal College of
Radiotherapists.93 The same data from RAGE
also informed an independent review
commissioned by the Royal College of
Radiologists, at the request of the Department
of Health, into brachial plexus neuropathy
following radiotherapy for breast cancer.94
This report identified research questions about
the impact of dose and application of
radiotherapy. The work of the earlier
committee led to a randomised controlled trial
of hyperbaric oxygen with patient
representatives actively involving the design of
the study, recruitment, support of participants
and monitoring of outcomes (Bradburn J,
personal communication. Cancer Support and
Information Centre, Mount Vernon Hospital,
Northwood, Middlesex. 1997).
Reviewers’ commentary
We found several examples of ‘communities’
identifying and prioritising individual research
topics by drawing on their pooled experience:
these topics were issues they faced in their daily
lives, issues that defined the nature of the group.
In each case, their achievement was seeing the
research conducted, not merely identifying the
research need.
Key messages
When research programmes respond to
consumers’ campaigns:
Details of Type E approaches are given in Table 5.
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  Collaboration followed where there 
was a greater experience of consumer
activism.10,58,82–90,92,93
  Formalised consumer involvement 
ensued on a grand scale where much
of the dialogue was about the process
of decision-making, in addition to the
decisions, in research agenda
setting.67,83–87
  Consumer groups proactively identify 
and prioritise individual research topics
as part of their mutual support
activities. These topics often reflect the
issues that define the group.89,90,92,93
  Research with a consumer perspective
has resulted from collaborating with
geographical consumer communities88
or special interest consumer
communities.90,93
  Consumer activism has led to
structural changes in research funding
not seen in other types of engagement,
or in the UK. Participative approaches
to building research programmes on a
national scale avoided ‘tokenism’ and
were seen as successes by consumers
and research managers.82–86
  In the UK, activism has not led to
collaborative efforts to restructure
research agenda-setting programmes,
but to more modest individual research
projects.10,93
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TABLE 5 Type E Responding to consumer groups with collaborations
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
E.1 Teamwork
Cohen et al.,
199981
Homeless research
programme in
New York
Advocates and
individual homeless
people
Teamwork –
collaboration in
conducting a
survey
Equal partnership Record of client
and staff research
preferences
Description by
participant
researchers/
managers
E.2 Multi-level participation designed in partnership with consumers
The National
Breast Cancer
Coalition, 199484
and undated85
Breast cancer NBCC in USA Committee
membership
multiple
Consumers forced
positive action; led
to a partnership
approach
Consumers
secured extra
funding for breast
cancer research.
National Action
Plan aimed to
include consumers
at every level of
the decision-
making processes
Campaigns leading to summit
and National Action Plan
Description by
participant
consumer group
Rich et al., 199886 Department of
Defense Breast
Cancer Research
Grassroots breast
cancer
organisations
nation-wide
Committee
membership,
scientific peer
review
Organisational
change
Human dimensions
of breast cancer
considered in
funding decisions
Description by
participant
researchers/
managers
California Breast
Cancer
Organisation83
California Breast
Cancer
Organisation
Breast cancer
survivors and
related organisation
advocates
CI incorporated
throughout
programme –
ongoing – “a
pyramid of
influence”:
consumer
involvement
through committee
Chair, membership
and public
meetings
One-third of Breast
Cancer Research
Council consumer
members
(enshrined in law)
Description by
participant
consumers
continuedH
e
a
l
t
h
 
T
e
c
h
n
o
l
o
g
y
 
A
s
s
e
s
s
m
e
n
t
2
0
0
4
;
 
V
o
l
.
 
8
:
 
N
o
.
 
1
5
5
9
©
 
Q
u
e
e
n
’
s
 
P
r
i
n
t
e
r
 
a
n
d
 
C
o
n
t
r
o
l
l
e
r
 
o
f
 
H
M
S
O
 
2
0
0
4
.
 
A
l
l
 
r
i
g
h
t
s
 
r
e
s
e
r
v
e
d
.
TABLE 5 Type E Responding to consumer groups with collaborations (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Parboosingh et al.,
199782
Canadian Breast
Cancer Initiative
Development of
multiple levels of
involvement in
agenda setting at
Canadian Breast
Cancer Research
Initiative, following
consumer group
advocacy
Participatory
research approach
Survivor-driven
national network of
organisations and
individuals
established to,
amongst other
aims, increase
openness and
accountability in
the research
process
Consumers involved in setting
structures
Description by
participant
researchers/
managers
E.3 Consumer activism leading to organisational change and multi-level participation
National Breast
Cancer Centre,
199859
NBCC in Australia Committee
membership and
consensus
conference
Ethos: consumer
involvement
throughout
programme
Research agenda
published without
detailing consumer
contributions
NBCC set up in response to
consumer concerns. Criteria
for choosing participants;
independent facilitator; pre-
reading sent week ahead.
“Focused on the needs of the
end user”. Consumer identified
and ranked topics. Informed
debate. Full participation
Description by
participant
researchers/
managers
Institute of
Medicine,
undated67
NIH Patients/their
families and
advocacy groups
Committee
membership,
liaison office;
Director’s Council
of Public
Representatives
Organisational
change
Recommendations
on processes for
involvement and
funding
Independent
review by
committee
E.4 Community-based research
Rice et al., 199488 Contract social
scientists
Residential
community
Community
initiated research
project – bottom
up approach
Social action Consumers
identified issues
and ‘commissioned’
researchers to do
project
Greater shared knowledge and
increased ability/confidence to
participate in decision-making.
“Stronger voice” to the
community
Description by
participant
researchers/
managers and
participant
consumer
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TABLE 5 Type E Responding to consumer groups with collaborations (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Dunbar, 199189 HIV activists Partnership
approach, following
range of lobbying
tactics
Social action Community
Research Initiative
– one idea to
design clinical trials
with patient input
Prior activist experience Independent
unsystematic
review
Campbell, 1995;90
Scherr, 199591
UK Coalition of
People Living with
HIV/AIDS
Collaborating with
range of
professional
partners – HEA,
Royal Free Hospital
to set up team
working on issue
Partnership
(implicit)
Research project Outcome of lobbying on suicide
issues
Description by
participant
consumers
Renfrew and
McCandish, 199292
National perinatal
epidemiology unit
National consumer
group: NCT
NCT approached
NPEU with
research question –
developed joint
agenda
Completed
randomised
controlled trial
Shared learning Description by
participant
researchers/
managers
Maher, 1995;93
Bates and Evans,
199594
Maher committee National consumer
group: RAGE
Committee
membership
Independent
researcher’s
review of
interaction
Description by
participant
researchers/
managers and
participant
consumerType F: responding to consumers
with consultation
Where research programmes responded to
consumer action by consulting consumers, we
designated it as Type F engagement (Figure 8). 
We found two examples of consultations mounted
on a national scale in response to consumer
activism.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type F approaches to consumer involvement.
  In the UK, widespread lobbying for
improvements in maternity services indirectly
led to consumer influence of the research
agenda at a national and local level. This story
has been retold from an American
perspective.10 A major government enquiry by
the Select Committee on Health into maternity
services coincided with an increasingly
organised body of research evidence collated by
the National Perinatal Epidemiology Unit,
growing consumer activity led by national
organisations and a more sophisticated political
awareness of a major provider group, the Royal
College of Midwives. The resulting report
advocated widespread change in the
organisation of services and greater information
and choice for childbearing women. “The
Department of Health adopted classic
bureaucratic strategies in responding … calling
for more research, naming study groups,
generally agreeing to the principles involved
and promising little.” It named a nine-member
‘Expert Maternity Group’ to continue the
inquiry into maternity services, and this
included a consumer group member, a
journalist and a representative from the Asian
Family Counselling Service. This group
commissioned a national study of women’s
attitudes concerning their experiences with
maternity services to inform their work. Their
final report, ‘Changing Childbirth’, following a
formal consultation period, provided a
framework for national and local initiatives
many of which involved either research into
alternative systems for organising maternity
care or assessment of the maternity care needs
of women from different population groups.
These projects often included consumers as
active partners.
  In Canada, following intensive lobbying by a
national coalition of women, the Government
convened a Royal Commission on new
reproductive technologies. This established a
Health Technology Assessment 2004; Vol. 8: No. 15
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer groups
Type A Type B
Inviting
individual
consumers
Type C Type D
Responding to
consumer action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner or
absent
Type H
Type F: political
enquiries
FIGURE 8 Framework for describing Type F consumer involvement in research agenda setting: responding to consumer action with
consultationConsultation and Communications programme
involving public hearings across Canada on
issues which were to be reflected in the other
stream of work, the Research and Evaluation
programme.95 The consultation included public
hearings in 17 centres across the country, a
national survey to 15,000 people and toll-free
telephone lines for individuals to transmit
viewpoints. There were also informal discussion
groups for academics, practitioners and
advocates together to develop a framework for
research and development and identify research
gaps. The Royal Commission allowed for “an
arm’s-length review of a contentious issue and
[made] recommendations back to the
government of the day”. The report does not
clearly record contributions made by
consumers.
Reviewers’ commentary
The two examples show how intensive and
sustained lobbying by well-organised and politically
astute consumer groups has led to public enquiries
on a national scale. Both instances involved many
consumer groups; the Canadian example involved
a formal coalition of groups. Both ensuing
consultations involved individuals and consumer
groups and kept the issues in the public eye, but
neither reports distinguished consumer
contributions from those of others.
Key messages
The key message is as follows:
Details of Type F approaches are given in Table 6.
Results of systematic review
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  Well-established, politically aware
consumer groups have sufficient critical
mass to provoke sustained public debate
and influence the research agenda.10,95
UKH
e
a
l
t
h
 
T
e
c
h
n
o
l
o
g
y
 
A
s
s
e
s
s
m
e
n
t
2
0
0
4
;
 
V
o
l
.
 
8
:
 
N
o
.
 
1
5
6
3
©
 
Q
u
e
e
n
’
s
 
P
r
i
n
t
e
r
 
a
n
d
 
C
o
n
t
r
o
l
l
e
r
 
o
f
 
H
M
S
O
 
2
0
0
4
.
 
A
l
l
 
r
i
g
h
t
s
 
r
e
s
e
r
v
e
d
.
TABLE 6 Type F Responding to consumer action with consultation
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Declercq, 199810 Maternity care National groups
and individuals
NCT/AIMS
campaigns – review
of activities leading
up to reform.
Committee had
one consumer
group member
Social action Consumers putting
maternity care
reform on to
government
agenda. Led to
Department of
Health Expert
Maternity Group –
Changing
Childbirth Report
Conclusion of review: public
interest groups can influence
policy agendas
Independent
review by
researcher
Roberts 1999,95 Royal Commission
for new
reproductive
technologies,
Canadian
Government
Coalition of
women
Public hearings in
17 centres across
Canada, national
surveys to 15,000
people, toll-free
telephone lines,
informal discussion
between
academics,
practitioners and
advocates
Social action Framework of
R&D programme,
but no analysis of
the identified topics
Broad public involvement
combined with advocacy
contributed to review of
contentious issues
Description by
participant
researchers/
managersType G: responding to consumer
action with research
Where research programmes responded to
consumer action by mounting research, we
designated it as Type G engagement (Figure 9).
The research provoked by consumer action may be
about the topics raised by activists, or topics
chosen in defence of consumer action.
Alternatively it may seek consumers’ views about
research. Either way, we present here examples of
consumer action indirectly influencing research
agendas.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type G approaches to consumer involvement.
G.1 Provoking research about
patients’ views
  The power of a poignant personal message was
apparent from the commentary on an essay by a
Professor of English. George Zimmer was a
cancer patient in Chicago. He participated in
several Phase I cancer trials for ascertaining
treatment doses and toxicity. His views
appeared in a paper for which he was a
posthumous co-author with his doctors in
1997.96 He considered that:
“ …important facets of the whole person are
largely ignored when trial protocols are designed.
… Patients who do seek to participate in protocols
are those who question the status quo and those
who are most eager to alter it. These useful traits
often make them the despair of those who care for
them because they question the programme in
detail: they want to redesign the protocol to fit self-
perceived needs. To a minor extent they often do
succeed in having the protocol adjusted, thereby
rendering trial results still more suspect.
“What would happen if a control group of more or
less uncontrolled participants were permitted to
change a protocol in radical ways? For example, if
participants were allowed to combine substances as
long as the combination was not known to cause
death? Or, what if participants were allowed to
increase drug doses as long as the amount was not
known to cause permanent crippling? A hundred
such patients might improve the chances of finding
a cure a hundredfold….
“That some of the 100 participants would die of
the effects of their medication would be
unavoidable – but better that a few fall in the
storming of a bastion than no storming be
attempted…. Letting a patient choose the poisons
(under professional guidance) adds something to
the will to struggle. We who are struggling to
escape cancer do not obviously want to die of it.
We do prefer death in the struggle to life under
cancer’s untender rule. The enemy is not pain or
even death, which will come for us in any
eventuality. The enemy is cancer and we want it
defeated and destroyed…
Results of systematic review
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer groups
Type A Type B
Inviting
individual
consumers
Type C Type D
Responding to
consumer action
Type E Type F Type G
Researchers’
degree of
engagement
Minor partner or
absent
Type H
Type G:
document
analysis; public
correspondence;
lobbying/
campaigning
FIGURE 9 Framework for describing Type G consumer involvement in research agenda setting: responding to consumer action with
research“This is how I want to die – not a suicide and not
passively accepting, but eagerly in the struggle.”
He died of cancer approximately 6 months after
writing his essay. His doctors were receptive to
rethinking their approaches to research.
“His ideas are eloquently expressed and have had a
profound effect on our investigational research for
anticancer agents…. We must also listen carefully
and thoughtfully to our patients. This is
particularly true when, as research participants in
the face of sacrifice and the threat of life-ending
diagnoses, they have made the effort to express
their concerns. On a personal level the essay by
Professor Zimmer has had a significant effect on
our research efforts. Thus it is with a sense of
respect and honor that we share George Zimmer’s
thoughts and our comments about the influence he
has had on our research practice.”96
The researchers were influenced by this
emotionally charged essay, but not sufficiently
to abandon their reason. Rather than simply
adopting George Zimmer’s recommendations,
they re-evaluated their views on Phase 1 cancer
trials, and initiated a research programme to
investigate to what extent his views were shared
by other patients. Finding that most patients
enter Phase 1 trials exclusively for therapeutic
reasons, and not altruistic reasons, often
ignorant of their investigative nature, George
Zimmer’s physicians conducted a feasibility
study that attempted to incorporate the
personal decision-making process of patients in
Phase 1 trials and that allowed patients to
determine the amount of risk they are willing to
accept. The goals of this study were to increase
patient understanding and autonomy through
direct participation in research decisions and to
increase patient satisfaction with clinical
research.
  In 1997, ‘Dolly’ the lamb was the first successful
cloning from an adult cell of a mammal. This
was followed by a wave of concern expressed by
political and religious leaders worldwide. The
USA and the European Union both responded
by commissioning a review of the ethics of
cloning research.97
  Bombings, hunger strikes and death threats
have been used to protest against the use of
animal experimentation. A MORI poll was
commissioned to ask a representative sample of
British adults whether they supported or
opposed each of a series of hypothetical
experiments.98 The wording of the questions
was criticised for its bias and for the assumption
that people’s “gut reaction is based on
misunderstanding”.99
G.2 Research matching consumers’
priorities
In contrast, when consumers expressed their
research ideas in detail and in a medium familiar
to researchers, there was a route to influencing
subsequent research.100,101
  When mothers of hyperactive boys, following
their hunch about a possible cause,
substantiated their claim with a local survey and
published their work in the academic
literature,100 they attracted the interest of
scientists sufficiently motivated to investigate
their research ideas further.102
  A letter from the NCT published in the BMJ103
in 1990 refuted a consultant’s claim104 that
there had been no published investigations
concerning long-term problems associated with
epidural anaesthesia in labour. Unsolicited
reports of postnatal morbidity had prompted
members of the NCT to undertake their own
retrospective study of members’ experiences.
They had found long-term symptoms, including
headaches, bladder problems, tingling or
numbness, sensory confusion and, in particular,
backache.105 The letter called for “a prospective
study of the administration of epidurals and
care of anaesthetised women … to show the
cause of injuries and indicate ways of avoiding
them in future”. The consultant criticised in the
letter subsequently led a randomised controlled
trial of two types of epidural analgesia
evaluating short- and long-term outcomes
including backache.106 This trial was
commissioned by the NHS Mother and Child
Health programme as part of their priority for
addressing interventions in labour – short- and
long-term outcomes. It ran from 1997 until
2001.
  The Kendal Lakes Women Against Cancer
Community Group has been described by
Public Health and Oncology Consultants as
typical of community responses confronted by
medical environmental concerns.107 In 1985,
residents of this suburban community in South
Florida became concerned when several young
women were diagnosed with breast cancer. The
women formed a community-based organisation
to coordinate their community action and
publicity. They had little or no prior experience
of research, but their efforts led to an
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University of Miami and funded by the State
Department of Health and Rehabilitative
Services. The aim was to find out whether some
agent or toxic exposure existed in the
community that may have caused breast cancer.
Ultimately the study concluded that there was
no environmental or chemical agent directly
causing death in the Kendal Lakes Community
and the consumer organisation disbanded. This
episode was discussed in the context of a brief
literature review. Other examples have shown
harm; most notorious was the story of Love
Canal where residents used community action,
pressure and publicity to reveal high levels of
benzene and other chemicals in their homes,
and they were eventually able to relocate their
families.108
Collective action resulting in research was 
not always seen as in the interests of the 
public. The authors interpreted other
environmental research in Pittsfield, MA, as 
the US Environmental Protection Agency
employing the ‘need for further research’ as a
tactic to delay implementation of legislation to
regulate the General Electric Company’s
production and disposal of polychlorinated
biphenyls.107
The authors described how cases of community
activism shared a basic pattern of activities:
citizen identification of the problem; formation
of an action-oriented group or committee;
initial apathy of governmental or other official
authorities; local or national publicity;
development and implementation of an
epidemiological or community-based
investigation; and resolution of the issue. The
authors considered this a rational community
response to a threat rather than a panic
reaction to be contained, and concluded that
such community persistence, first by individuals
and then as a group, has proven necessary in a
variety of cases to address medical
environmental issues objectively and
systematically.
G.3 Research contradicting
consumers’ priorities
  Age Concern commissioned a survey from the
Gallup Organisation to find out what women
aged 65 years or over knew about the screening
programme and risks of breast cancer.109 Basing
their case on this and their interpretation of
professional research,110,111 Age Concern
criticised the current arrangements for
screening for breast cancer112 and the
government’s proposal for two pilot projects to
investigate screening for breast cancer in
women aged 65–69 years.112,113
“Age Concern is disappointed and believes the
government’s proposal to set up two small pilot
projects is an unnecessary delay, since major
research trials from abroad already confirm that
substantial numbers of deaths can be prevented by
screening women up to and beyond the age of 69.
The charity has also called on the government to,
at the very least, implement a public education
programme to publicise the benefits of screening
to women of all ages over 50, so that those who are
currently not invited are encouraged to request a
screening”.114
Reviewers’ commentary
Some researchers have responded to consumer
action with a positive attitude towards consumer
influence, either seeking consumer views indirectly
through records of their individual or group
action, or by conducting research on topics
suggested by consumers. However, without
engaging directly with the consumers themselves,
they have limited understanding about consumers’
views.
On some occasions consumers interpret research
conducted without their input as an unhelpful sop
to their demands: research called for by
consumers has been delayed, and other research
has been conducted in preference to meeting
consumers’ other demands.
Key messages 
Consumer views have:
Details of Type G approaches are given in Table 7.
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  Inspired new research when
consumers wrote in their own words
but in a medium that would reach
researchers.96,101,102
  Profoundly influenced researchers’
attitudes and the direction of their
research when offered as a poignant
message with emotive language.96
  Provoked bad publicity for authorities
where consumers perceived them
delaying research that would meet
consumer demands, or conducting
research as a delaying tactic.107,115
  Attracted attention to conflicts –
campaigns against cloning research,
animal experimentation.97,99
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TABLE 7 Type G Responding to consumer action with research
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
G.1 Provoking research about patients’ views
Daugherty et al.,
199796
Clinical cancer
department
Patient Patient’s essay Changed attitudes
in associated
research project
Personal influence due to
patient’s knowledge,
motivation, intelligence and
comprehension
Description by
participant
researchers/
managers
G.2 Research matching consumers’ priorities
Colquhoun and
Bunda, 1995;100
Stevens et al.,
1995102
Clinical research:
hyperactivity
Mothers of
hyperactive
children
Consumer-led
research published
in journal
Social action Consumer
research and
subsequent
professional
research
Consumer control and adapting
their communication style to
suit professional literature. No
direct communication.
Research topics directly linked
to individual consumer
concerns. Topic expressed in
consumers’ own words and a
research framework. Impact on
research fortuitous
Description by
participant
researchers/
managers; and by
participant
consumers
Newburn, 1990;103
MacArthur,
1990;104 Kitzinger,
1987;105 National
Research Register,
2001106
National consumer
group
Letter in medical
journal
Social action Consumer priority
on national
research agenda
and commissioned
research project
Wide readership but no direct
engagement
Letter by
participant
consumers
Butler and
Wadman, 199797
Cloning Public opinion Media attention Bioethics Led to US- and
EU-commissioned
reviews on the
ethics of cloning
research
Wide readership but no direct
engagement
Description by
journalist
Aldous et al.,
1999;98 Balls,
199999
Cloning Public opinion Public opinion poll Bioethics Controversy and
publicity
Lack of clarification about
public priorities
Description by
participant
researcher/
manager and
critique by
researcher
continued
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TABLE 7 Type G Responding to consumer action with research (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
McCoy et al.,
1992;107 Gibbs,
1982108
State Department
of Health and
Rehabilitative
Services
Women in the local
community
Lobbying Social action Epidemiological
study
Description by
independent
researchers
G.3 Research contradicting consumers’ priorities
Age Concern
England, 1996;109
Hendry and
Entwistle, 1996110
Horton Taylor 
et al., 1996;111
Age Concern
England, 1995113
and undated; 112
Age Concern
England,
undated114
Age Concern
England,1995115
UK Department of
Health
Age Concern Lobbying Social action Controversy and
publicity
Reports by
consumer
participantsType H: independent consumer
action
Where consumers acted independently in
identifying or prioritising research topics, we
designated it as Type H engagement (with research,
rather than researchers or research programmes)
(Figure 10). In searching for consumer involvement
in setting research agendas, we found examples of
consumers calling for specific research where we
found no evidence of this call being heeded.
Consumers sometimes placed their calls for
research in the national press or the scientific press,
and sometimes their actions were recorded by
journalists or researchers. We have not addressed
the many examples of consumers prioritising and
conducting their own research.
Summaries of all the reports based on authors’
original descriptions of the processes and outputs
of individual examples for each forum appear
below. These are followed by our own comments
as reviewers on these methods and, finally, key
messages that we have deduced from reviewing
Type H approaches to consumer involvement.
Unheeded calls for research?
  We found a call for controlled trials on multiple
sclerosis.116 It was supported by in-depth
knowledge of the subject and an understanding
of research design.
  An article from a consumer group in the
scientific press invited researchers to join HIV
activists in debating whether and how AIDS
vaccine research should be conducted.117
  Research priorities held by parents of autistic
children did not match research priorities of
professionals, and a closer relationship between
the consumer group Autism Society of America
and the NIH would be required if their
priorities were to be met.118
  The Consumer Federation of America
conducted its own national survey on a variety
of consumer issues, in which questions about
indoor air quality were raised. This led to a
well-resourced campaign for the Federal
Government to conduct additional research on
air pollution.119 We found no record of a
government response.
  The National Depressive and Manic Depressive
Association of America is a network of self-help
groups. It convened a consensus conference 
that addressed six key questions, including
issues about the gap between our knowledge 
of the diagnosis and treatment of depression
and actual treatment received. The target
audience included health policy makers,
clinicians, patients and their families and the
public at large. The consensus statement
included a call for conducting research on
development and testing of new treatments for
depression.120
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Consumers’ degree of engagement
Consumer
Control
Collaboration Consultation Minimal
Inviting
consumer groups
Type A Type B
Inviting
individual
consumers
Type C Type D
Responding to
consumer action
Type E
Type H
Type F Type G
Researchers’
degree of
engagement
Minor partner or
absent
Type H: consumer calls
for research; consumer-
conducted research
FIGURE 10 Framework for describing Type H consumer involvement in research agenda setting: independent consumer actionReviewers’ commentary
Consumers have sometimes taken the initiative to
construct their own research agenda, whether or
not they have identified research programmes that
may have the remit to adopt and commission such
research. Their calls for research have been
supported by resources, organisation and well-
informed, sophisticated argument. Sometimes
consumers invited professionals to collaborate.
Consumers’ own research
We have not included here the vast literature of
consumer-led research. However, two of the UK
programmes that we investigated with interviews
and document analysis included examples of
consumer-led research: the Mental Health
Foundation and the NCT (see the next chapter).
Key messages
The key message is as follows:
Details of Type H approaches are given in Table 8.
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  Consumers call for research and 
conduct research in many different
areas. This probably provides a rich
and largely untapped pool of research
topics.117–121
  Consumer activism that has had a
profound effect on health policy and
services has not had the same impact
on research agendas in the UK that has
been seen abroad.10,82–86
UK
UKH
e
a
l
t
h
 
T
e
c
h
n
o
l
o
g
y
 
A
s
s
e
s
s
m
e
n
t
2
0
0
4
;
 
V
o
l
.
 
8
:
 
N
o
.
 
1
5
©
 
Q
u
e
e
n
’
s
 
P
r
i
n
t
e
r
 
a
n
d
 
C
o
n
t
r
o
l
l
e
r
 
o
f
 
H
M
S
O
 
2
0
0
4
.
 
A
l
l
 
r
i
g
h
t
s
 
r
e
s
e
r
v
e
d
.
TABLE 8 Type H Independent consumer action
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
H.1 Consumer calls for research
Hanson, 1992116 National consumer
group
Social action Consumer-
identified research
topic – national
press publicity
Wide readership but no direct
engagement
Article by
participant
consumer
H.2 Consumer-controlled research
The Mental health
Foundation, 2000129
Case investigated in
more depth for UK
episodes (see
Chapter 5)
Mental Health
Foundation
Service users and
those who have
suffered mental
distress
Survey Empowerment 
Equal opportunities
3 research topics
identified and
prioritised
Broad involvement of consumers Report by
participant
researcher/
manager who was
also a consumer,
and interview
Harrington,
1992117
HIV/AIDS
consumer group
Social action Consumer-
identified research
topic – scientific
press publicity
Schopler, 1996118 National consumer
group
Social action Comparison of
consumer group
priorities with
national research
programme
Fise, 1992119 National consumer
federation
Social action Consumer-
identified research
topic – press
publicity
Reported by
participant
consumer
Hirschfield et al.,
1997120
Consumer groups
and members of
the public
Consensus
conference
Social action Identified research
priorities
Consumer-led consensus
conference with professionals
continued
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TABLE 8 Type H Independent consumer action (cont’d)
Authors(s) Research Consumer Method of Theory of Output of Advantages/disadvantages Nature of
programme group(s) interaction interaction interaction evidence
Oliver, 199342
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NCT Maternity service
users/NCT 
members
Written
consultation,
conference and
meetings
Social action 15 topics and 5
priorities
Consumer networks facilitated
consultation
Description by
participant
consumerTypes of interactions in the UK
The UK cases that we chose to investigate with
interviews and document analysis varied widely.
Some were focused primarily on the action of
consumers (Mental Health Foundation, NCT and
the IDDT) or charities (Alzheimer’s Society,
Health Action for Homeless People). Others were
focused on NHS national and regional research
programmes, which sought input from a range of
consumers (HTA programme, Northern and
Yorkshire’s Older People Programme, PCD
programme, Primary Dental Care programme and
SDO programme).
Research focused on specific conditions (Alzheimer’s
disease, diabetes, pregnancy and childbirth, mental
health) on populations (older people, homeless
people) and services (primary dental care, service
delivery and organisation). Some research
organisations drew on direct experience of
consumer involvement in health services and
research more generally (HTA programme,
Northern and Yorkshire’s Older People
programme).
Consumers were members of experienced
campaigning groups (NCT, Mental Health
Foundation), members of charities (Alzheimer’s
Society, Health Action for Homeless People),
individual patients (primary dental care
programme) or carers (Alzheimer’s Society) or
members of the public (primary dental care
programme). Some consumers had long
experience of research (NCT, Mental Health
Foundation), whereas others were more often new
to research (Alzheimer’s Society). Some examples
were consumer led (Mental Health Foundation,
NCT).
Engagement was through collaboration (HTA
programme, PCD programme) and consultation
(SDO programme). Methods included written
consultations, face-to-face consultations,
committee membership and indirect methods such
as scanning consumer literature, and questions to
helplines and Members of Parliament.
Each case is described below. The advantages and
disadvantages attributed to the different methods
are presented without reference to the individual
cases. We have adopted this approach to maintain
the confidentiality of key informants who have
willingly allowed us to learn from their failures as
well as their successes.
Northern and Yorkshire R&D
Directorate’s older people’s
programme – Health and Social Care
Issues for Older People
This case is described from unpublished reports
and working papers,36,122–125 and interviews with a
member of the Northern and Yorkshire R&D
Directorate programme staff and with two
individual consumer participants from programme
workshops.
Identification and prioritisation of research
topics
From 1998 to 1999, Northern and Yorkshire NHS
Regional R&D Directorate used a combination of
methods to determine priorities for research.
Questionnaires and focus groups initially
identified older people as a priority area. Two
workshops were convened later to identify and
prioritise research questions within this area. 
Approach to engagement
This is a Type A example where the research
programme invited members of consumer groups
to collaborate. A range of consumers was involved
in each of these stages of the process. The
programme worked with local individual
consumers and representatives of consumer
groups with little previous experience of research.
The programme manager was experienced in
terms of consumer involvement.
Methods of interaction
A questionnaire was distributed to consumers
through a range of routes, including GP practices,
nurses, midwives, health visitors and market
researchers interviewing on streets. Focus groups
were convened using Patient Partnership and
Community Health Council networks. Older
Health Technology Assessment 2004; Vol. 8: No. 15
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Chapter 5
UK experience of consumer involvement in 
agenda settingpeople were identified as the first priority group
for research.
Two workshops were then held in May and
November 1999. The May workshop was aimed at
older people, and aimed to identify broad areas
for research. Health and social care professionals
gave presentations, and an older person chaired
the day. There were individual older people
present at each workshop, invited because of 
their links with local healthcare groups 
(e.g. primary care groups), in addition to
representatives of older people’s organisations,
such as Age Concern and the Association of
Retired People over 50. Participants discussed
issues in small groups and raised a number of
broad issues for research.
The November workshop was aimed
predominantly at researchers and health
professionals, although the consumers (older
people and representatives of older people’s
groups) from the first workshop were also invited.
This workshop developed the areas identified at
the May workshop into 30 research questions. A
postal prioritisation exercise was subsequently sent
out to workshop participants asking them to select
five research questions from the 30.
One of the consumer participants, a local ‘older
person’ sent out the final prioritisation exercise to
other older people’s organisations in the York
region, as she felt that the exercise would benefit
from a broader spectrum of older people’s
opinions.
Output 
The five research priorities selected by the final
postal exercise were:
1. What are the interventions that prevent extra
disability in older people and promote health
and well-being?
2. Evaluate different models of rehabilitation for
their impact on health outcomes and well-
being for older people.
3. What are the most effective ways of identifying
and working with older people suffering from
depression associated with physical illness,
disability and social isolation?
4. What are the educational and training needs of
staff in nursing and residential care homes and
how can their profile be raised in order to
promote recruitment and retention?
5. What are the definitions and indicators of
quality care in nursing and residential care
homes from the perspectives of residents,
potential residents, families of residents and
people working in the homes?
In the call for research proposals in February
2000, these questions had been subsumed into
three broader research areas. The commissioning
brief also asked researchers for “recognition of the
user perspective within applications”.
NHS R&D Health Technology
Assessment (HTA) programme
This case is described from the published report
of the Advisory Group and the unpublished report
of the consumer consultation,32,126 from the
programme’s web pages and from interviews with
one programme staff member and two consumer
panel members. Four authors of this report played
a role in developing consumer involvement in the
HTA programme. The interviewer, who had not
been involved in this way, interviewed another
member of staff supporting consumer involvement
in the HTA programme.
Identification and prioritisation of research
topics
The HTA programme is a national programme
aimed at ensuring that high-quality research
information on the costs, effectiveness and
broader impact of health technologies is produced
in the most efficient way for those who use,
manage and provide care in the NHS. People from
all these groups have been involved in
determining priorities for the programme.
Widespread consultation identified up to 1500
suggestions each year. These were prioritised by
expert panels, aided by short scientific summaries
of possible research areas (vignettes) written by in-
house NCCHTA staff with the help of experts in
the field. Researchers were then commissioned,
following peer review, to produce health
technology assessments, which were published –
again after full peer review – in the HTA
monograph series.
Approach to engagement
This research programme employed Type A
engagements (inviting members of consumer
groups to collaborate) and Type B engagements
(consulting members of consumer groups).
Consumers were formally introduced into this
process in 1997, and have been engaged
throughout the process.
Methods for interaction
In a short action research pilot study, consumers
were involved in all stages of the programme:
identifying and prioritising research topics,
UK experience of consumer involvement in agenda setting
74commissioning and reporting research and
communicating openly about the programme. The
programme drew on the experience of
campaigning, self-help and patient representative
groups, national charities, health information
services, consumer researchers and journalists for
various tasks. Potential consumers were identified
through national consumer groups and by using
informal networks and databases such as
Helpbox,127 which was a database of organisations
providing patient information (more recently
made available on the Internet128), and the NHS
Users and Carers Database held by the NHS
Executive office in Leeds.
Consumer literature was explored as a potential
source for research questions and as a route for
disseminating research findings. These
innovations were complemented by training, one-
to-one support and discussion. A reflective
approach included interviews with consumers, co-
ordinating staff, external observers and other
programme contributors, document analysis and
multidisciplinary discussion (including consumers)
between programme contributors.
Consumer involvement became more established
with a dedicated Consumer Liaison Manager post
in 1998. The programme’s documents assumed
consumer involvement to be necessary for
improving the quality of research. Job descriptions
and person specifications were developed.
Procedures were established for identifying
consumers and inviting and supporting their
involvement. Two consumers joined each
prioritisation panel of 18–20 members. They were
asked to call upon their consumer expertise but
not to aim to represent any particular interests 
per se. When giving their expert views on research
vignettes consumers were asked to comment on
the importance of the research question, the tone
or flavour of the vignette and changes or additional
information that would be useful. Consumer
referees of research proposals were particularly
asked to consider the choice of outcomes, patients’
views about healthcare, their needs for information
and support and patients’ relevant experiences in
healthcare settings and everyday life.
Feedback was invited from consumers and those
working with them. Key developments in response
to this feedback included establishing a mentor
scheme for new consumer panel members,
amending guidelines and forms for referees to
make them more ‘consumer friendly’ and training
NCCHTA staff to seek and support consumer
expertise.
Output
When seeking research topics, face-to-face
discussion with a consumer group was more
productive than scanning consumer research
reports. The research questions identified were:
1. How effective are primary care interventions
for parents of children with mental health
problems?
2. Can acupuncture relieve symptoms of
schizophrenia, manic depression or acute
severe depression?
3. What impact does addressing religious and
spiritual needs have on mental health?
None of these were prioritised for research to be
commissioned by the programme.
Where consumers were involved in refining short
scientific summaries of possible research areas,
they were able to make useful suggestions for how
health service interventions should be evaluated:
the outcomes against which they should be
assessed (e.g. social and emotional outcomes in
addition to clinical measures), the implications of
the context of the evaluations (e.g. patients’
relationships with their carers), the impact of
evaluation on patients (e.g. how data collection
methods relate to support during care) and the
information and support that patients would need
if they are involved in such evaluations. However,
it remains to be seen whether these suggestions
were retained as far as the commissioned research.
Where consumers were involved as members of
prioritisation panels, no records were kept of
consumers’ priorities or how they influenced the
research topics that resulted from the
prioritisation process.
Mental Health Foundation’s Strategies
for Living programme
This case is described from a published research
report,129 and an interview with a Strategies for
Living project worker.
Identification and prioritisation of research
topics
The Strategies for Living Programme was funded
by the National Lottery Charities Board for
3 years, between 1997 and 2000. A final report has
now been produced. Consultation took place with
a range of users for topic identification and
research design. A previous survey of mental
health service users, undertaken by the Mental
Health Foundation, ‘Knowing Our Own Minds’,
identified three main areas requiring further in-
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treatments, religious and spiritual beliefs and
complementary therapies, were taken as the
starting points for the Strategies for Living
qualitative study, for which mental health service
users were interviewed. A ‘user consultant’ then
did a preliminary piece of work, visiting 15 user
groups across the UK to develop user networks
and gauge user views on the topics and focus of
the programme. A user advisory committee was set
up for the project, with regional and national user
groups and voluntary organisations, such as the
Asian Mental Health Project, Manchester, and the
Depression Alliance and Manic Depression
Fellowship.
Approach to engagement
This is an example of a Type H engagement
where a consumer group has control of setting the
research agenda for its own research. This Mental
Health Foundation project was a 3-year national,
voluntary sector research project. The project’s
work with mental health service users illustrates an
empowerment model based on user-led research. 
Methods for interaction
The programme incorporated user involvement
throughout the project, from directing the project
as a whole to identifying topics and designing,
undertaking and disseminating the research.
Consumers involved in the project were defined as
individual current or past mental health service
users “or those who have suffered mental distress”.
This included Mental Health Foundation project
staff, representatives of a range of user groups on
the advisory committee, and interviewers and
researchers employed on the project. The project
strove to “uphold principles of empowerment,
consultation, involvement and equal
opportunities”.
Output
The programme incorporated different strands or
themes, including a qualitative research study, a
research support network with six user-led projects
and dissemination. This programme of work has
since been published as a book giving an account
of the development and implementation of
innovative projects in user-led research130 and five
individual project reports about the role of
mosques, acupuncture, massage, drop-in centres
and user groups for people with mental health
problems.
National Childbirth Trust (NCT)
This case is described from the text of a
conference presentation and internal consumer
group working papers.42 The consumer member
of the NHS Mother and Child Health programme
sub-panel was unavailable for interview.
Identification and prioritisation of research
topics
The NCT is a national voluntary membership
organisation with considerable experience of
participating in research. The NCT was founded
over 40 years ago. It aimed to enable every parent
to make informed choices through campaigning
and offering information and support in
pregnancy, childbirth and early parenthood. It has
over 250 branches across the UK, operated largely
through the work of trained volunteers, and has
funded and led research projects to inform its
work. The NCT has its own Research and
Information Group and has developed working
relationships with the NHS research community.
Research priorities were set by discussion within
the Research and Information Group and by
consulting the wider membership. This
description focuses on this exercise and on the
NCT’s subsequent submissions to national
research programmes within the NHS.
Approach to engagement
This example is of a user-controlled agenda
setting exercise (Type H engagement) where the
findings were subsequently used in response to
research programmes’ consultations of consumer
groups (Type B engagement). 
Methods for interaction
Formal processes for setting research priorities
attracted increasing attention in the UK with the
launch of the NHS R&D strategy in 1991. In
response to an invitation, the NCT submitted
eight principles to the Strategy for Nursing,
Midwifery, and Health Visiting Research in
1992.131 A year later, another invitation to the
NCT to present ‘consumers views of midwifery
research’ at a midwives’ study day prompted the
organisation to set its own research priorities.
Several articles about research featured in an issue
of the organisation’s quarterly journal. The profile
of research was raised at the annual national
conference and leaflets were circulated to all NCT
branches asking members what research they
would like to see conducted. To generate ideas,
members got together locally and held discussions
in committee meetings, at social events and
training sessions and in branch newsletters.
Responses were received from over 15 branches
who had held discussion groups on the subject,
from five individuals and from members of the
Research and Information Group. Topics were
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Information Group, resulting in a list of 15 topics.
These topics were then scored by a panel of 10
NCT members. The list and scores were circulated
on a smaller scale to the Research and
Information Group, the Trustees of the NCT and
four NCT branch members with no special interest
in research to prioritise five topics.
The NCT drew on this exercise in order to
respond to written consultations from NHS R&D
programmes: Mother and Child Health;
Primary/Secondary Care Interface; and the HTA
programme. The NCT also responded to a survey
by the National Perinatal Epidemiology Unit
(NPEU) (a research centre funded by the
Department of Health to improve the health and
well-being of women and their babies during
pregnancy, delivery and after birth).
Output
The NCT made four recommendations to the
NHS R&D programme on the primary/secondary
care interface. The first was that the
primary/secondary care interface should not pose
a barrier to long-term outcome measures. Topics
for evaluation were counselling skills to allow
women informed choice; caring for carers; and
evaluation of all named midwife schemes.
Ultimately, the programme addressed 20 research
priority areas, the 11th of which was patients’ and
carers’ social needs. Evaluations of a patient
information programme and a carer support
programme were commissioned, but neither of
these was in maternity care.
Twenty-one research topics were recommended to
the HTA programme: the value of full information
and support in pregnancy, during labour and
following birth; effectiveness of antenatal
education; ultrasound during pregnancy;
treatment of women with high blood pressure at
home; eating and drinking in labour; high
intervention rates during childbirth; inducing
labour after term; epidural anaesthesia for labour;
‘mobile’ epidurals; scalp clips for electronic fetal
monitoring in labour; delivery of breech babies;
giving birth in water; prevention of postnatal
infections; repairing the perineum; bili-blankets
for phototherapy of jaundice in newborn babies;
postnatal exercise; counselling and advisory role of
health visitors; support for postnatal depression;
named midwife schemes; developmental screening
for young children; and immunisations. One of
these, a systematic review of ultrasound screening
in pregnancy was subsequently commissioned by
the HTA programme. Other topics were
commissioned by the Mother and Child Health
programme: epidural anaesthesia, ‘mobile’
epidural anaesthesia and support programmes for
postnatal depression.
Five priority areas were recommended to the
NPEU. These were methods for effective
communication and support to meet individual
needs; methods for preserving an intact perineum;
attitudes of midwives to breast feeding rates of
mothers; current practice in midwifery training on
breastfeeding; and withholding food and drink in
labour. These were also submitted to the
programme on Mother and Child Health. The
NPEU study of consumers’ priorities was not
published. None of the NCT’s top five priorities
appeared as priorities or commissioned research
projects in the Mother and Child Health
programme.
Health Education Authority’s Expert
Working Group on Homelessness
This case was described from the published report
of the working group and interviews with two
members of the group.24
Identification and prioritisation of research
topics
This group was part of a wider HEA strategy,
which set up 10 expert working groups to look at
the potential for health promotion with vulnerable
population groups. The working group was asked
to produce a research agenda based around five
questions: 
1. Which health interventions, if any, work to
promote the health and well-being of
individuals, families and communities, and to
prevent ill health? 
2. How well do they work? 
3. Do they currently contribute to a reduction in
inequalities in health? 
4. What are the principal health promotion needs
of these groups? 
5. What are the implications for new research,
development and policy agendas?
A literature review was circulated to members
before the group met. Members were asked to add
to this and prioritise issues. The aim was to
achieve a ‘broad-based agenda’. The expert
working group met over 2 days. The first day
involved discussion of the issues each member felt
should be included in the research agenda. Each
member was asked to prepare a position paper
addressing the above questions and did a short
presentation to the group on topics they had
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gaps in the research agenda and further defining
and prioritising issues. A report was produced
from the day. Each member was asked to comment
and further position papers were drawn up. The
homelessness agenda setting expert group was
allocated a budget of £12,000.
Approach to engagement
This is an example of a research programme
inviting members of a consumer group to
collaborate (Type A engagement) in setting the
research agenda through committee membership.
Representatives of two organisations representing
homeless people were involved in identifying and
prioritising issues for research on the HEA’s
expert working group, which produced the report,
‘Promoting the health of homeless people, setting
the research agenda’.
Methods for interaction
The Health Education Authority’s expert working
group included 11 members, comprising
academics, practitioners and representatives
(members of staff) from two homeless
organisations, Health Action for Homeless People
and Homeless Alliance. Health Action for
Homeless People is a regional grant-funded
voluntary group that works on health and
homelessness issues in London, carries out policy
development and provides information, research,
seminars and training. It encourages participation
and involvement of homeless people in
developing services. The Homeless Alliance is an
umbrella group for homeless organisations.
Output
The five priority areas identified were housing and
health, service provision, health promotion needs,
approaches of health promotion and social policy
and development programmes. Health Action for
Homeless People went on to do a subsequent piece
of work, which involved two pilot exercises, one on
the resettlement of homeless people. This
involved talking to homeless people about how
they saw their health. The Chair of the group also
set up further research work with vendors of a
weekly magazine produced and distributed by
homeless people, the Big Issue. This research was
about peer education in disseminating health
promotion issues, in which the users (Big Issue
vendors) were involved in the research design.
NHS R&D Physical and Complex
Disabilities (PCD) programme
This case was described from the unpublished
report of methods of working, a previous study of
consumer involvement in the NHS R&D
programme,55 and interviews with a non-consumer
member of the programme’s advisory group and
the consumer member of the programme’s
advisory group.
Identification and prioritisation of research
topics
The priority setting phase of this national NHS
programme of commissioned research took place
over a period of 7 months from November 1992.55
It was directed, like all the other so-called ‘time-
limited’ NHS programmes, by an advisory group.
Approach to engagement
This is an example of a research programme
collaborating with members of a consumer group
(Type A engagement) and consulting members of
consumer groups (Type B engagement). This was
the second national time-limited NHS R&D
programme (after Mental Health) but the first to
have a consumer representative as an advisory
group member. This consumer was a
representative of The Society for Research in
Rehabilitation (RADAR), a national disability
organisation.
To identify topic areas for the programme,
consumer groups, along with other organisations
nation-wide, were targeted by a written
consultation. Regional workshops were held to
gauge the regional concerns and needs of users
and carers. The programme’s advisory group had
a consumer member. In addition to helping direct
the programme, the advisory group members
identified and prioritised the research areas
identified through the written consultation and
workshops.
Methods for interaction
The programme identified areas for research
through a written consultation that targeted
national groups;140 organisations were consulted.
Consumer groups included the Alzheimers Disease
Society, the College of Health, MIND and the
National Consumer Council. RADAR also worked
with the programme to convene a set of regional
workshops to identify regional R&D needs. These
workshops involved individual service users and
carers, in addition to health professionals and
researchers. The advisory group prioritised the
areas raised through written consultation and
regional workshops.
Output
There were no separate records of consumer
priorities. The 11 broad research priorities
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to develop and evaluate new forms of support’,
and these were well represented in the
subsequently commissioned research. Three
commissioned projects gave consumers a role in
service planning and evaluation: practice
guidelines for primary healthcare teams to meet
the needs of Asian carers’ needs; evaluating
service support to families with a child with sickle
cell disorders or thalassaemia; and carers’
perspectives on discharge procedures for young
adults with physical and complex disabilities (see
http://www.doh.gov.uk/research/swro/rd/national/pcd/
funded/fulllist.htm). 
NHS R&D Primary Dental Care
programme
This case was described from the published report
of the Advisory Group45 and an interview with a
programme staff member.
Identification and prioritisation of research
topics
The priority-setting phase of this national NHS
programme of commissioned research spread over
a period of 11 months from 1993 to 1994. Like
the other time-limited NHS R&D programmes,
the programme was directed by an advisory group.
The 260 areas were first condensed into 26 broad
topic areas and justification papers were prepared
for each topic area by independent reviewers,
identified by the advisory group. These broad
areas were then prioritised by the advisory group,
with a final 20 priorities being identified, of which
the top 10 were noted as the highest priority.
Approach to engagement
This is an example of a research programme
inviting a member of a consumer group to
collaborate (Type A) and a trawl of sources of
consumer views. This advisory group had a
representative from the Patients Association as a
member who participated in the prioritisation of
topics found through the consultation and
retrospective searches.
Methods for interaction
A variety of routes were accessed in order to gain
the consumer view, including indirect methods
such as retrospective searches of parliamentary
questions and of queries to a consumer health
information line. A broad written consultation also
took place and a representative of a national
consumer group was a member of the
prioritisation advisory group. One of the terms of
reference of the programme was to gain the
consumer perspective to a greater extent than in
previous similar programmes. A programme staff
member explained that the reason for engaging
with indirect routes was the difficulty in defining
consumers of primary dental care. One indirect
approach involved a retrospective search over a 
3-year period of Oral Parliamentary Questions,
Written Parliamentary Questions and Early Day
Motions, in order to identify expressions of
concern from MPs. This revealed areas of concern,
such as access and availability, school dental check-
ups, water fluoridation and cross-infection control
in general practice.45 The second indirect method
was use of a consumer health information
helpline, Healthwise on Merseyside. The R&D
programme staff carried out a retrospective search
of issues relating to dentistry during a 6-month
period. This method also raised issues relating to
access and availability of NHS dental treatment,
including emergency treatment out of hours, cost
and confusion amongst consumers regarding their
status as NHS or private patients.45 In addition, a
written consultation targeted consumer
organisations and charities, who were asked to
provide priority areas of research need. The
response to this was described as ‘disappointing’,
with 40% of the organisations contacted
responding, but it did reveal concerns about access
to dental care for certain special needs groups and
the general availability of NHS dentistry. Finally,
there was a review of the evidence submitted to
the Health Select Committee on Dental Services
with particular interest paid to evidence submitted
from the Association of Community Health
Councils for England and Wales. This also raised
issues around access, registration and the dividing
line between NHS and private dentistry.
The programme staff had no prior experience of
working with consumers but tried to build on the
experience of other NHS R&D programmes. The
second term of reference for this advisory group
was “to develop and evaluate an approach to
setting priorities … with particular reference to
methods of incorporating a consumer viewpoint
into the process”.45 The group was encouraged
when the Patients’ Association showed considerable
interest and the Executive Director was
subsequently invited to participate in workshops
and join the advisory group. On reflection,
“capturing the consumer view was not without
difficulty. Having consulted with consumer groups
nationally and locally, and having also approached
the problem through examination of the
parliamentary structure, there is, without doubt, more
work that could be done in this area. The relevance of
methodologies such as focus groups is perhaps a little
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it is difficult to clearly define a primary dental care
consumer and, furthermore, there are no specialist
organisations or groups who represent specifically
those who use the primary dental care system.”45
However, the four methods described above
provided a consistent picture of the consumer’s
view and they provided a basis for future work in
this area.
Output
The final priorities were phrased in terms of
broad topic areas. Some of these matched
consumers’ priorities, including
availability/accessibility of dental services (first
priority), healthcare for older people (ninth
priority), school screening research (11th priority),
fluoridation and alternatives (16th priority) and
professional interface (19th priority). In addition,
the ‘consumer voice’ was the fourth research
priority. No information about the research
subsequently commissioned was available on the
website in June 2001.
NHS R&D Service Delivery and
Organisation (SDO) programme:
National Listening Exercise
This case is described from interviews with a
member of programme staff who was present at
three-quarters of the events and three consumers
who were involved in separate focus groups: one
from a carers’ organisation, one patient
representative from a Primary Care Group and
one member of the public.
Identification and prioritisation of research topics
The priority setting phase of this national NHS
programme of commissioned research was a
National Listening Exercise over a 6-month
period, from October 1999 to March 2000. This
specifically aimed to consult a wide range of
stakeholders, “especially service users”,74 and
identify broad “areas of particular concern” or
themes for service delivery R&D.
Approach to engagement
This is an example of a research programme
consulting members of consumer groups (Type B)
and the wider public (Type D).
Methods for interaction
The programme used a focus group model
combined with expert groups. Sixteen regional
‘mixed stakeholder’ focus groups were held
around the country74 and six expert groups met
(three of research funders, two of educators and
one of consumers), with a total of 24 events.
Programme managers engaged with existing
regional R&D networks through R&D Directors to
recruit consumers for focus groups. They included
members of groups of consumers, such as patient
members of Community Health Councils, Primary
Care Groups and carer and other voluntary
organisations, plus individual members of the
public who did not have an affiliation with a
specific consumer group. The consumer expert
group was made up solely of 11 members of the
public (users/patients/carers). The final report’s
description of the exercise’s methods was
particularly clear and made it possible to
determine the proportion of consumers involved:
consumer representatives, members of the public
and service users made up 19% of all
participants.74
Each focus group was a half-day or evening event
led by SDO staff. The sessions included a
presentation of the context of NHS R&D. Group
discussions were then structured around seven key
questions. Examples of the questions discussed at
each session are, ‘If there was one change to the
organisation of NHS services which you would like
to see, what would it be?’, and ‘Thinking 5 years
ahead, what would make you say the SDO R&D
programme was a great success?’ Travel expenses
were paid for all participants.
Output
There was no record of consumers’ priorities for
research. The 10 broad areas identified as a result
included ‘user involvement’.
CABI Bioscience’s Farmers
Participatory Training and Research
programme
This case is described from an unpublished report,
the organisation’s website66,132 and an interview
with a member of the programme staff.
Identification and prioritisation of research
topics
CABI Bioscience is a programme that evolved
from the London-based Commonwealth
Agricultural Bureaux. The original aim of
supporting agricultural scientists by identifying
insects and providing scientific information and
technical assistance has since broadened to an
international remit to tackle problems in agricultural
sustainability and biological diversity. There are no
methods for identifying and prioritising research
topics for the Integrated Pest Management
programme independent of working with farmers
in developing countries, as described below.
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This is an example of a research programme
inviting individual consumers to collaborate (Type
C). The Integrated Pest Management programme
employs an action research model, where local
farmers are trained through discovery-based
learning to choose topics for research and then
carry out their own research projects.
Methods for interaction
This programme trained farmers in developing
countries to become researchers, through
discovery-based learning at Farmer Field Schools.
During the training process, farmers suggested
topics for experimentation. Trainers/facilitators
worked with farmers to find solutions to their
problems. Farmers then learnt through doing
their own research, generally on pest and disease
management. The field was seen as ‘the primary
classroom’. The aim of the programme was two-
fold; to bring Integrated Pest Management
knowledge, which has been developed over the
last 20 years but remains at the level of
researchers, to the farmers, and to work with
farmers so that they can develop their own skills
in experimentation and research.
Farmer Field Schools were set up in local settings,
generally for one season. Communities were
approached and asked whether they would be
interested in having a Farmer Field School.
Decisions were made in partnership with the
village elders, who selected the farmers to
participate in the programme. The participants
were smallholder farmers, who had difficulties
earning enough money for their livelihoods. They
had no previous experience of research, and often
little background education. The overall aim was
to encourage the spreading of knowledge and
skills, so that those farmers trained would be able
to take knowledge back to the village and train
others within their communities.
The programme had a participatory ethos, with
two-way communication and partnership between
farmers and facilitators encouraged during the
learning/research process. There was an ongoing
element to such programmes, with a follow-up
session the year after the Farmer Field School had
taken place. The programme worked with a range
of partners to fund Farmer Field Schools and
developed networks between non-governmental
organisations, international organisations and
local governments.
Output
Farmers suggested topics for experiments in
Kenya. These included ‘soil pest and disease
management for nursery beds, and use of milk
sprays to control leaf diseases in tomato’.66 A
range of traditional methods were tested
experimentally, and where conclusions were clear
cut farmers subsequently adopted more methods
giving better crops.
Alzheimer’s Society’s Quality
Research in Dementia programme
This case was described from the Society’s web
pages and an interview with a member of staff.
Identification and prioritisation of research topics
The Alzheimer’s Disease Society is a charitable
organisation founded in 1979 by a consumer and
subsequently led by professionals and renamed the
Alzheimer’s Society. It is a leading UK charity for
people with Alzheimer’s disease and other
dementias and their families and carers and funds
a research programme by responding to
researchers’ proposals.
Approach to engagement
The research programme was relaunched in 
1999 as Quality Research in Dementia. Plans
included involving consumers in setting the
research agenda in partnership with professionals
(Type C).
Methods for interaction
The programme literature64 describes plans for
matching its research agenda to the real needs of
people with dementia and their carers.
An open invitation was put out, via the
Alzheimer’s Society newsletters and the Internet,
to carers and people with dementia to become
involved in the Society’s Quality Research in
Dementia programme in April 1999. A Quality
Research in Dementia Advisory Network was set
up, which was made up in large part of carers of
people with dementia. Members of this network
were then involved in agenda setting within
regional workshops. The workshops included a
prioritisation and training exercise, designed
primarily to introduce carers to the complexities
of research funding and the issues associated with
prioritising the three broad streams of the
Society’s responsive research programme: cause,
cure and care. As a training exercise, participants
were provided with Monopoly money and were
asked to allocate funds amongst the three areas
and to discuss this.
The Society has a budget for consumer training
and support and has appointed training consultants
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research issues. Carers have been involved in a
range of research activities. They have commented
on research grant applications being made to the
Society, helped to decide which research should be
funded, been involved in research in their local
area, commented on research that the programme
is funding and helped get the results of research
into practice in their local area.
Output
The consumer advisory network was asked about
their priorities for research in 2001. Ideas from
150 carers and people with dementia were posted
on the website as a relatively unedited list of
suggestions. These included general research
issues such as identifying gaps in knowledge and
how they can be filled and addressing the
challenge of getting research into practice. More
specific ideas supported basic science to identify
the causes of Alzheimer’s disease, epidemiology,
genetics, methods for diagnosis, clinical research
including prevention and treatment and research
specifically on family carers, institutional care and
daily experiences and activities of people with
dementia. Researchers intending to apply for
research funding were advised to consult this
document before submitting their proposals.
Insulin Dependent Diabetes Trust
working with the Cochrane Diabetes
Review Group
This case was described from the perspective of
the consumer group. We were unable to interview
any of the professionals involved in the group. We
interviewed a consumer member of the group and
drew on the IDDT Newsletter.30
Identification and prioritisation of research topics
The research goal of the IDDT is to try to ensure
that independent, large-scale, long-term,
methodologically correct research is carried out
into all the reported problems with ‘human’
insulin so that insulin treatment is evidence based.
The IDDT worked with the Cochrane Diabetes
group, within the Cochrane Collaboration, whose
mission is to prepare, maintain and promote the
accessibility of systematic reviews of the effects of
healthcare policy and practice. Its key principles
for working, include “minimising bias through …
ensuring broad participation; striving for
relevance by promoting the assessment of
interventions using outcomes that matter to
people; [and] enabling wide participation … by
reducing barriers to contributing and by
encouraging diversity”. These principles
encapsulate consumer involvement. However,
another key working principle of building on
enthusiasm presents a barrier to formal agenda
setting. How topics for research were prioritised
varied between review groups. In most cases it was
through responding to the enthusiasm of
volunteers to undertake systematic reviews.
Approach to engagement
The approach of the Cochrane Collaboration as a
whole can be described as Type A and Type B
approaches to engagement, as there is an open
invitation to collaborate, which includes individual
consumers and members of consumer groups.
Within individual Review Groups, the
collaboration may be at the instigation of the
Group, with a personal invitation to an individual
consumer or consumer group, or it may be at the
instigation of the consumer who volunteers their
services to the Group.
The IDDT is a small national self-help group run
by parents and people with diabetes. It aims to
provide care and support to people with diabetes
and their carers and, in the longer term, promote
research into human insulin and its effects. This
group had a consumer representative on the
Cochrane Diabetes Review Group for 3 years from
1996. The consumer representative was a member
of the IDDT, had previous experience of
contributing to research agendas and was actively
involved in trying to get topics on to the review
agenda within this group.
Methods for interaction
The IDDT consumer member was involved,
alongside professional members, in identifying
topics for systematic review within the Cochrane
Diabetes Review Group. The consumer
representative consulted IDDT members and put
forward 12 topics for review in 1997. These 12
topics included a “review of actions and effects of
all available insulins”, an issue of particular
importance to the IDDT.30
Output
None of these proposed topics was taken on by the
Review Group. The Review Group was disbanded
in 1999.
Consumer and researcher
experiences: some individual
reflections
How consumers and researchers perceived these
agenda-setting exercises is described below from
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facilitators and advantages and disadvantages
follows. Their views are presented first in
chronological order: engaging with consumers,
convening a forum, identifying topics, prioritising
topics and consumers having an impact on the
agenda. These views are then recast in the
following section to identify advantages and
disadvantages of methods for consumer
involvement.
The consumer and researcher
experience
Consumer involvement in agenda setting was a
learning experience for consumers and
researchers in all these UK cases. Within the
recently established NHS R&D programme,
managers often did not know what to do. Every
step in engaging with people and providing a
forum for the tasks of identifying and prioritising
research topics was new, both with and without
consumers. Later programmes found that “it
made an enormous difference being able to
benefit from conceptual developments in all other
[NHS R&D] priority setting groups – avoided an
awful lot of mistakes”. The need to learn from the
process was integrated into the terms of reference
in later R&D Advisory Groups.
Being part of a programme that was developing
and learning felt daunting for one consumer,
despite her extensive experience in related areas.
She felt that she would carry some responsibility if
the programme was a failure, and sceptics would
consider their views justified. She appreciated the
support from other professionals and considered
this particularly valuable where consumers might
struggle with technical terms and procedures. She
also acknowledged the learning within the
programme management and valued the
purposeful attempts to elicit feedback and respond
appropriately.
Talking to people who had experience of research
agenda setting was particularly helpful for
programme managers outside and inside the
NHS, as was experience of working with
consumers in other research settings and talking
to consumers through their own networks. One
programme manager found her prior experience
in disability research and working with consumers
particularly helpful.
One consumer interpreted the tendency to
exclude consumers not as deliberate but as a
consequence of a “total lack of comprehension of
the whole nature of the process”. She raised the
commonly held view that consumers are biased
and asserted that everyone, not only consumers, is
biased – each with their own agenda. She also
rejected the assumption that the need for training
is often focused on consumers’ needs for dealing
with issues and participating in research groups.
Instead, she believed that professionals needed to
learn to value other people’s views and recognise
that people outside the medical profession were
capable of expressing valid views. Indeed, in
another programme, induction training was
provided for consumers, clinicians and researchers
together. This was described as very helpful, but
needed to be complemented by accumulated
direct experience. Elsewhere, contact was limited
to a one-off event and consumers were given no
feedback on their contributions or the progress of
the programme.
One research manager described the different
responses to working with consumers. It could be
“refreshing on a personal level, but some staff
found it more difficult … [managers] need to
move into a more supportive role, take seriously
the concerns of consumers … also need to
encourage, support and inspire confidence in
people”.
Engaging with consumers
Programme managers and consumers described
the importance and difficulties encountered in the
initial engagement. This was portrayed as
“crossing the barriers between researchers and
consumers” and it required being able to “explain
what research is, what it can and cannot do, and
persuading consumers that their views are
important and will be acted on”.
Identifying appropriate consumers to engage with
was difficult. Approaching individuals or groups
raised different issues. Finding individuals to suit
the task could be difficult. Managers found groups
easier to identify, but some consumers were
disappointed when they saw people not personally
affected by a condition speaking for people who
were. “Someone living with the condition” was
distinguished from paid members of staff “who
have their own agenda – a job to keep”. When
managers had found consumers helpful, with
hindsight they would have liked to have involved
more of them, but they had sometimes limited
involvement by purposely avoiding ‘competing’
consumer groups.
After identifying appropriate types of consumers,
recruiting individuals raised other difficulties for
managers. This involved, for example, explaining
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more often, persuading consumers to work
without it. ‘Cold calling’ was difficult. It required
talking about the purpose and structure of a
research programme to people who had never
heard of it. Some managers approached
consumers they had met in other settings, or
through consumer networks with which they were
familiar, and invited their participation without
explaining clearly their role in advance. These
consumers “struggled to know what to contribute”
and “didn’t feel able to key into [the programme’s]
objectives”. They would have liked more
information in advance, and if one of them “had
known what it would entail [he] wouldn’t have
gone”. These difficulties were not mentioned by
those involved in episodes where consumer groups
had involved consumers in their own research
programmes or research agenda-setting exercises.
In two very different cases (national and local),
choosing the appropriate individuals was left to
the consumers themselves, after they had been
given a set of desirable characteristics and
restrictions.
Convening a forum
The UK cases included a variety of forums:
committees, workshops, written consultations,
informal meetings and training events. Although
written consultations were routine within the NHS
R&D programme for identifying research topics,
they were barely mentioned by research
programme managers, and the consumers we
interviewed had not participated in them. The one
exception was a consumer member of a committee
who had the task of sorting the responses to the
written consultation, although no further
comment was made.
Several consumers reported committee
membership as a challenging experience. Typically
there were only one or two consumer members on
a committee. This was considered difficult but not
unusual. Even when ‘civil servants’ were perceived
as very supportive and willing to listen, a
consumer could feel like a ‘lone voice’ in an area
that could be difficult to understand. Despite this
consumer seeing herself as having relevant
research experience and able to have an influence,
being the token consumer member of a group was
“not a very pleasant experience … and less
effective”. Another experienced consumer said
that she “felt out of her depth when attending the
meeting – not with the content – but with the
general way of working and understanding how
the committees fit into the bigger framework of
the R&D programme… . The first time it felt very
strange. There was a very set way of working…. 
At the second meeting it was much easier … I
knew the process.”
The role of the Chair was mentioned as an
important influence on the profile of consumers in
committee meetings, as were the minutes of the
meeting. One consumer noted that although other
committee members were named in the minutes
when they made specific comments, she was not
named alongside her suggestions; rather, the
minutes recorded that the suggestion “was
discussed”. Such subtleties were seen as
undermining and undervaluing consumers’
contributions.
Another consumer committee member “felt it was
a struggle … that [she] had to push to get views
on board … [she] felt that as a representative of a
voluntary organisation, she was marginalised
amongst the group of academics who were ‘all
mates’, and was made to feel an outsider”. Despite
the difficulties, she felt the Chair handled the
situation well and her concerns were taken on
board.
Committee procedures could be ‘fast and furious’,
although consumers found it easier when
attending for a second time. Supportive comments
from other committee members helped. Less
formal meetings could also be challenging. There
were feelings of being isolated and needing to be
“courageous to speak up among people who were
leaders in their field”. If there had been two
consumers, even though still not considered
enough “at least they could have offered each
other support”.
Consumers expressed only difficulties rather than
competence or achievements when speaking about
one-off events. Unlike committee members, they
had no opportunity to learn from their experience
and cope better a second time.
Involving consumers indirectly successfully
identified topics, but was not suitable for
prioritisation where there was no opportunity for
discussing and refining topics.
Identifying topics
Consumers were not always involved directly in
topics. Rather, consumer representatives inferred
their views from their experience of talking to
consumers in other settings.
Sometimes consumers found that their interests
did not fit the expectations of the programme.
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Broad topics rather than specific research
questions were seen as more appropriate in one
programme, although the reverse was required in
another.
Identifying research topics in a workshop setting
was difficult. People found it difficult to get
beyond discussing a problem to expressing a
productive idea. They “had lots of ideas about how
health services could be improved, but found
writing research questions difficult”. Some
managers designed questions to engage non-
researchers, piloting and amending them
appropriately. 
Prioritising topics
Sometimes consumers were not involved in
prioritising topics at all. When they were, they
found it challenging.
Consumers found prioritising as part of a group
discussion difficult. In one instance, when asked to
combine similar topics under a single heading,
“people were quite determined that whatever
point they were concerned with was kept. They
didn’t want to relinquish their own issues”.
Consumers found influencing discussions difficult.
One consumer described herself as “harping on
about a few things I wanted to get across about
qualitative research, user involvement in research
and complementary therapies”.
Scientific evidence appeared to be given more
weight than consumers’ views, and consumers’
perspectives often being presented anecdotally was
problematic. In time, one consumer perceived “a
gradual shift”. She found her questions tended to
be about qualitative issues that were less easy to
measure, and that suggestions for such topics were
not well received.
There was occasional cynicism about the
prioritising of topics, a feeling that “whoever was
in charge of the programme had their own ideas
to start with. Perhaps they were concerned (not
deliberately) that the spirit of their own ideas
[should be] incorporated into the final topic
suggestions”.
Impact
The impact of consumer involvement in the
research agendas was unclear. One consumer felt
that consumer involvement would happen
gradually. The pressure for new research agendas
is not coming only from consumers. Consumers
and professionals are calling for a wider, more
holistic, context-based social research agenda.
One manager saw consumer involvement as
potentially having a great impact on the
professional research community. Because
traditionally “people learn more and more about
less and less, to some extent consumer
involvement puts a brake on this. People would
have to stop and think about the impact on the
NHS patient…. If you can’t convince users who
are involved in the development of the
programme, should that be what you are investing
time and resources into researching?”
When consumer organisations involved their own
consumer members, they felt it made a difference
to the research topics.
Consumers could be impressed by efforts to
involve them. “If that’s the start of things to come,
it can only be good news…. Now that people
realise there’s a chance to become involved more
personally and directly, I think there will be a lot
more people taking the opportunity.”
Advantages and disadvantages
seen in the UK
Circumstances or activities that appeared to
disadvantage consumer involvement were
identified from interview notes and programme
documents by the authors of this review. These are
addressed as ‘barriers’ below. Circumstances that
appeared to be particularly advantageous for
involving consumers in agenda setting were
similarly identified and reported as facilitators.
The outcomes of UK interactions were identified
as their ensuing advantages and disadvantages.
The reviewers’ conclusions about barriers,
facilitators, advantages and disadvantages are all
presented below, but without reference to specific
research programmes described above in order to
maintain confidentiality of the key informants.
Barriers
Poor representation
Consumers were concerned about the poor
representation in several of the UK examples. Some
consumers would like to see more individuals
involved in workshops in addition to representatives
from consumer organisations. In committees
consumers were often a very small minority,
sometimes acting alone. Where committees
included a range of academic disciplines, there was
“only room for one consumer” rather than
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situations they received complaints from other
consumer organisations that had been excluded.
One consumer also commented on the weighting
towards academics where they would have preferred
more service providers. One consumer had “felt like
a lone voice” and thought consumers would be
more confident and “have a greater impact” on the
priority setting process if more consumers were
recruited.
Sometimes consumers were unclear as to whether
they should be expressing their own views or those
of a further consumer constituency.
Participation rates in some written consultations
were disappointing and programmes have little
experience of approaching hard-to-reach groups.
Unfamiliarity
Unfamiliarity, whether with agenda-setting tasks
or the people with whom they were to work, was a
recurrent theme with consumers. Initially,
consumers were unsure of what agenda setting
was, but understood more clearly as the work
progressed. They had to adapt very quickly to
procedures that were well established. Consumers
were easily able to identify problems that needed
addressing, but found it challenging to move on to
developing research questions. Observant staff
could identify from consumer responses a need for
further training. More experience would solve
some problems, but not when consumers were
involved in single events, not to be repeated.
Even consumers with a “broad working knowledge
of NHS services” could find some discussions
overly technical and that it was difficult to
contribute effectively. Training for consumers was
not always the suggested solution: consumers also
called for training and changing attitudes amongst
the professionals.
Unfamiliarity of researchers with consumer-
centred approaches was also an issue. Researchers
sometimes saw consumer views as additional
information to be considered alongside research,
rather than as a starting point for framing
research questions. Some people found it difficult
to adapt research to the needs of consumers.
Working relationships
Consumers could feel isolated. Even when made to
feel very welcome, they could still feel like an
outsider during discussions. Despite good group
facilitation, a consumer could still feel different
amongst a “group of academics” who were perceived
as “all mates”. In such circumstances, it felt a
struggle to get consumer perspectives on board.
Attitudes
A committee atmosphere was not always wholly
supportive, and a consumer perceived an
imbalance in their status with professionals.
Although attitudes appeared to be gradually
changing, consumers thought professionals
regarded their own views as having more intrinsic
value than those of consumers. This was perceived
in subtle ways, such as was mentioned above when
consumer suggestions were not being recorded in
the meeting minutes with a name, compared with
professionals’ suggestions, which were. Consumers
perceived some programme staff and professional
participants as finding working with consumers
difficult, as having a “different mind set”. A
contrasting attitude would be staff adopting a
more supportive role for consumers and taking
their concerns more seriously. In one programme,
professionals trained alongside consumers. In
another, a consumer thought they should do so in
order to learn to value others’ views. This issue
was raised by staff in another programme where
the need to train professionals how to interact with
consumers had not been resolved.
Conversely, some staff reported consumers being
resistant to their approach, saying “you are the
expert, you tell us the answer”. Elsewhere staff
considered, with hindsight, that consumers wanted
to be involved in identifying broad areas rather
than dealing with specific research questions,
involved in the “nitty gritty” as “research
groupies”. They thought consumers wanted to be
involved only at the initial stages of a research
programme and then again when selecting which
research bids to fund. This conclusion was
contradicted by cynical views of consumers (see 
p. 88). Consumers were critical about time
constraints, lack of advance information and
feedback and poor communication at meetings,
and expressed a need for developing working
relationships for effective consumer involvement.
Elsewhere, programme staff expressed concern
about the difficulties of trying to empower and
protect consumers who are often very busy dealing
with illness. Consumers did not express a need for
such protection.
Time constraints
Lack of time was a recurrent theme. Two-hour
focus groups or workshops were considered fairly
limited for discussing the range of issues involved.
It could be difficult to find common ground within
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research priorities were rushed.
As highlighted above, committee meetings could
be “fast and furious” with time-constraining
discussion. In addition, there were tight deadlines
for completing work outside of meetings, which
should have been agreed in advance.
Concern was also expressed about the lack of
notice given prior to an event, which possibly
precluded carers who needed to find alternative
care in advance. Time constraints precluded the
involvement of consumers who needed more
support because of their personal health problems.
Lack of time presented difficulties for considering
research needs across a broad area. When time was
limited, some participants would have preferred to
have selected more specific research areas and set
priorities within these. Sometimes it was the
consumer perspective that was not considered in
much depth.
Programme staff could be caught between
criticisms of slow progress and the time they felt
was required to establish a two-way communication
and learning process with consumers.
Communication
Consumers found some advance information
insufficient or too general, and were disappointed
by lack of feedback. Staff for this programme said
they would have liked time to brief all consumers
individually, but that this had not been possible.
In contrast, this did happen for consumers
involved in a parallel programme. Language, or
more specifically jargon which could be perceived
as a “foreign language”, presented a barrier to
participation. Consumers met concepts and
acronyms in wide consultation meetings that
would probably not be accessible to the “average
person in the street” and said that the exercises
could have been more open and accessible.
Elsewhere, programme staff made specific efforts
to use plain language or explain technical terms.
Facilitators
Leadership
Commitment to consumer involvement was
evident where staff expressed appreciation of the
support for involving consumers from their
programme director. In committees, the facilitative
role of committee Chairs was seen as key and their
participation in less formal but supportive training
activities was highly valued. Consumers were also
seen in leading positions, such as chairing
workshops or leading their own work. This was
viewed positively by professional colleagues and
consumers.
Breadth of involvement
Broad involvement was achieved via disseminating
questionnaires through a wide variety of routes
within the NHS and more broadly by market
researchers identifying a broad range of
consumers (patients, carers, representatives and
the wider public), recruiting consumers through
their networks and inviting them to meetings,
travelling around the country as necessary, and
combining a range of methods to involve
consumers at different stages in the process.
Working relationships
Some interactions could build on established
working relationships, especially where there is a
long history of consumer involvement. Face-to-face
meetings helped working relationships develop.
Consumers identified the interactions with other
participants before, during and after workshops as
very important, as were the information received
in advance, the social aspects of a lunchtime meal
and a letter of thanks and payment of expenses.
Programme staff could be particularly important
in developing working relationships. One
emphasised the importance of “encouragement,
support and inspiring confidence in people who
may think they have nothing interesting or
important to say”. Another described how it was
important to get to know “where each consumer is
coming from” so as to work with them effectively.
Consumers also described being helped by
supportive comments from other committee
members and programme staff.
When more than one consumer was involved, they
were able to give each other support.
When consumers consulted more widely, they felt
that people were more willing to be interviewed by
consumers than researchers, especially about
sensitive health issues.
Communication
Good communication was a distinct advantage for
consumer involvement. Where information about
events and attendees was sent in advance, and
follow-up information circulated later, consumers
felt better able to understand the process. Face-to-
face or telephone contact was seen as important
for working with consumers, rather than relying
on letters or e-mail alone. Plain English, without
the technical jargon, was considered essential in
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necessary, the use of languages other than English.
Training and support
Consumers appreciated the training and support
provided by some programmes. These training and
support programmes had a common history,
evolving from the Critical Appraisal Skills
programme to help make sense of research,133 the
NCT’s VOICES project designed to help
multidisciplinary service planning groups work
together more effectively134 and IMPACT for
developing skills and confidence to influence health
care decisions (http://www.phru.org.uk/~casp/
impact.htm). However, training needed to
complement experience: they found it was difficult
to learn in the abstract, with “no hook to hang
anything on”, and needed to understand the
programme’s purpose and how their task fitted into
the bigger framework of the programme. A training
day convened once they had some experience, with
practical exercises, was “very useful”.
Programme resources
Programme staff stressed the need for sufficient
resources and time to involve consumers, preferably
with a budget specifically for this purpose. Some
programmes developed policies for paying
honoraria. National consumer groups were able to
draw on their own resources to set priorities,
including staff, organisation networks and funds.
Time was essential for thinking and discussion.
Building on experience
Ongoing working relationships allowed consumers
to develop their skills and confidence. Similarly,
staff appreciated the value of their personal prior
experience of working with consumers. Informed
consumers were seen as particularly useful. One
consumer member of an agenda setting group was
described as “knowledgeable and practical”.
Comments about local issues from consumers who
“know the needs of a particular area” were also
valuable.
Where feedback was invited about consumer
involvement, consumers and programme staff
talked of the programme’s consumer involvement
in terms of it being a developing process. This
development was evident in the increasing clarity
about consumer involvement with the development
of procedures, guidelines and job descriptions.
Advantages
Enthusiasm
Consumers with experience of collaboration
expressed enthusiasm for working together. This
enthusiasm led to a willingness for future
collaboration and a continued practical interest in
research. Enthusiasm was not an outcome of
consultations. 
Impact
Where setting research priorities led to a
subsequent task of consumers conducting their
own research, consumer impact appeared stronger.
Records of consumers’ priorities were available
only where consumers took leading roles.
Disadvantages
Cynicism
Consumers were sometimes disappointed not only
with their lack of influence, but also the lack of
opportunities to influence even when formally
involved. Consumers were concerned about how
research topics were chosen even for consideration
in priority-setting exercises. Involvement was
unsatisfactory for consumers who found their
perceived needs for structural changes in the NHS
were not on the agenda for discussion. Particular
frustration was expressed when professional
agendas were able to lead discussions and
advanced the process without effective
participation from consumers because
professionals’ background knowledge of the topics
was not shared with consumers in their briefing
materials. “Issues went beyond requirements for
end-users and focused on a lot of internal
problems…. I got the impression that they 
had to have a few members of the public. 
For what I had to say, it was of no value”. 
The charge of ‘tokenism’ was made when
individual consumers were invited to join large
committees, and when events accommodated
larger numbers but discouraged effective
participation.
Impact
There was little evidence of consumer involvement
influencing research agendas. It was often hard to
separate professional and consumer impact. In
programmes where the influence of consumers’
views on the final priorities was considered by
participants to be strong, priorities for 
consumers were also priorities for professionals.
Where consumers felt their views on priorities 
had been taken on board, there was no 
mechanism for recording who had influenced
decisions.
Most records did not distinguish between
consumers’ and professionals’ priorities. Where
they did, consumer priorities did not often lead to
commissioned research.
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he analysis of examples of consumer
involvement employing similar approaches to
engagement (Types A–H) suggested advantages
and disadvantages associated with these different
approaches. The analysis of UK cases suggested
common themes to be addressed when supporting
consumer involvement in research agenda setting.
Neither of these analyses compared different
approaches or addressed in depth the
complexities of multilevel methods that combine a
range of approaches to engagement, different
forums for interaction and methods for
exchanging ideas and setting priorities.
Questions remain about the implications of
choosing particular methods. What are the
advantages or disadvantages of:
  Involving particular consumers (individuals or
organised groups, with specific or general
interests)?
  Involving them in consultations or
collaboration, in different forums, or guided by
different philosophical approaches (such as
organisational change or participatory research)?
  Research programmes extending an invitation
to consumers rather than waiting to respond to
consumer action?
  Do these advantages and disadvantages vary
with the context, such as the type of research, or
the organisational or geographical setting of the
research or the consumers? 
  How strong is the evidence supporting the
findings?
  Which methods have contributed most to our
knowledge about consumers’ priorities for
research or to developing methods for involving
consumers in research agenda setting?
We attempt to answer these questions by
comparing individual episodes of consumer
involvement across different dimensions of
consumer involvement methods and their
evaluation in the following narrative synthesis,
which rests on an analysis of the data presented in
Chapters 4 and 5 and the data in Appendix 2.
Who was involved?
Many different methods were chosen to involve
consumers in setting research agendas. Some of
these involved choosing representative samples
from broad populations, as in opinion surveys,68,69
or choosing samples for the purpose of capturing
views of people with personal experience of
specific conditions.72,73 Other methods involved
choosing people with the skills and contacts to
represent consumers’ views. These included
Members of Parliament asking questions on behalf
of their constituents,45 and members of organised
groups who could draw on the views and
knowledge of the wider group membership (Types
A and B).
Only two reports compared different ways of
sampling consumers in order to set research
agendas.32,45 The NHS Primary Dental Care
programme45 found that the same general broad
themes of concern were consistently identified
through different routes: written consultations to
consumer groups, reviewing parliamentary
questions and questions to telephone helplines
and consumer membership of the prioritising
panel. This finding diminishes concerns that self-
selection of consumers, at least on this topic,
distorts the research agenda. The NHS HTA
programme32 found that reviewing questions to
telephone helplines identified general broad
themes but that these could not be translated into
research questions. Also, reviewing consumer
literature identified research questions, but these
were often out of date or fell outside the remit of
the programme.
Generally, it seems that where efforts were made
to increase inclusion by the use of large numbers,
this was at the expense of depth of involvement.
Where small numbers of consumers were involved,
there were some concerns about ‘tokenism’. Some
programmes sought a middle path with consumer
membership of committees combined with wider
consultation,32,34,38–40,45 sometimes conducted by
the consumer committee member.33,34,37
Working with consumers with specialist interests
encouraged informed debate, allowed consumers
to consult their own networks and identified topics
and priorities for research.33,37,59 Working with
established community groups was feasible,
although it could be time consuming. It provided
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Chapter 6
Synthesis of findingsa route for gauging local opinion from broad
sections of the community, including people who
were not activists and people who may be
unfamiliar with the English language.26,52,53,59,123
Working with consumers whose shared interests
were not health focused faced difficulties with lack
of attendance, lack of understanding and lack of
commitment.52,53 Patients recruited in clinical
settings have been interviewed to identify
interventions and outcomes to frame a research
agenda.72,73 Involving consumers with personal
experience of problems has sometimes added an
immediacy to the debate which is expressed in
emotive and persuasive language.72,75,79,96
Who initiated the engagement?
Consumer-initiated engagement
When consumers have taken the initiative with
collective social action, collaborative relationships
with research programmes followed where there was
a greater experience of consumer
activism.10,58,82–88,90,92,101 Formalised consumer
involvement ensued on a grand scale when much of
the dialogue was about the process of decision-
making, as well as the decisions, in research agenda
setting.67,83–87 Well-established, politically aware
consumer groups have had sufficient critical mass
to provoke sustained public debate and influence
the research agenda (Type F10,95). Less experienced
activists have provoked individual studies94,102 and
influenced small programmes.96 Activism has drawn
attention to conflicts about, for instance, animal
experimentation98 and cloning research97 and
attracted publicity where consumers have perceived
authorities as delaying research that would meet
consumer demands, or as conducting research in a
delaying tactic for other policy changes.107,115
Research programme-initiated
engagement
Research programmes took the initiative to involve
consumers in a variety of ways. When embarking
on organisational change they sometimes involved
consumers.32,33,37,45–47,49,51–53,55,57,59,60 Less often
their reflections considered the methods for
involving consumers,32,33,37,45,49,51–53,55,59 and more
rarely still they adapted methods to support input
from a greater diversity of people.32,33,37,45,51–53,59
The greater investment in involving consumers
and reflecting on the experience, the more was
learnt in terms of consumer priorities and
methods for involving them.
Other approaches initiated by researchers
included participatory research, which either
involved individuals in specific research projects61
or involved consumer groups in developing
structures and procedures for whole research
programmes.82 Programmes involved both
individuals and groups in community
development or community-based health
promotion initiatives.54,70
Consultation or collaboration?
Consumers in NHS Research has simplified
Arnstein’s ladder of involvement,18 to describe
degrees of involvement as consumer control,
collaboration and consultation.4 By recording the
precise methods, and the influence that consumers
had on research in a variety of circumstances, we
confirmed a general trend that these approaches
did relate to how much consumers could influence
how they were involved and the influence they had
on the research agenda. Within this general trend,
the consumer profile prior to establishing a
working relationship and the consumer profile
within the working relationship also appeared to
relate to the degree of influence that consumers
had.
Generally, in terms of consumer influence,
collaborations were more successful than
consultations, consultations were more successful if
consumers were consulting their peers, face-to-face
consultations were more successful than written
consultations and iterative interactions were more
successful than one-way communication. The
opportunities for individual thought, discussion
and an iterative process were also linked to greater
consumer influence.
Collaboration that had evolved directly from
collective consumer action appeared to support
greater consumer influence than collaboration that
came at the invitation of research programmes.
When hard won by collective consumer action
(Type E), collaborations rested on changes in
organisations that institutionalised consumer
involvement (e.g. NIH,67 Breast Cancer Research
Program in the USA86), whereas research
programmes could invite consumers to collaborate
without making any structural allowances for their
different backgrounds, thereby demanding that the
consumers themselves accommodate to working
together (Type A). These are the circumstances
where consumer involvement may be interpreted
as a token gesture to a changing political climate.
In some instances, consumers’ involvement was
increased by efforts to empower them in their role
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consumers invited to collaborate have included
young people in poverty,61 older people,62
subsistence farmers66 and people with disability63
or dementia.64 Although four of these episodes
were predicated on theories of
empowerment,61–63,66 none of them involved a
consumer in writing the report. Some of the
interactions which employed team working61–63,66
led to consumers conducting their own
research.61,62,66 This method of working was
resource intensive and the identified topics and
priorities were a relatively small part of the output,
which included small-scale research projects
completed by consumers. Elsewhere, consumers
were part of a multidisciplinary research network
that developed assistive technology,63 or through
face-to-face and written communication they
identified or prioritised topics to be undertaken by
professional researchers.64
Forum for exchange
Within each type of engagement, ideas were
exchanged within a range of forums.
Collaborative committees, when working well,
provided a structure for consumer members to
introduce a broader range of views by consulting
their peers.29,33,37 Such committees needed
facilitated democratic processes, openness,
appropriate choice of members, support and
training.32 Consumers needed to be informed
about the technical and organisational 
background of the work.37 Collaborations needed
to confront tensions and benefited from careful
management to avoid division or breakdown in
communication.32 Individual consumers needed to
be empowered to collaborate. This required
investment of time, resources and personal
relationships.61–63 Collaboration within a
framework of participative research provided the
motivation of finding research-based answers, not
just identifying the questions32,63,66 and also
provided a learning opportunity for the
trainers.62,66
When research programmes consulted consumers,
more was learnt from interactions where consumers
were more directly involved in the debate, for
instance through an iterative Delphi study49 or
face-to-face meetings,32,33,37,52,53,55,58,59,66 or
encouraged to participate by an independent
facilitator,58 or were even leading the debate.37
Least was learnt from simple written consultations,
either in terms of consumers’ ideas and priorities
for research or about the methods used to involve
them47,48 Commercial interests that involved
consumers as partners were particularly successful
in capturing and making use of consumers’ views,
and these are considered in more depth
below.75–79
Eliciting and prioritising ideas
Most of the reports we found were about methods
of engagement. They described how consumers
had been approached (proactively or reactively),
which consumers had been involved (individuals
or organised groups) and the media within which
ideas were exchanged (e.g. focus groups,
questionnaires, committee meetings). They rarely
considered in detail how opinions were elicited,
for instance how questions were framed or the
mechanisms for expressing priorities. Nor did
they report how priorities were aggregated, either
the priorities of all the consumers involved or the
priorities of the consumers and the health
professionals. One exception was a Delphi study
for eliciting research priorities for physiotherapy.49
A number of interactions resulting in consumer
influence employed independent facilitators or
consumers to lead discussions about prioritisation.
It may be relevant not only who engages directly
with consumers, but also specifically how they do
it. We found descriptions of committees, their
membership, their terms of reference and even
sometimes criteria for establishing priorities.
However, we found no detailed reports of how
consensus was achieved in committee meetings,
how they were facilitated, to what extent members
participated, how voting was managed and how
opinions were aggregated.
We have been able to draw on some notable
exceptions, mainly from the commercial sector,
where engineers have employed consensus
development methods to guide their development
agenda. In a two-step process, focus groups have
been employed to identify development needs,
followed by a broader survey to prioritise
them.76,77 Another approach was ‘brainstorming’
with consumers, followed by five rounds of
voting.75
Implementation
Interviews with participants in UK examples gave
us most detail about the implementation of
consumer involvement in agenda setting. Vivid
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poor communication, tenuous working
relationships, attitudes not wholly welcoming or
supportive of consumers and serious time
constraints were not limited to particular methods
for involving consumers. Commitment from senior
staff, broad consumer involvement, investing time
and resources in meetings to develop working
relationships, communication, training and
support and building on experience were all seen
as valuable.
Nature of the evidence
Any causal relationship inferred from this analysis
is necessarily tentative largely because evidence
has rarely been gathered in a systematic unbiased
way. Reflections on the methods for agenda setting
sometimes neglected to consider the methods for
consumer involvement, and opportunities for
learning and sharing were lost.54,60 In particular,
organisational change approaches to setting
research agendas did not capture consumers’ ideas
and priorities32,33,37,49,59 or lessons about
consumer involvement32,33,37,55 unless reflection on
methods specifically addressed consumer
involvement.47,48 More was learnt about consumer
priorities and methods for identifying them when
programmes reflected on the methods for
involving consumers.45 Consumer involvement
methods were developed further when consumers
were involved as partners in reflecting on working
practices.28,29,32
Most of the reports that we found were written by
researchers or research managers who had been
directly involved in working with consumers
through the different types of engagement (Type
A,24,25,28,29,32,66 Type B,32,47–49,54,55,58,59,70 Type
C,61,62,64,66 Type D,68,69,71–73,76,77 Type E,82,86,92 and
Type G32,45.96). Consumers reported specific
interactions where they had been invited to
collaborate (Type A33,37), where their lobbying had
led to collaboration (Type C83–85,87,88,90), where
they had facilitated consultations42,52,53 and where
they had influenced the course of research.100
These authors, researchers and consumers alike,
were often advocates of and key players in the
events they were reporting. A few reports had
authors independent of the interactions, and these
were written by a consumer,31 researchers75,79,80 or
a committee with the remit of reviewing an
interaction.67
Very few reports were of formal studies with
methods sections describing the investigation of
the interaction. Exceptions were an action research
study introducing consumers into the
management of the NHS HTA programme,32 a
formal review by committee of the NIH research
priority setting process and Health Sciences Policy
Program,67 a report of farmer participatory-
training and research in traditional pest and
disease management in Kenya66 and some reviews
that necessarily reviewed descriptions by authors
who had participated.35,56 The evidence is no
stronger in the UK cases that we investigated in
more detail. We interviewed very few people for
each case. The value of these cases is in raising
current issues that are particularly relevant to the
UK and the NHS.
Seeking advantages and disadvantages implies a
comparison with alternative methods. However, 
it was very seldom that we found alternative
methods being compared. Exceptions 
included the NHS Dental Research programme,
which informally concluded that the general 
broad themes of concern were consistently
identified through different routes: written
consultations to consumer groups, reviewing
parliamentary questions and questions to
telephone helplines and consumer membership 
of the prioritising panel.45 In an engineering
setting, one-to-one interviews were found to be
more cost-effective than focus groups, even 
though identifying 90–95% of consumer needs 
for product development required interviews 
with 20–30 consumers and several analysts 
reading and interpreting raw 
transcripts.75,79
Much more often we are left with descriptions,
often subjective, of what was good, or not so good,
from which we have inferred advantages and
disadvantages.
The nature of the evidence cannot support strong
conclusions; rather, it demands a wary
interpretation. Nevertheless, an overview of the
different types of interactions reported allows us to
describe the advantages and disadvantages
associated with different methods previously
employed for involving consumers in identifying
and prioritising research topics and the
circumstances in which these advantages and
disadvantages have been experienced. This we do
here, by considering research programmes facing
different circumstances: in terms of their research
focus (health topic and research methodology),
organisational setting (geographical scope,
leadership and funding) and assets available for
consumer involvement.
Synthesis of findings
92Context of consumer
involvement in agenda setting
Findings from this review are also tentative
because of the number of potentially confounding
variables that could not be clearly disentangled,
particularly details of implementation, as well as
contextual factors that may influence the methods
for involving consumers and their subsequent
influence on the research agenda. These include
the focus of the research and the organisational
settings of the research programme and related
consumer activity.
Researchers and consumers would like to know
which methods are most appropriate for different
circumstances. Although particular methods have
evolved in different circumstances, as we describe
below, whether these may be the most appropriate
setting or to what extent they are transferable to
others is largely speculative.
Condition-specific research
Three topics held particularly high profiles within
the review because consumer involvement here was
so widespread or influential: biotechnology, assistive
technology and breast cancer. The motivation and
methods for consumer involvement in these areas
varied, as did the outcomes. Biotechnology,
including reproductive technology, appeared in
three widespread consultations about contentious
issues, two of which involved 10,000–15,000
participants.68,69,95 None of these consultations
were seeking ideas for research that could be
readily provided by a lucrative biotechnology
industry. Instead, they were mounted to gauge
attitudes and priorities in areas where ethics of
science are at the centre of a widespread public
debate. Rather than researchers seeking consumer
input to research and development, public
opinion was sought about appropriate constraints
to research and development.
In contrast, individual consumers were assiduously
recruited and supported by commercial interests
in order to identify and prioritise topics for
research and development in assistive
technology.63,75–79 Here considerable effort was
invested in developing collaborative relationships
with consumers who were seen as the end-product
experts. This learning was not transferred to the
NHS R&D programme for physical and complex
disabilities. Here consumer involvement was far
less developed and the research programme
report concluded that a more balanced
involvement of participants, including consumers,
was needed in future.55
A third area notable not only for the number of
examples we found, but also the degree of
consumer involvement, was breast cancer. Breast
cancer organisations have been exceptional in
influencing the structures for managing research
programmes in the USA,83–86 Canada82 and
Australia.58 It is probably relevant that breast
cancer has a long history of advocacy and that,
demographically, it affects a well educated group
who would find engaging with the conceptual and
organisational aspects of research agenda setting
less challenging than many other groups.
Some types of interaction seemed to be associated
with particular research foci. For instance,
collaborations which evolved from consumer
initiatives (Type E) were focused on condition
specific issues such as HIV/AIDS,89,90 breast
cancer,58,82–85,87 radiotherapy injury,93
breastfeeding,92 poor housing88 and
homelessness.81 These conditions provided a focus
for collective social action on a national, regional
or local scale.
The stories of these interactions have been told
both by consumers83–85,87,90 and by researchers or
research managers63,82,92 directly involved,
sometimes working together,92 and by
independent researchers10,89,93 or independent
committees.67
From these reports, we have gathered a variety of
methods for consumer lobbying led by national
consumer groups, advocacy groups and coalitions
of consumers calling for research and research
funding for their particular interests. They
engaged with governmental bodies,10,86 national67
and regional research programmes83,87 and teams
of doctors and researchers.81,88–90,92 They achieved
community based research88–90,92,93 and influential
committee membership,10,58,84–86 and multilevel
participation67,82,83,87,92 in national and regional
programmes. The resulting output was an
impressive list of changes in working methods and
research priorities. Consolidated consumer action
has also directly led to broad consultations
(Type F).10,95 As consumer involvement became
more widely acceptable, research programmes
took the initiative in contacting consumers.
Consumer groups were invited to collaborate
(Type A) with condition-specific research
programmes about homelessness,24
musculoskeletal problems,29 breast cancer and
HIV/AIDS.28 Similar invitations have been limited
to involvement through consultations (Type B), for
instance about cancer,47 asthma60 and physical and
complex disabilities.135
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important foci for collective consumer action and,
subsequently, considerable influence of public
health sector research management structures. The
commercial sector has also invested in consumers
to direct research and development. This learning
has not necessarily been transferred to research
programmes not directly targeted by consumer
campaigns or motivated by commercial interest.
Opportunities remain for research programmes to
invite very modest involvement from organised
consumer groups for relatively little benefit or cost.
Broader research topics
Since the advent of consumer lobbying for
condition-specific research, research programmes
have sought to broaden the impact of consumer
involvement either by inviting consumer groups to
collaborate in research programmes with a
broader focus (Type A), by conducting broader
consultations (Types B and D) or by empowering
traditionally marginalised individual consumers in
collaborative relationships (Type C).
Consumer groups have been invited to collaborate
in research programmes (Type A) characterised
not by the health topic of the research, but by the
type of research undertaken: health technology
assessment25,32 and systematic reviews of
effectiveness.28–31 The examples we found were
national UK programmes24,25,32,33,37 and Cochrane
Collaboration review groups.28–31 Collaboration
initiated by research programmes was often
conducted within a framework of organisational
change, where the remit of work often included
formal reflection on the processes employed to set
the research agenda25,32,33,37 Such programmes
engaged national consumer groups, largely
through committee membership. Where reflection
focused on consumer involvement, it is clear these
interactions led both to topics identified for
research and recommendations for the process of
consumer involvement. However, very little light is
shed on the process of consumer involvement in
priority setting across a broad range of health
topics.
Broad consultations have also drawn on
experienced consumer groups (Type B) to set the
agenda for specific services (physiotherapy,49
midwifery,48 nursing51), for specific settings
(occupational health and safety54), assessing health
technologies,32 organising services33,74 and the
issue of getting research findings into practice.33,37
Research that is broader than specific conditions
has not generally been the prime interest of
consumer groups as they are commonly organised
around specific conditions. Methods for involving
consumers in agenda setting across broad areas of
research have been less influenced by consumers,
and modelled more closely on the usual working
practices of the research community: committee
meetings, surveys or participative research.
Organisational setting for research 
Geographical scope
National programmes in the UK have successfully
engaged with national consumer groups and
others within a framework of organisational
change to set research agendas (Type A24,25,32,33,37).
National consumer groups often had national
networks informing them of their consumers’
views and concerns, and they had the
organisational structure and experience to engage
with research programmes that make few
concessions to newcomers. Consultations by
national programmes of consumer groups 
(Type B) have been less successful46,47,51 unless
they have been led37,42 or hosted32 by consumers
or had an independent facilitator.58
These national UK programmes had very different
histories from national programmes that we found
in other countries. Rather than adopting a
framework of organisational change to set agendas
and invite consumer group involvement in
established programmes (Type A engagements),
national programmes in Canada and the USA
involved consumers in developing the structures
and working practices in order to set research
agendas (Type E engagements). There were very
few Type E engagements in the UK. The only
example was a policy change (and consequent new
emphasis in research agenda) and a 5-year
programme in response to lobbying by maternity
service users.10 This was a small achievement for
consumers’ interests in research agendas
compared with the changes in breast cancer and
HIV research in North America.83–87,89
We found two very different methods for engaging
consumers on an international scale. Either effort
was directed at consulting a representative
population sample (Type D) to gauge general
attitudes about the value of research,68,69 or effort
was made to develop working relationships with a
small number of consumers across national
boundaries, many of whom were active members
of organised consumer groups (Type A). Once
working relationships were established, this
method led to prioritising topics in condition-
specific areas,28 identifying patient-defined
outcomes31 and developing collaborative working
Synthesis of findings
94practices29 for systematically reviewing literature
about effects of healthcare.
Two regional NHS programmes had broad health
topics: inner city health and the health of older
people. Both involved established community
groups (with no special interest in health) in face-
to-face encounters within the relevant
geographical boundaries. The report of priority
setting for inner city health (Type B) recorded
consumers’ criteria for setting priorities across
health topics.52,53 Broad priorities were also set for
researching the health of older people after a
collaborative exercise with associations for older
people (Type A). Another regional programme in
Nebraska engaged stakeholders in setting the
agenda for school health services.70 All these
examples required considerable investment in the
process, using facilitators with prior experience of
consumer involvement in research52,53 or carefully
structured face-to-face encounters in addition to
written communication over several months.70
Some UK national programmes have used
regional structures to host workshops.38,39,135 This
allowed access to individual consumers, raised
awareness of the programme and consumer
involvement more widely and developed working
relationships for the future.
Engagement on a local scale tended to invoke
theories of empowerment to establish
teamworking. Examples focused on evaluating
services or voluntary sector groups (Type A26) or
empowering Californian young people (Type C61 )
or Israeli elders (Type C62) to undertake their own
research. Engagement on a local scale was found
in developing countries where the predominant
method for involving consumers was participatory
research, and this was applied to environmental
research for farming66 and conservation.71
Comparing the examples above, the geographical
scope seems to have had little influence on the
choice of methods for involving consumers. Very
different approaches (consumer initiated and
research programme initiated) have been adopted
on a national scale in different countries, and on
an international scale (opinion polls and team
work) for different purposes.
Institutional setting
Within the UK NHS R&D programme, the Type
A collaborations and Type B consultations were
the predominant approaches set within structures
engaging with organisational change. Specific
contributions from consumers were rarely
recorded and only when organisational change
specifically reflected on consumer involvement
were any lessons learnt about the process.
The professional bodies that we found engaging
consumers in agenda setting did so with simple
consultation exercises, either a written
consultation49 or a single face-to-face event.51
University research teams also engaged in
relatively small events, but several of these
embraced the principle of empowerment through
teamworking and participatory research (Types A,
C and E26,61,62,66,81). Academics responded to
consumer action with collaborative research81,88,92
and independent research.96,102
It was commercial organisations who invested
most in involving consumers in directing the
research agenda. They followed a principle of
partnership and engaged individual users with a
variety of focus group consultations and priority-
setting exercises63,75–79
The three national charities that we investigated
in depth conducted their own consultative and
collaborative exercises42,64,129 amongst their own
members. They influenced the research agenda by
conducting their own research in collaboration
with their own members,129 by involving their
members in prioritising research64 or by feeding
the results of their priority setting into national
research programmes.42
Institutions have employed those consumer
involvement methods most similar to their usual
working practices: the NHS convened committees
and conducted consultations; academics
conducted research and engaged with consumers
within an educational framework; commercial
organisations worked with their customers; and
charities worked with their members. Although
this may mean that organisations have played to
their strengths, their choice of methods have been
conventional, and they may have much to learn
from each other.
Which methods have contributed
most knowledge?
Despite the weaknesses in the evidence and the
potential confounding factors, we identified
themes relating to success associated with each
type of engagement. Some success was seen with
most types of engagement, but only in certain
circumstances. We considered knowledge of
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FIGURE 11 Characteristics of initiatives perceived as successful (causal relationships inferred)methods to be most advanced when we found 
both a record of consumers influencing research
agendas and a reflection on the methods of
involvement. The characteristics of methods
perceived to be successful, and the terms in which
this success was apparent, are presented in
Figure 11.
For instance, there was reflection on methods and
consumer influence when research programmes
invited consumers to collaborate (Type A
interactions), but only where the collaborating
consumers were also conducting their own
consultation of their peers29,33,37 or where the
research programme manager had considerable
experience of working with consumer groups.
Typically, under these circumstances, involving
networked consumers who were informed about
the task, took a lead in consulting their peers and
participated in facilitated discussion and
reflections on the process, led to a record of
consumer priorities and lessons about the
methods for identifying them. Between them,
these specific episodes were set in international,
national and regional programmes and they
addressed condition-specific, population-specific
and broader health research agendas.
Consulting consumer groups (Type B interactions)
also enabled consumers to influence research
agendas, but only when staff had considerable
experience of consumer groups52,53 or where the
consumer groups had considerable experience of
research.51 Direct and repeated involvement in
debate facilitated discussion with consumers with
specific health interests and led to research topics
being identified and prioritised. Greater effort in
terms of time and resources was needed when
working with general community groups, although
here too the broader community, including
marginalised groups, could identify and prioritise
research.
Empowering individual consumers to collaborate
(Type C interactions) also showed some successes,
whether the underlying philosophy was
participative research in an academic setting61,62,66
or consumerism and commercial interest.75
Participative learning led to few topics, although
these appeared highly relevant to consumers and
led directly to research.
Similar outputs in terms of the research agenda
and reflections on the process were achieved with
consultations of consumer groups (Type D
interactions) where the driving principle was
participative research71 or commercial success.75–78
Conventional social research methods were easily
applicable to patients in clinical settings for
identifying interventions and outcomes for an
evaluation agenda.73,73
Where research programmes have responded to
consumer action with collaboration (Type E) we
saw that consumers appeared to have influenced
the research agenda and the processes of
involvement.10,81,84–86 Consultations in such
circumstances (Type F) appeared less successful in
these terms, although well established, politically
aware groups that managed to sustain public
debate did influence research agendas.10,50,95
We found isolated examples of consumers
influencing research agendas through their use of
emotive language addressed to researchers or
publishing in the research media.96 However,
independent consumer action more often
attracted criticism and bad publicity for services or
research.97,107
Independent consumer action (Type H), whether
in conducting research129 or setting research
priorities,42 was successful in identifying consumer
priorities although in these circumstances
consumer groups also needed to influence a
programme of research. In these instances they
either conducted their own programme of
research129 or they were able to offer suggestions
to other programmes.42,49,59 However, this remains
a rich but poorly tapped pool of consumers’ ideas
for research.
Many successful examples of consumer
involvement that either contributed to our
knowledge about consumer priorities or methods
for involving them in setting research agendas
shared a common theme of investment in, and
experience of, working relationships. This
investment and experience was evident in various
forms, where:
  Engagement was collaborative and consumers
were empowered to play leading roles or
researchers drew on extensive experience of
working with consumers.
  Consultations were led by researchers with
extensive experience of working with
consumers, or consumers drew on extensive
experience of campaigning and/or research.
  Time and effort was invested in facilitating
extended debate.
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he current study has identified reports of
consumers contributing to R&D agenda
setting, some of which have documented
consumers’ ideas and priorities, and some of
which provided lessons for developing methods of
involvement. This evidence depends largely on the
reports of people directly involved in agenda
setting, either researchers, research managers or
consumers. Circumstances and methods appeared
to present a range of advantages and
disadvantages. Much more rarely we found
independent reports that also documented
advantages and disadvantages.
Success in terms of consumers actually identifying
and prioritising research topics, rather than
merely being present (in person or through
correspondence) during the process, appears to
have been related to the degree of consumer
participation and control. Topics and priorities
were more often documented following
collaborations rather than consultations,
particularly where communication between
consumers and research programmes, or amongst
consumers themselves, was supported by
investment in time, training, consumer networks
and iterative discussion.
The strengths of the current study include the
systematic and exhaustive search of electronic
bibliographic databases, extensive networking
within the UK and the systematic approach to
describing and analysing the reports found. It also
rests on having contacted 250 consumers and
researchers who were important for providing up-
to-date information in a rapidly developing field.
The majority of the reports that were sufficiently
detailed to include in the review were found
through consumer or researcher networks. Those
reports that were identified only through
electronic searches of bibliographic databases were
more often not set within a narrow definition of
health services. It was by electronic searching that
we identified examples of consumer involvement
in research agenda setting for occupational
safety,54 biotechnology,68,69,95 indoor and
outdoor61,107 environmental health, school
health,70 conservation,71 science80 and
engineering,76,79, homelessness81 and social
research.62 Few of these used the combination of
committee membership and written consultation
so commonly chosen by Advisory Groups
convened specifically to set the initial NHS R&D
agenda. Rather, they provided descriptions of
alternatives such as town meetings;54 training and
support for conducting research26,62 and a survey
of priorities;81 representative opinion polls;68,69,95
questionnaire and workshop;70 interviews, focus
groups and workshops;50,71 participatory
research;61 consensus development methods;75,76,78
and toll-free telephone lines.95
Searching electronically beyond narrow definitions
of health also highlighted how relatively few
examples of health research agenda setting have
been formally reported in peer-reviewed journals.
This may reflect the lack of importance attached
to this aspect of agenda setting hitherto.
We sought purposeful and opportunistic examples
of consumer involvement in setting research
agendas. This approach had an inherent bias
towards successful interactions. Opportunistic
interactions were by definition successful, and
purposeful ventures that were unsuccessful were
less likely to be reported. Our search was directed
towards interactions of consumers and the
research agenda, and we reviewed the methods
reported. This approach highlights those methods
that have been (usually more or less successfully)
applied to involving consumers in setting the
research agenda. It obviously does not highlight
those methods that have not been reported,
whether this was because they have not been
attempted or because they have not been
successful. Nor has it captured the numerous
opportunistic episodes where consumers
influenced the research agenda although it was
not reported in these terms: excluded was a rich
literature of consumers actively participating in
research.
Related literature
These findings have been complemented by other
reviews of published and unpublished literature.
Although we have not been able to find any
previous systematic attempt to review methods for
involving consumers in setting research agendas, a
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Chapter 7
Discussionsurvey of UK research programmes has identified
both matches and mismatches in consumer
priorities for research.35 This review defined
mismatches as differences or disagreements in
perception, opinion, view or practical decision
concerning the problems or needs to be addressed
by research. The authors concluded that such
mismatches and the implications that flow from
them have been under-recorded. Very few of the
studies they found allowed for direct comparisons
to be drawn between the priorities of professionals
and consumer groups. As with the current study,
the evidence collated was weak but indicative.
Consumers would seem to support research on
broader social and environmental influences, on
alternative treatments and on long-term health
problems. Mismatches may be more prevalent in
respect of social and organisational aspects of
healthcare than in the more basic biosciences.
Another report particularly pertinent to consumer
involvement in health research agenda setting in
the UK is the guidelines for researchers published
by Consumers in NHS Research. This differs from
the current work in being based not on a review of
international literature but on the pooled
experience of consumers, academics and NHS
staff. Their experience included direct
involvement in citizens’ juries, community
development and its evaluation, action research
and consumer involvement in systematic
reviewing, research management and guideline
development; across social work, education,
genetics, maternity and disability. This experience
provided a route for purposively sampling
successful examples of consumer involvement to
illustrate the guidelines.
The current review adds to that document by
providing evidence in terms of outputs from more
and less successful examples of consumer
involvement in agenda setting exercises. It
supports their assertion that “the task of
identifying a research topic should be a
dialogue…the best way to involve consumers is
face-to-face”.4 The current review provides a
broader range of examples of consumer
involvement in agenda setting leading to research
projects, and several examples where a broad
range of consumers were involved in agenda
setting. The current review supports Consumers in
NHS Research’s assertion that the choice of
consultation, collaboration or consumer control as
an approach depends on the researchers, the
consumers, the research method and the funding
body. It also supports their recommendation that
each exercise of consumer involvement should be
evaluated. However, the current review shows that,
so far, despite extensive experience of consultation
exercises particularly in the NHS, least has been
learnt from these simpler methods of involvement
in research agenda setting, compared with
experience of collaboration or consumer control.
This may have disheartening consequences,
particularly as least is learnt about how to involve
consumers simply but well, and most is learnt
about those methods that require greatest
investment. Most reports of consumer involvement
in research agenda setting are not sufficiently
detailed to judge the extent to which they met the
guidelines prepared by Consumers in NHS
Research. This lack of detailed reporting of both
the methods and the outputs suggests an
additional principle of reflecting on experience in
order to learn, share the lessons and build a
rigorous and publicly accessible knowledge base
about consumer involvement in research agenda
setting.
By comparing what we found with Mullen’s
distinction between methods for engagement and
methods for eliciting and aggregating findings,9
we see that reports of consensus development are
notable for their absence. Searching for reports of
consensus development and reviewing them for
their applicability to consumer involvement in
research agenda setting could fill this gap, or
direct research to fill it. When this approach was
taken to study consensus development for clinical
guidelines, Murphy and colleagues drew a number
of conclusions which might be applicable to
research agenda setting.8 These conclusions
related to selecting the participants, choosing and
preparing background information, structuring
the interaction and synthesising individual
judgements. However, Murphy and colleagues
found few studies that specifically related to
consumers. Where literature addressing public
preferences has been reviewed, it was restricted to
eliciting these preferences and did not address the
challenge of integrating public preferences into
decision-making.7 There is a need for more
detailed study of consumer involvement in
consensus development.
In terms of implementation, our review concurred
with the findings of a survey of health bureaucracy
consultations.8,136 The key conditions that the
survey highlighted as enabling an organisation to
consult effectively were similar to those in
involving consumers in research agenda setting:
official endorsement of consultation at senior
levels; staff with expertise, experience and skills in
consultative practices; constructive and on-going
Discussion
100relationships with communities; valuing the
knowledge and experience of community
members; and representative mechanisms which
recognise and respect difference. Other conditions
that may also be transferable to consumer
involvement in research agenda setting were
decentralised and devolved decision-making for
greater accessibility, responsiveness and flexibility;
simple, clear and consistent structures and
procedures; stability in functional responsibilities
and continuity of staff; and balanced requirements
for economic efficiency and social justice.
There is little direct link between many of the
reports included in this review and the broader
relevant theoretical or empirical literature. The
exception is the link with Arnstein’s work, which
has penetrated policy discourse about
consultation, collaboration and consumer
control.18 Other than this, consumer involvement
initiatives in research agenda setting appear to be
developing largely in isolation, with little direct
experience or guidance to build on. This is
reminiscent of earlier literature about self-help
groups where “the bulk of the literature consists of
simple, descriptive case studies, with little or no
attempt at quantification and still less attempt to
test hypotheses about relationships using
quantitative data. There is a dearth of comparative
studies as well … [and] it is fair to say that most of
the researchers in the field of self-help group
study seem essentially oblivious of the large extant
literatures on social movements and voluntary
action more broadly”.3 This lack of grounding in
prior research is unsurprising, since advances in
this field currently rely largely on enthusiasts
amongst consumers and managers of research.
Indeed, the main weakness of our findings stems
from the dearth of formal studies by non-
participants. Most reports were prepared by
participant researchers or managers and a few by
participant consumers. This balance of participant
authors is likely to have biased reporting in favour
of successful ventures, perhaps glossing over more
difficult experiences. In some instances, reports or
interviews offered both perspectives on the same
events. While there was corroboration, there was
also some disagreement.
Potential impact of consumer
involvement
We have tried to evaluate consumer involvement
by addressing its impact. We were disappointed to
find how rarely records had been kept of
consumers’ ideas and priorities: far more often
kept by consumers than by researchers. Where
records had been kept, even when they matched
the subsequent research agenda, it was not
possible to determine the extent to which
consumers had influenced the agenda, if at all.
Even more difficult was determining whether the
research agenda led to research which matched
consumers’ priorities. This was because such
information was not recorded in the same
documents. Scanning NHS R&D websites
identified some research that appeared to match a
few consumer priorities, but whether consumers
had been influential was impossible to tell.
Another potential impact of consumer
involvement was changes in structures and
processes for setting agendas. Most radical were
examples in North America, where new research
programmes were designed in partnership with
consumers. A little more common was consumer
involvement in designing procedures for
consumer involvement: this occurred in some
Cochrane Review Groups. Typically within the
NHS R&D programme, consumer involvement
was not even reported in the reflections of the
advisory panels.
The most far-reaching potential impact could be
on the management, conduct and findings of the
funded research and subsequent changes in
practice and health outcomes. A tenuous link can
be traced from consumer concerns about perineal
care during childbirth. These were raised by the
NCT in a 1981 survey of members’ experiences of
episiotomy, and again in 1993 with a survey of
women’s experiences and midwives’ practices for
perineal care. The initial survey prompted a trial
of episiotomy that was reported in 1984.137,138
Episiotomy rates fell.125 Research about perineal
repair was summarised in two Cochrane systematic
reviews.139,140 For these reviews, consumer views
regarding what outcomes they would expect were
sought from local focus groups, members of the
NCT and other postnatal support groups. The
main outcomes of interest from consumers’ point
of view were the extent of short- and long-term
pain, the removal of suture material and the
resumption of pain-free intercourse. The evidence
from one of these reviews140 was used by a midwife
to change the stitching practice in her hospital
and her description of this work won her the
Cochrane Library prize in 1998. This story spread
over 4 years from expressed concern about
episiotomy rates to trial findings in the first
instance, and over 5 years from expressed concern
about perineal repair to changed practice in the
second.
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examples of participative research where
consumers identified the questions and 
worked with researchers to find the answers.
Farmer participatory schools in developing
countries could identify problems, compare
methods and have the answers in a single season.
Similarly, Californian young people addressed
their chosen topics within a summer break from
school.
In summary, what we know about the advantages
and disadvantages of methods for involving
consumers in agenda setting rests on weak short-
term evidence and almost entirely speculative
long-term evidence.
Discussion
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he conclusions and recommendations are
drawn from the findings of the literature
synthesis and the analysis of the UK cases. They
rest on evidence that is weakened by the difficulty
of accessing literature on consumer involvement,
the patchy nature of the research and the lack of
independent reports or rigorous studies.
Nevertheless, it is clear that consumers can
identify and prioritise research topics, despite the
technical nature of research and the added
complexity of debating the relative importance of
gaps in research evidence. However, attempts to
involve consumers were not always successful,
either in gathering consumers’ ideas or in using
consumers’ ideas to influence research agendas, so
we have tried to identify common difficulties and
possible solutions.
In the absence of comparative studies, we cannot
conclude that any methods are more or less
advantageous than others. The choice of approach
to engagement and methods of interaction will
depend on the researchers, the consumers, the
research task, the funding body and the social
context and values informing the research process.
However, there is some indication that different
methods may be associated with specific
advantages and disadvantages. We can also draw
conclusions about how methods have been
implemented in advantageous or disadvantageous
ways. Most of our conclusions relate to the
uncertainties of knowledge in this area and inform
our recommendations for research.
Implications for research
programmes
Conclusions about consumer involvement in
research agenda setting are not fundamentally
different from conclusions about consumer
involvement in research or service planning more
widely, despite the added complexity of prioritising
gaps in evidence. Research programmes have
sufficient collective experience of involving
consumers to plan their agendas, working directly
or indirectly with consumers. Appropriate methods
depend upon the tasks to be undertaken, the
consumers to be involved and the support required.
Productive methods for involving consumers
require appropriate skills, resources and time to
develop and follow appropriate working practices.
Support and training may be adapted from
programmes developed to enable
multidisciplinary groups to discuss evidence for
service planning or for consumers to develop skills
and confidence to influence healthcare decisions.
The more that consumers are involved in
determining how this is to be done, the more
research programmes will learn from consumers
and about how to work with them. Unless
consumer involvement is to be a late addition to a
programme (apparently one of the least effective
approaches), planning for consumer involvement
and securing the necessary investment need to
start at the same time as planning for the
programme as a whole. Where programmes are
already established and consumer involvement is
necessarily a late addition, the programme may
face considerable challenges.
Although the choice of methods for involving
consumers should be made in discussion with
consumers themselves, this discussion can be
informed by the experiences collated in this
review. More success might be expected if research
programmes embarking on collaborations
approach well-networked consumers and provide
them with information, resources and support to
empower them in key roles for consulting their
peers and prioritising topics. To be worthwhile,
consultations should engage consumer groups
directly and repeatedly in facilitated debate; more
resources and time are required if consumers are
drawn from groups whose main focus of interest is
not health. Participative research methods can
either lead to a small number of completed
research projects or can be applied to designing
and implementing novel research management
structures for agenda setting. Well-developed
commercial consultation or social research
methods can engage individual consumers;
opinion surveys tend to be less informative in
setting research agendas.
There are barriers to be overcome whatever the
method for engagement or forum for exchange of
ideas: poor representation of consumers;
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Chapter 8
Conclusions and recommendationsconsumers’ unfamiliarity with research and
research programmes’ unfamiliarity with
consumers; negative attitudes and poor working
relationships; difficulties in communication and
time constraints. These barriers can largely be
overcome with good leadership, purposeful
outreach to consumers, investing time and effort
in good communication, training and support,
thereby building good working relationships and
building on experience.
Some methods, such as occasional consultations,
do not lend themselves to long-term investment,
and these approaches have more often failed to
show the advantages of enthusiasm for involvement,
or increased knowledge about consumers’
priorities or constructive ways of working with
them. Occasional consultations, conducted without
input from consumers themselves, risk
disappointing outcomes and cynicism.
There is an urgent need for research programmes
to improve their record on reflection and
documentation of consumer involvement if they
are to learn from their experience anything about
consumers’ priorities and appropriate methods for
involving them. Past experience shows that more
has been gained from reflection and
documentation when consumers have played a
part in this too. Reports should include details of
the participants, approaches to engagement,
forums for discussion, methods for decision-
making and the context of the work.
Implications for consumers
Organised consumer groups capable of identifying
research priorities need to find ways of
introducing their ideas into research programmes.
Consumers may be disheartened by their apparent
lack of influence on UK research programmes.
They should be aware that responding to written
consultations may not be a good use of their time.
If they wish to be involved in setting research
agendas they may prefer to offer more time in
order to collaborate. As collaborators they could
seek funding to conduct consultations of a broader
range of consumers in order to record consumers’
views and better inform the research programmes.
They should be aware that consumers making
efforts to (re)design structures and procedures has
led to greater influence over research agendas.
Consumers are particularly well placed to reflect
on their experience of research agenda setting in
order to build the evidence about consumers’
priorities and methods for involving them.
Recommendations for research
This review has provided vivid descriptions of
poor consumer representation, poor
communication, tenuous working relationships,
attitudes not wholly welcoming or supportive of
consumers and serious time constraints for
involving consumers. Commitment from senior
staff, broad consumer involvement, investing time
and resources in meetings to develop working
relationships, communication, training and
support and building on experience were all seen
as valuable. We recommend research to develop
and evaluate different training methods,
information and education and other support for
consumers and those wishing to involve them.
Where consumers are capable of identifying and
prioritising research topics, they have had
relatively little impact on research agendas. 
We recommend research addressing the 
barriers to consumers’ ideas influencing research
agendas. 
Given that the evidence about consumer
involvement in research agenda setting rests
largely on reflective reports by participants, we
recommend that research programmes embarking
on working with consumers do so within an ethos
of reflexive research. At a minimum they should
involve consumers in reflecting on and reporting
the process and outcome. Whenever possible they
should involve consumers in considering the
methods and implications of working together
both in advance and with hindsight. There is also
a place for independent researchers to work with
research programmes and consumers to
investigate and record working practices, and to
attempt to assess the impact (and costs) of such
involvement. Consumers should be involved in
conducting and reporting this work.
This review found very few formal evaluations of
consumer involvement in research agenda setting.
These employed retrospective analysis or action
research. Therefore, we recommend prospective
comparative studies of different methods for
involving consumers. 
We found very few reports detailing how decisions
were made. Exceptions included Delphi studies in
face-to-face or written consultations. We
recommend that research about collective
decision-making be further advanced by
addressing the processes and outcomes of
consensus development that involve consumers.
Conclusions and recommendations
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Appendix 1
Search strategy for agenda setting report
Commercial and specialist database searches
Medline (UnixSPIRS): 1989 – August 1999
No. Search
#1: RESEARCH / all subheadings
#2: explode RESEARCH-DESIGN / all subheadings
#3: explode HEALTH-SURVEYS / all subheadings
#4: TECHNOLOGY-ASSESSMENT-BIOMEDICAL / all subheadings
#5: DELPHI-TECHNIQUE / all subheadings
#6: explode CONSENSUS-DEVELOPMENT-CONFERENCES / all subheadings
#7: FOCUS-GROUPS / all subheadings
#8: DELPHI
#9: TECHNIQUE*
#10: DELPHI TECHNIQUE*
#11: DELPHI
#12: STUD*
#13: DELPHI STUD*
#14: WORKSHOP*
#15: NOMINAL
#16: GROUP*
#17: NOMINAL GROUP*
#18: #1 or #2 or #3 or #4 or #5 or #6 or #7 or #10 or #13 or #14 or #17
#19: STAKEHOLDER*
#20: CONSUMER
#21: PARTICIPATION
#22: CONSUMER PARTICIPATION
#23: USER
#24: GROUP*
#25: USER GROUP*
#26: CONSUMER
#27: INVOLVEMENT
#28: CONSUMER INVOLVEMENT
#29: PATIENT
#30: PARTICIPATION
#31: PATIENT PARTICIPATION
#32: CONSUMER-PARTICIPATION / all subheadings
#33: CONSUMER-ADVOCACY / all subheadings
#34: CONSUMER-ORGANIZATIONS / all subheadings
#35: #19 or #22 or #25 or #28 or #31 or #32 or #33 or #34
#36: #35 and #18
Key: *, truncation.Appendix 1
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EMBASE (OVID): 1988 – August 1999
Set Search
1 consumer.sh.
2 exp consumer/
3 exp research/
4 exp health care organization/
5 health care organization.sh.
6 health services research.sh.
7 health care policy.sh.
8 health care planning.sh.
9 consumer$.tw.
10 research.tw.
11 delphi technique$.tw.
12 consensus.sh.
13 public opinion.sh.
14 public participation.sh.
15 (research adj5 priority).tw.
16 (research adj5 priorities).tw.
17 (research adj5 agenda).tw.
18 (research adj5 agendas).tw.
19 patient participation.tw.
20 consumer participation.tw.
21 user group$.tw.
22 (consumer adj5 advoca$).tw.
23 consultation exercise.tw.
24 consumer organisation$.tw.
25 consumer organization$.tw.
26 consumer group$.tw.
27 self-help group$.tw.
28 consumer involvement.tw.
29 stakeholder$.tw.
30 lay.tw.
31 (lay adj5 participa$).tw.
32 (lay adj5 participat$).tw.
33 (lay adj5 involv$).tw.
34 delphi stud$.tw.
35 consensus development.tw.
36 consensus conference.tw.
37 staticised group$.tw.
38 statisticed group$.tw.
39 (citizen$ adj jur$).tw.
40 consultation round$.tw.
41 postal consultation$.tw.
42 workshop$.tw.
43 (workshop$ adj10 research).tw.
44 focus group$.tw.
45 consensus method$.tw.
46 1 or 9 or 13 or 14 or 19 or 20 or 21 or 22 or 24 or 25 or 26 or 27 or 28 or 29 or 32 or 33
47 3 or 5 or 6 or 7 or 8 or 11 or 12 or 15 or 16 or 17 or 18 or 23 or 34 or 35 or 36 or 40 or 43 or 44 or 45
48 research topic$.tw.
49 47 or 48
50 49 and 46
Key: sh, controlled terms; tw, search in title, abstract and controlled terms; $, truncation.CINAHL: 1982 – June 1999
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Set Search
1 “Consumer-Advocacy”/all subheadings
2 “Consumer-Attitudes”/all subheadings
3 “Consumer-Organizations”/all subheadings
4 “Consumer-Participation”/all subheadings
5 “Consumers”/all subheadings
6 “Public-Opinion”/all subheadings
9 consumer involvement in ab, ti 
12 consumer participation in ab, ti 
15 patient participation in ab, ti 
18 patient involvement in ab, ti 
21 user group* in ab, ti 
23 stakeholder* in ab, ti 
26 lay involvement in ab, ti 
29 lay participation in ab, ti 
30 “Research”/all subheadings
31 “Human-Genome-Project”/all subheadings
32 explode“Research-Disciplines”/all subheadings
33 explode“Research-By-Type-and-Subject”/all subheadings
34 “Research-Ethics”/all subheadings
35 “Research-Measurement”/all subheadings
36 “Research-Measurement”/all subheadings
37 “Research-Methodology”/all subheadings
38 “Study-Design”/all subheadings
39 “Research-Personnel”/all subheadings
40 “Research-Priorities”/all subheadings
41 #30 or #31 or #32 or #33 or #34 or #35 or #36 or #37 or #38 or #39 or #40 
42 #1 or #2 or #3 or #4 or #5 or #6 
43 #9 or #12 or #15 or #18 or #21 or #23 or #26 or #29 
44 #42 or #43 [ALL CONSUMER TERMS]
45 “Seminars-and-Workshops”/all subheadings
46 “Focus-Groups”/all subheadings
47 “Delphi-Technique”/all subheadings
48 #45 or #46 or #47 
51 consensus method* in ab, ti 
54 consensus conference* in ab, ti 
57 committee membership in ab, ti 
60 working group* in ab, ti 
63 advisory group* in ab, ti 
66 consultation exercise* in ab, ti 
68 #51 or # 54 or #57 or #60 or #63 or #66 
69 #41 or #48 or #68 [ALL RESEARCH TERMS]
70 #44 and #69 [BASIC SEARCH]
Key: ab, abstract; ti, title; *, truncation.SSCI (BIDS ISI): 1989 – November 1999
All searches free text (searches look for search string in keyword, title and abstract fields). A facility for
searching for keywords only was not available through the BIDS ISI platform. Search strings were also
restricted in length.
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Set Search 
1 consumer participation
2 lay participation 
3 consumer involvement 
4 consumer* 
5 consumer advocacy 
6 consumer group* 
7 consumer organization* 
8 consumer organisation* 
9 self help group* 
10 public opinion 
11 public debate* 
12 stakeholder* 
13 lay involvement 
14 patient group* 
15 research charit* 
16 user group* 
17 patient organization* 
18 patient organisation* 
19 patient bod* 
20 research 
21 research agenda* 
22 research priorit* 
23 agenda setting 
24 priority setting 
25 research program* 
26 delphi method* 
27 delphi technique* 
28 consensus method* 
29 consensus conference* 
30 consensus development conference* 
31 working group* 
32 advisory group* 
33 workshop* 
34 committee membership 
35 consultation round* 
36 consultation exercise* 
38 postal consultation* 
39 focus group* 
40 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
41 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19
43 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30
44 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39
45 43 or 44 [ALL SPECIFIC RESEARCH TERMS (excluding ‘research’)]
46 40 and 45 [1st SET CONSUMER TERMS COMBINED WITH RESEARCH TERMS]
47 41 and 45 [2nd set CONSUMER TERMS COMBINED WITH RESEARCH TERMS]
Key: *, truncation.ASSIA (Bowker Saur A & I): 1986 – August 1999
Consumer terms combined with research terms
Consumer terms not combined with research termsa
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Set Search 
1 ft = self help group*
2 ft = public opinion
3 ft = public debate*
4 ft = stakeholder*
5 ft = patient group*
6 su = consumer*
7 su = consumer satisfaction
8 su = consumer products
9 su = consumer protection
10 cs = 7 or cs = 8 or cs = 9
11 cs = 6 not cs = 10
12 ft = user group*
13 ft = service user*
14 ft = consumer*
15 su = research*
16 su = medical research
17 ft = research priorit*
18 ft = research agenda*
19 ft = agenda setting
20 ft = priority setting
21 ft = delphi*
22 ft = consensus conference*
23 ft = research
26 cs = 15 or cs = 16 or cs = 17 or cs = 18 or cs = 19
27 cs = 20 or cs = 21 or cs = 22 or cs = 23 or cs = 26
[ALL CONSUMER TERMS]
28 cs = 1 or cs = 2 or cs = 3 or cs = 4 or cs = 5
29 cs = 11 or cs = 12 or cs = 13 or cs = 14 or cs = 28
[ALL RESEARCH TERMS]
30 cs = 29 and cs = 27
Key: ft, in title, abstract and controlled terms; su, controlled terms; cs, combine set; *, truncation.
No. Search string
1 ft=consultation exercise*
2 ft=consumer participation
3 ft=lay participation
4 ft=lay perspective*
7 ft=consumer involvement
11 ft=citizen* jur*
12 cs = 1 or cs = 2 or cs = 3 or cs = 4
13 cs = 7 or cs = 11 or cs = 12
a The Barker Saur database platform restricts the number of search strings for any one search, necessitating two separate
searches.Caredata: 1989 – June 1999
ERA database (held by EPPI-Centre)
Search term: ‘research priorities’.
Centre for Reviews and Dissemination Health Technology Assessment database
(via International Network of Agencies of HTA)
Search terms ‘consumer’ OR ‘consumers’.
Publications on the Internet (POINT) database published by the Department of
Health
Search terms ‘(consumer AND research) OR (user AND research) OR participation OR involvement’.
Handsearching
All conducted November 1999.
1. Abstracts of the 3rd International Conference on the Scientific Basis of Health Services.
2. Abstracts of the VII Cochrane Colloquium Conference.
3. Conference reports since 1989 of the International Society for Technology Assessment in Health Care
(via ISTAHC database, URL http://www.istahc.org/en/dataind.html, consumer in title or in abstract).
4. Oliver and Buchanan (1997, ADD full reference report to Standing Group Consumers in NHS
Research).56
5. C Grant-Pearce et al., (1998, ADD full reference PREST report).35
6. Dixon, Peart and Carr-Hill (1999, ADD full reference York Database). 
7. H Bastian, The power of sharing knowledge: consumer participation in the Cochrane Collaboration,
December 1994, ADD full reference.
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1 ‘user involvement’ AND ‘research’ in keywords field 
2( ‘research’ AND ‘report’) in abstract field AND ‘user involvement’ in keywords field
3( ‘research’ AND ‘review’) in abstract field AND ‘user involvement’ in keywords field
4(   ‘Priority’ OR ‘agenda’ OR ‘priorities’ OR ‘agendas’) in abstract field AND ‘user involvement’ in keywords
5 1 OR 2 OR 3 OR 4Health Technology Assessment 2004; Vol. 8: No. 15
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Appendix 2
Tabular synthesis of findingsA
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Type A Inviting consumer group involvement through collaborations
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
A.1 Committee membership
Power et al.,
199924
Case investigated in
more depth for UK
episodes (see
Chapter 5)
HEA Condition specific:
homelessness
UK, national Government-funded
body
Experience of
collaboration led to
research project
A.2 Teamworking
Lackey et al.,
199726
Centre for Health
Policy and
Programme
Evaluation,
University of
Wisconsin Medical
School
Activists from
grass roots
organisations,
service users,
volunteers
Evaluation of
empowerment
USA, local Academia Empowerment Consumer and
academic criteria
for evaluating
empowerment
A.3 International collaboration
Kelson, 199931 Cochrane Review
Groups
Consumer groups Condition specific International Academia Partnership Consumers
identifying patient-
defined outcomes
for some groups
Kelly, 199829 Cochrane
Musculoskeletal
Review Group
National consumer
groups
Condition specific:
musculoskeletal
problems
International Academia Partnership Consumer
suggestions for
research and ways
of collaborating
NHS Management
Executive, 200025
New and
Emerging
Technologies
Health
technologies
UK, national NHS R&D
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Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Ghersi et al.,
199928
Four Cochrane
Review Groups
National review
groups
Condition specific:
musculoskeletal;
breast cancer;
HIV/AIDS;
consumers and
communication
International Academia Partnership
Hirst, 199730
Case investigated in
more depth for UK
episodes (see
Chapter 5)
Cochrane Diabetes
Review Group
National review
group: IDDT
Condition specific:
diabetes
International Academia Partnership
A.4 Combining collaboration and consultation
Oliver, 1995;32
NHS Management
Executive, 199533
NHS R&D
implementation of
research findings
Individual
consumers,
consumer
representatives
and community
groups
Service
development
UK, national NHS R&D Organisational
change
Consumers
identified:
promising methods
for involvement;
topics for research;
reflections on
agenda-setting
process
CRDC Advisory
Group on Mother
and Child Health,
1994;38 Trent
Regional Health
Authority, 1994;40
NHS R&D
Directorate,
199439
NHS R&D Mother
and Child Health
Consumer groups
and individual
service users
Mother and child
health
UK, national NHS R&D Area with history
of consumer
involvement
Organisational
change
Research agenda
published without
detailing consumer
contributions
continuedA
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2
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Hills and Farrell,
200034
Department of
Health Health in
Partnership
Patient and carer
groups
Service
development
UK, national NHS R&D Partnership Research agenda
focus on lay
involvement in 3
areas: individual
treatment and
carers, service
development, lay
involvement in staff
training
Oliver, 199832
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS HTA National consumer
groups; journalist
Health technologies UK, national NHS R&D Organisational
change; learning
organisation
Three consumer
topics identified;
research priorities
published without
detailing consumer
contributions
Breckenridge,
199445
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D Primary
Dental Care
Members of public,
consumer groups
Dental care UK, national NHS R&D Organisational
change; learning
organisation
Identified areas of
concern to
consumers
Doble, 1999;36
Northern and
Yorkshire Regional
Research and
Development
Programme,
1999122–125
Case investigated in
more depth for UK
episodes (see
Chapter 5)
Northern and
Yorkshire Older
People 
Older people’s
groups
Population specific UK, regional NHS R&D Manager has
personal experience
of voluntary sector
Five topics
prioritised, without
specifying
contributions of
consumers. Grant
applications asked
for ‘recognition of
the user perspective’
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Type B Inviting consumer group involvement through consultation
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
B.1 Written consultations
NHS Management
Executive, 199447
NHS R&D Cancer 16 patient interest
groups
Condition specific:
cancer
UK, national NHS R&D Organisational
change
Research agenda
published without
detailing consumer
contributions
Advisory Group on
Setting Priorities in
Cardiovascular
Disease and
Stroke R&D,
undated46
NHS
Cardiovascular
Disease and
Stroke
Wide range of
consumer
organisations
Condition specific:
cardiovascular
disease and stroke
UK, national NHS R&D Organisational
change
Research agenda
published without
detailing consumer
contributions
Chartered Society
of Physiotherapy,
199849
Chartered Society
of Physiotherapy
Recorded on
ASLIB
Service specific:
physiotherapy
UK, national Professional body
without allocated
research funding
Organisational
change
Consumer-
identified research
topics (not unique
to consumers)
Sleep and Clark,
1993;48 Sleep 
et al., 199543
NPEU: midwifery
research
Maternity
consumer groups
UK, national Academia Reflective
professional
practice
Research agenda
published without
detailing consumer
contributions
B.2 Single face-to-face consultations
Oliver, 199537
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D HTA National consumer
group
UK, national NHS R&D Manager had
experience of
consumer
involvement
Organisational
change
3 research topics
from consumer
group submitted to
the programme –
not prioritisedA
p
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4
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Poulton, 199451 Royal College of
Nursing
National consumer
groups
UK, national Professional body Organisational
change
Consumer-
suggested research
topics and views on
methods of
involvement
NHS Management
Executive, 1995;33
Oliver, 199537
NHS R&D
implementation of
research findings
Individual
consumers and
representatives of
consumer and
community groups
UK, national NHS R&D Organisational
change
Consumer-
identified research
topics, promising
methods for
consumer
involvement
Jeste et al., 199957 Geriatric mental
health
Advocacy groups Geriatric mental
health
USA, national Research agenda
published without
detailing consumer
contributions
B.3 Multiple face-to-face consultations
Rosenstock et al.,
199854
NIOSH ‘Stakeholders’, e.g.
employees
USA, national Professional body Health promotion,
community
development
Research agenda
published without
detailing consumer
contributions
NHS R&D,
undated55
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D Physical
and Complex
Disabilities
National consumer
organisations and
individual users and
carers
UK, national NHS R&D Organisational
change
Research agenda
published without
detailing consumer
contributions.
Lessons for
consumer
involvement
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Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Wiles and
Brownfoot,
1997;52 NHS
Executive North
Thames, 199653
North Thames
Inner City Health
Established
community groups
and voluntary
sector groups
UK, regional NHS R&D Consumers set
criteria for
prioritising; 3 broad
priorities outlined
and key messages
for research
Schibeci et al.,
199950
Public Perceptions
of Biotechnology,
Perth, Australia
Consumer groups
and voluntary
organisations
Biotechnology Australia, regional University Consumer
concerns about
broader contextual,
social and ethical
issues
B.4 Combining face-to-face and written consultations
NHS Management
Executive, 199459
NHS R&D
interface of
primary and
secondary care
National carers’
group
UK, national NHS R&D Organisational
change
Agenda item:
“systematic
evaluation of
patients’ and
carers’ needs and
views of services”
Department of
Health, 199560
NHS R&D Asthma Consumer groups
for asthma
UK, national NHS R&D Organisational
change
Research agenda
published without
detailing consumer
contributions
continuedA
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Type C Inviting individual consumer involvement through collaboration
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Schwab, 199761 Young people from
low-income
families
Teamworking –
participatory
action research
USA, local Academia Empowerment/
partnership/
power sharing
Young people
selecting and
framing issues for
own research
Glanz and
Neikrug, 199562
Gerontological
Research
Older people Training
programme
Israel, local Academia Empowerment Older people doing
own research;
articles published in
journals
Newroe and
Oskarsdottir,
199763
Consumer
Assistive
Technology
Transfer Network
Disabled people Committee
membership
USA, national Commercially and
publicly funded
research and
development
Consumerism,
partnership
Consumers defined
problems and
tested prototype
solutions
Alzheimer’s
Society, undated;64
Harvey, 200065
Alzheimer’s
Society
Alzheimer’s
patients and carers
Network, Internet
and training
UK, national Charity Consumer
priorities posted on
WWW to inform
research grant
applicants
Kimani et al.,
undated66
Case investigated in
more depth for UK
episodes (see
Chapter 5)
CABI Bioscience –
Integrative Pest
Management
Farmers Farmer
participatory
training and
research
Developing
countries, local
Academia Empowerment,
learning
organisation
Farmer identified
research topics.
Farmers become
‘active learners’
C.1 TeamworkingH
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Type D Inviting individual consumer involvement through consultation
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
European
Commission,
199368
European
Biotechnology
Representative
sample over age
15 years
Biotechnology International,
Europe
Ethics Public’s
preferences for
biotechnology
identified
Macer, 199469 Public attitudes
towards IVF,
genetic
engineering,
biotechnology
Representative
sample
Biotechnology Japan, national Ethics Public’s
preferences for
biotechnology
identified
D.2 Face-to-face encounters on a small scale
Cramer and
Iverson, 199970
Nebraska School
Health
‘Stakeholders’
including student,
parent
Setting specific:
schools
Canada, regional School Health
Authority
Health promotion/
community
development;
public
accountability
Research agenda
published without
detailing consumer
contributions
Hannah et al.,
199871
Conservation in
Madagascar
Farmers,
ecotourism
operators, forest
gatherers
Environmental
conservation
Developing
country, local
Academia Participatory
research
Identified research
needs without
detailing consumer
contributions
Wennberg et al.,
199372
Prostate Disease
PORT
Patients with
experience of the
disease
Focus group Academia Evidence informed
patient choice
Research agenda
published without
detailing consumer
contributions
Department of
Health, 199560
NHS R&D Asthma Patients Condition specific:
asthma
UK, national NHS R&D Organisational
change
Suggested
problems needing
R&D
D.1 Opinion pollsA
p
p
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x
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2
8
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Tallon et al.,
200073
Contract
researchers
Patients with
arthritis
UK, local Academia Evidence-informed
patient choice
Consumer-
identified priorities
Lane et al., 1997;76
Stone et al.,
199877
Rehabilitation
Engineering
Research Center
on Technology
Evaluation and
Transfer
‘Experienced’
technology users
USA Commercial Consumerism,
partnership
Consumer
priorities for
criteria for
evaluation
Batavia and
Hammer, 199078
Assistive devices
engineering
All users of
assistive
technology 
devices on panels
Face-to-face:
modified Delphi
method
Commercial Consumerism,
partnership
Evaluation criteria
incorporated by
research
programme
Griffin and Hauser,
199379
Various face-to-
face multiple
Individual product
users
Consumerism,
partnership
Evidence about
methods for
involving
consumers
Brienza et al.,
199575
Wheelchair
engineering
3 out of 7 in the
group were
individual
wheelchair users
Commercial Consumerism,
partnership
5 priorities set
D.3 Face-to-face encounters on a large scale
Joss and Durant,
199580
Various authorities Members of the
public
Participatory
democracy
Few research
topics identified
D.4 Combining face-to-face and written consultations
Dalziel and Fulop,
200074
Case investigated in
more depth for UK
episodes (see
Chapter 5)
NHS R&D SDO Consumer groups,
patients and carers
Service delivery UK, national NHS R&D ‘Listening’ Research agenda
published without
detailing consumer
contributions
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Type E Responding to consumer groups with collaborations
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Cohen et al.,
199981
Homeless research
programme in
New York
Advocates and
individual
homeless people
Condition specific:
homelessness
USA, local Academia Equal partnership Record of client
and staff research
preferences
E.1 Teamwork
The National
Breast Cancer
Coalition, 199484
and undated85
Breast cancer NBCC in USA Condition specific:
breast cancer
USA, national Government
programme
Social action Consumers
secured extra
funding for breast
cancer research;
National Action
plan – aim to
include consumers
at every level of
the decision-
making processes
Rich et al., 199886 Department of
Defense Breast
Cancer Research
Grassroots breast
cancer
organisations
nation-wide
USA, national Government
programme
Organisational
change
Human dimensions
of breast cancer
considered in
funding decisions
California Breast
Cancer
Organization83
California Breast
Cancer
Organisation
Breast cancer
survivors and
related
organisation
advocates
USA, regional Social action Consumers as one-
third of
membership of
Breast Cancer
Research Council –
enshrined in law
E.2 Multi-level participation designed in partnership with consumersA
p
p
e
n
d
i
x
 
2
1
3
0
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Parboosingh et al.,
199782
E.3 Consumer activism leading to organisational change and multilevel participation
Canadian Breast
Cancer Initiative
Breast cancer
survivors and their
families
Participatory
research approach
Survivor-driven
national network of
organisations and
individuals
established to,
amongst other
aims, increase
openness and
accountability in
the research
process
National Breast
Cancer Centre,
199858
NBCC in Australia Breast cancer Australia, national Ethos: consumer
involvement
throughout
programme
Research agenda
published without
detailing consumer
contributions
E.4 Community-based research
Rice et al., 199488 Contract social
scientists
Residential
community
Accident
prevention
UK, local Academia Social action Consumers
identified issues
and ‘commissioned’
researchers to do
project
Dunbar, 199189 Physicians HIV activists HIV Prior activist
experience
Social action Community
Research Initiative
– one idea to
design clinical trials
with patient input
Institute of
Medicine,
undated67
NIH Patients/their
families and
advocacy
Organisational
change
Recommendations
on processes for
involvement and
funding
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Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
Campbell, 1995;90
Sherr, 199591
UK Coalition of
People Living with
HIV/AIDS
Collaborating with
range of
professional
partners – HEA,
Royal Free
Hospital to set up
team working on
issue
Partnership
(implicit)
Research project Outcome of
lobbying on suicide
issues
Research project
Renfrew and
McCandish, 199292
National perinatal
epidemiology unit
National consumer
group: NCT
Breastfeeding UK, national Academia Completed
randomised
controlled trial,
shared learning
Maher, 1995;93
Bates and Evans,
199594
Maher committee National consumer
group: RAGE
Committee
membership
Research with
patient
involvement
Independent
researcher’s
review of
interaction
continuedA
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Type F Responding to consumer action with consultation
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Declercq, 199810 Maternity care National groups
and individuals
Condition specific:
pregnancy and
childbirth
UK, national Government
enquiry
Representational
democracy and
social action
Consumers putting
maternity care
reform on to
government
agenda. Led to
Department of
Health Expert
Maternity Group –
Changing
Childbirth Report
Roberts, 199995 Royal Commission
for new
reproductive
technologies,
Canadian
Government
Coalition of
women
Reproductive
technologies
Canada, national Government body Social action Framework of
R&D programme,
but no analysis of
the identified topicsH
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Type G Responding to consumer action with research
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Daugherty et al.,
199796
Clinical cancer
department
Patient Cancer USA, local Hospital Changed attitudes
in associated
research project
Butler and
Wadman, 199797
Cloning General public Cloning International Market research Social action Led to US- and
EU-commissioned
reviews on the
ethics of cloning
research
Aldous et al.,
1999;98 Balls,
199999
Cloning General public Cloning UK, national Market research Controversy and
publicity
G.1 Provoking research about patients’ views
Colquhoun and
Bunda, 1981;100
Stevens et al.,
1995102
Clinical research:
hyperactivity
Mothers of
hyperactive
children
Consumer-led
research
Collective social
action
Consumer
research and
subsequent
professional
research
Newburn, 1990;103
MacArthur et al.,
1990;104 Kitzinger,
1987;105 National
Research Register,
2001106
NHS R&D Mother
and Child Health
National consumer
group
Childbirth UK, national NHS R&D History of
campaigning and
research
experience
Collective social
action
Consumer priority
on national
research agenda
and commissioned
research project
McCoy et al.,
1992;107 Gibbs,
1982108
State Department
of Health and
Rehabilitative
Services
Women in the
local community
Lobbying Collective social
action
Epidemiological
study
G.2 Research matching consumers’ prioritiesA
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Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Age Concern
England, 1996;109
Hendry and
Entwistle, 1996110
Horton Taylor 
et al.; 1996;111 Age
Concern England,
undated112
Age Concern
England, 1995113
and undated114
Age Concern
England, 1995115
UK Department 
of Health
Age Concern Lobbying Controversy and
publicity
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Type H Consumer-led research programme
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
continued
Hanson, 1985116 National 
consumer group
Multiple sclerosis UK, national Consumer group History of
campaigning and
research
experience
Social action Article by
consumer –
national press
publicity
Harrington,
1992117
HIV activists AIDS vaccine Consumer activist Social action Consumer
identified research
topic – scientific
press publicity
Schopler, 1996118 National 
consumer group
Autism US, national Consumer group Social action Comparison of
consumer group
priorities with
national research
programme
Fise, 1992119 National 
consumer
federation
Indoor air
pollution
US, national Consumer group Social action Consumer
identified research
topic – press
publicity
Hirschfield et al.,
1997120
Consumer groups
and members of
the public
Depression US, national Consumer group Consumer-led
consensus
conference with
professionals
Social action Identified research
priorities
H.1 Consumer calls for researchA
p
p
e
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x
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3
6
Author(s) Participants Research focus Organisational setting Consumer involvement
Research Consumer Geographical Institutional Resources/ Theoretical Output
programme group(s) scope setting experience underpinning
The Mental Health
Foundation,
2000129
Case investigated in
more depth for UK
episodes (see
Chapter 5)
Mental Health
Foundation
Service users and
those who have
suffered mental
distress
Condition specific:
mental health
UK, national Charity, self-help
group
Empowerment
Equal opportunities
3 research topics
identified and
prioritised
Oliver, 199342
Case investigated in
more depth for UK
episodes (see
chapter 5)
NCT Maternity service
users/NCT
members
Condition specific:
pregnancy and
childbirth
UK, national Consumer group Social action 15 topics and 5
priorities
H.2 Consumer-controlled researchHealth Technology Assessment 2004; Vol. 8: No. 15
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us to transfer them to the website.
We look forward to hearing from you.